microRNA information: hsa-miR-182-5p
| Section | ID | link |
|---|---|---|
| Mature name: | hsa-miR-182-5p | miRbase |
| Accession: | MIMAT0000259 | miRbase |
| Precursor name: | hsa-mir-182 | miRbase |
| Precursor accession: | MI0000272 | miRbase |
| Symbol: | MIR182 | HGNC |
| RefSeq ID: | NR_029614 | GenBank |
| Sequence: | UUUGGCAAUGGUAGAACUCACACU |
Reported expression in cancers: hsa-miR-182-5p
| miRNA | cancer | regulation | reporting | PUBMED | method |
|---|---|---|---|---|---|
| hsa-miR-182-5p | bladder cancer | upregulation | "miR-182 is an important molecule in the regulation ......" | 24445397 | |
| hsa-miR-182-5p | breast cancer | upregulation | "MiR-182 is a member of the miR-183 cluster located ......" | 23333633 | Reverse transcription PCR; qPCR |
| hsa-miR-182-5p | breast cancer | upregulation | "Quantitative real-time PCR qRT-PCR was utilized to ......" | 23430586 | qPCR |
| hsa-miR-182-5p | breast cancer | upregulation | "To compare the carcinogenic process in tumors with ......" | 24810926 | qPCR |
| hsa-miR-182-5p | breast cancer | upregulation | "In this study up-regulation of miR-182 was validat ......" | 27476169 | |
| hsa-miR-182-5p | cervical and endocervical cancer | upregulation | "MicroRNA 182 plays an onco miRNA role in cervical ......" | 23313739 | |
| hsa-miR-182-5p | cervical and endocervical cancer | downregulation | "In present study we not only determine the miR-182 ......" | 26191165 | |
| hsa-miR-182-5p | colon cancer | upregulation | "Louis Medical Center miRNA profiles were determine ......" | 24865442 | Microarray; qPCR |
| hsa-miR-182-5p | colorectal cancer | upregulation | "Up regulation of miR 182 expression in colorectal ......" | 23474644 | qPCR |
| hsa-miR-182-5p | colorectal cancer | upregulation | "Enhanced miR 182 transcription is a predictor of p ......" | 24615484 | qPCR |
| hsa-miR-182-5p | colorectal cancer | upregulation | "microRNA 182 targets special AT rich sequence bind ......" | 24884732 | qPCR |
| hsa-miR-182-5p | colorectal cancer | upregulation | "In this study we investigated the status of miR-18 ......" | 25031782 | in situ hybridization |
| hsa-miR-182-5p | colorectal cancer | upregulation | "The oncogenetic properties of miR-182 have been de ......" | 25738520 | |
| hsa-miR-182-5p | gastric cancer | downregulation | "MicroRNA-182 miR-182 is significantly downregulate ......" | 25682742 | |
| hsa-miR-182-5p | head and neck cancer | upregulation | "To investigate the functional mechanism of microRN ......" | 27744260 | |
| hsa-miR-182-5p | kidney renal cell cancer | downregulation | "Downregulation of microRNA 182 5p contributes to r ......" | 24886554 | qPCR; RNA-Seq |
| hsa-miR-182-5p | kidney renal cell cancer | downregulation | "The purpose of our study was aimed to determine th ......" | 27468875 | qPCR |
| hsa-miR-182-5p | liver cancer | upregulation | "miR-182 is one of the most significantly up-regula ......" | 22681717 | qPCR |
| hsa-miR-182-5p | liver cancer | upregulation | "OncomiR miR 96 and miR 182 promote cell proliferat ......" | 25663355 | qPCR |
| hsa-miR-182-5p | liver cancer | upregulation | "Serum miR 182 and miR 331 3p as diagnostic and pro ......" | 25903466 | qPCR |
| hsa-miR-182-5p | liver cancer | upregulation | "The microRNA microarray was employed to search for ......" | 26126858 | Microarray |
| hsa-miR-182-5p | lung cancer | deregulation | "Four up-regulated microRNAs miR-210 miR-21 miR-31 ......" | 22672859 | |
| hsa-miR-182-5p | lung cancer | deregulation | "Using a recently published robust rank aggregation ......" | 23225545 | |
| hsa-miR-182-5p | lung squamous cell cancer | upregulation | "Microarray of expression of specific miRNAs in lun ......" | 24600991 | qPCR; Microarray |
| hsa-miR-182-5p | lung squamous cell cancer | upregulation | "Overexpression of microRNA-182 miR-182 is found in ......" | 25012722 | |
| hsa-miR-182-5p | melanoma | upregulation | "We find that miR-182 member of a miRNA cluster in ......" | 19188590 | |
| hsa-miR-182-5p | ovarian cancer | upregulation | "To identify the micro-ribonucleic acids miRNAs exp ......" | 24816756 | qPCR |
| hsa-miR-182-5p | prostate cancer | upregulation | "Recently miR-182 has been reported to be over-expr ......" | 23383207 | |
| hsa-miR-182-5p | prostate cancer | upregulation | "In the current study we report that miR-182 expres ......" | 23874837 | |
| hsa-miR-182-5p | prostate cancer | upregulation | "In this study we compared miRNA expression pattern ......" | 27109471 | RNA-Seq |
| hsa-miR-182-5p | sarcoma | upregulation | "MiRNA mimics or inhibitor were transfected for up- ......" | 25973950 |
Reported cancer pathway affected by hsa-miR-182-5p
| miRNA | cancer | pathway | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-182-5p | B cell lymphoma | Apoptosis pathway | "Mangiferin inhibition of proliferation and inducti ......" | 26870290 | MTT assay; Flow cytometry; Western blot |
| hsa-miR-182-5p | bladder cancer | Apoptosis pathway | "Onco-miR-182-5p has been reported to be over-expre ......" | 23226455 | Luciferase |
| hsa-miR-182-5p | breast cancer | Apoptosis pathway | "We aimed to evaluate the expression of microRNA-18 ......" | 23430586 | Flow cytometry; Cell migration assay; Luciferase; Western blot; MTT assay |
| hsa-miR-182-5p | breast cancer | cell cycle pathway | "The miRNA level was detected by LNA-based northern ......" | 25394902 | Luciferase; Flow cytometry; Colony formation; MTT assay; Wound Healing Assay; Western blot |
| hsa-miR-182-5p | breast cancer | Apoptosis pathway | "Knockdown of miR 182 promotes apoptosis via regula ......" | 27476169 | Western blot |
| hsa-miR-182-5p | breast cancer | cell cycle pathway | "MiR 182 promotes proliferation and invasion and el ......" | 27648365 | |
| hsa-miR-182-5p | cervical and endocervical cancer | cell cycle pathway; Apoptosis pathway | "MicroRNA 182 plays an onco miRNA role in cervical ......" | 23313739 | Western blot; Flow cytometry |
| hsa-miR-182-5p | cervical and endocervical cancer | Apoptosis pathway | "miR 182 induces cervical cancer cell apoptosis thr ......" | 26191165 | |
| hsa-miR-182-5p | colorectal cancer | Epithelial mesenchymal transition pathway | "microRNA 182 targets special AT rich sequence bind ......" | 24884732 | Colony formation; Luciferase; Western blot |
| hsa-miR-182-5p | glioblastoma | Apoptosis pathway | "miR 182 integrates apoptosis growth and differenti ......" | 25838542 | |
| hsa-miR-182-5p | glioblastoma | Apoptosis pathway | "Our group has been studying the role of miR-182 in ......" | 26506113 | |
| hsa-miR-182-5p | kidney renal cell cancer | Apoptosis pathway | "Herein we sought to investigate the impact of gemc ......" | 25833690 | Western blot; MTT assay |
| hsa-miR-182-5p | lung cancer | cell cycle pathway | "microRNA 182 inhibits the proliferation and invasi ......" | 21503569 | Cell proliferation assay; Cell Proliferation Assay |
| hsa-miR-182-5p | lung squamous cell cancer | Apoptosis pathway | "Quantitative real-time PCR assay was employed to c ......" | 27073334 | Flow cytometry; Wound Healing Assay |
| hsa-miR-182-5p | melanoma | Apoptosis pathway | "Aberrant miR 182 expression promotes melanoma meta ......" | 19188590 | |
| hsa-miR-182-5p | melanoma | cell cycle pathway | "Role of microRNA 182 in posterior uveal melanoma: ......" | 22848417 | Western blot |
| hsa-miR-182-5p | ovarian cancer | cell cycle pathway; Apoptosis pathway | "MicroRNA 182 promotes cell growth invasion and che ......" | 23296900 | Colony formation |
| hsa-miR-182-5p | ovarian cancer | Apoptosis pathway | "Downregulation of DNMT3a expression increases miR ......" | 27748882 | |
| hsa-miR-182-5p | prostate cancer | cell cycle pathway | "Overexpressed microRNA 182 promotes proliferation ......" | 23874837 | |
| hsa-miR-182-5p | prostate cancer | Apoptosis pathway | "Androgen receptor regulated microRNA miR 182 5p pr ......" | 27109471 | |
| hsa-miR-182-5p | sarcoma | Apoptosis pathway | "Expression and regulatory effects of microRNA 182 ......" | 27123060 | Flow cytometry; Cell migration assay |
Reported cancer prognosis affected by hsa-miR-182-5p
| miRNA | cancer | prognosis | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-182-5p | acute myeloid leukemia | poor survival; drug resistance | "HDAC Inhibition Induces MicroRNA 182 which Targets ......" | 26858310 | Luciferase |
| hsa-miR-182-5p | bladder cancer | staging; poor survival; recurrence | "Expression levels of miRNAs were assessed by quant ......" | 23169479 | |
| hsa-miR-182-5p | bladder cancer | poor survival | "Onco-miR-182-5p has been reported to be over-expre ......" | 23226455 | Luciferase |
| hsa-miR-182-5p | bladder cancer | metastasis; progression; cell migration | "TGF β upregulates miR 182 expression to promote g ......" | 24445397 | |
| hsa-miR-182-5p | breast cancer | staging | "These five miRNAs were measured in an independent ......" | 20490652 | |
| hsa-miR-182-5p | breast cancer | drug resistance | "miR 182 mediated downregulation of BRCA1 impacts D ......" | 21195000 | |
| hsa-miR-182-5p | breast cancer | progression | "Expression profiling of 365 miRNA by real-time qua ......" | 21375733 | |
| hsa-miR-182-5p | breast cancer | malignant trasformation | "Through immunohistochemistry analyses of tissue mi ......" | 22086602 | |
| hsa-miR-182-5p | breast cancer | tumorigenesis | "Up regulation of miR 182 by β catenin in breast c ......" | 23333633 | Western blot; Colony formation |
| hsa-miR-182-5p | breast cancer | metastasis; malignant trasformation; motility; worse prognosis | "Suppression of MIM by microRNA 182 activates RhoA ......" | 23474751 | |
| hsa-miR-182-5p | breast cancer | poor survival | "An independent dataset validated our findings for ......" | 24398324 | |
| hsa-miR-182-5p | breast cancer | metastasis | "The objective of the present study is to evaluate ......" | 25369070 | |
| hsa-miR-182-5p | breast cancer | poor survival | "The miRNA level was detected by LNA-based northern ......" | 25394902 | Luciferase; Flow cytometry; Colony formation; MTT assay; Wound Healing Assay; Western blot |
| hsa-miR-182-5p | breast cancer | metastasis | "Here we show that breast cancer metastasis can be ......" | 27641360 | |
| hsa-miR-182-5p | breast cancer | progression | "MiR 182 promotes proliferation and invasion and el ......" | 27648365 | |
| hsa-miR-182-5p | cervical and endocervical cancer | staging | "MicroRNA 182 plays an onco miRNA role in cervical ......" | 23313739 | Western blot; Flow cytometry |
| hsa-miR-182-5p | colon cancer | tumorigenesis; poor survival | "The differential expressions of miR-9 miR-31 and m ......" | 23019418 | |
| hsa-miR-182-5p | colon cancer | metastasis | "Effects of anti miR 182 on TSP 1 expression in hum ......" | 24053448 | |
| hsa-miR-182-5p | colon cancer | poor survival | "Louis Medical Center miRNA profiles were determine ......" | 24865442 | |
| hsa-miR-182-5p | colorectal cancer | worse prognosis; staging; metastasis; tumor size; poor survival; progression | "Up regulation of miR 182 expression in colorectal ......" | 23474644 | |
| hsa-miR-182-5p | colorectal cancer | poor survival; staging; metastasis; progression | "Enhanced miR 182 transcription is a predictor of p ......" | 24615484 | |
| hsa-miR-182-5p | colorectal cancer | metastasis; cell migration; tumorigenesis | "microRNA 182 targets special AT rich sequence bind ......" | 24884732 | Colony formation; Luciferase; Western blot |
| hsa-miR-182-5p | colorectal cancer | staging; metastasis; poor survival; worse prognosis | "In this study we investigated the status of miR-18 ......" | 25031782 | |
| hsa-miR-182-5p | colorectal cancer | progression; metastasis; tumorigenesis | "Circulating miR 182 is a biomarker of colorectal a ......" | 25115394 | |
| hsa-miR-182-5p | colorectal cancer | worse prognosis | "Screening miRNAs for early diagnosis of colorectal ......" | 27022275 | |
| hsa-miR-182-5p | endometrial cancer | malignant trasformation | "Expression profiling of normal and malignant endom ......" | 20028871 | |
| hsa-miR-182-5p | gastric cancer | staging | "miR-32 miR-182 and miR-143 dysregulated expression ......" | 21874264 | |
| hsa-miR-182-5p | gastric cancer | progression | "MicroRNA 182 inhibits proliferation through target ......" | 25682742 | Colony formation |
| hsa-miR-182-5p | gastric cancer | poor survival | "Then we further investigated these GC specific miR ......" | 27173517 | |
| hsa-miR-182-5p | glioblastoma | differentiation; poor survival | "miR 182 integrates apoptosis growth and differenti ......" | 25838542 | |
| hsa-miR-182-5p | glioblastoma | progression; drug resistance; worse prognosis; differentiation | "Our group has been studying the role of miR-182 in ......" | 26506113 | |
| hsa-miR-182-5p | head and neck cancer | recurrence | "Overexpression of TP53 mutation associated microRN ......" | 27744260 | Luciferase |
| hsa-miR-182-5p | kidney renal cell cancer | progression | "Downregulation of microRNA 182 5p contributes to r ......" | 24886554 | Flow cytometry; Colony formation; Western blot; Luciferase |
| hsa-miR-182-5p | kidney renal cell cancer | cell migration | "MicroRNA 182 suppresses clear cell renal cell carc ......" | 27468875 | Colony formation; Western blot; Luciferase |
| hsa-miR-182-5p | liver cancer | metastasis; worse prognosis | "MicroRNA 182 downregulates metastasis suppressor 1 ......" | 22681717 | Western blot; Luciferase |
| hsa-miR-182-5p | liver cancer | tumorigenesis | "OncomiR miR 96 and miR 182 promote cell proliferat ......" | 25663355 | Western blot; Luciferase |
| hsa-miR-182-5p | liver cancer | malignant trasformation; staging; tumor size; poor survival | "Serum miR 182 and miR 331 3p as diagnostic and pro ......" | 25903466 | |
| hsa-miR-182-5p | lung cancer | tumorigenesis | "Hsa mir 182 suppresses lung tumorigenesis through ......" | 20420807 | |
| hsa-miR-182-5p | lung cancer | staging | "We searched the published literature for the miRNA ......" | 21904633 | |
| hsa-miR-182-5p | lung cancer | worse prognosis | "Gene expression of members of the miR-183 family m ......" | 21920043 | |
| hsa-miR-182-5p | lung cancer | progression; metastasis; staging | "Sp1 mediated microRNA 182 expression regulates lun ......" | 24519909 | |
| hsa-miR-182-5p | lung cancer | tumorigenesis | "The microRNA 182 PDK4 axis regulates lung tumorige ......" | 27641336 | |
| hsa-miR-182-5p | lung squamous cell cancer | metastasis | "The miRs were quantified by microarray hybridizati ......" | 22295063 | |
| hsa-miR-182-5p | lung squamous cell cancer | drug resistance | "MicroRNA 182 modulates chemosensitivity of human n ......" | 25012722 | Western blot; MTT assay |
| hsa-miR-182-5p | lung squamous cell cancer | staging | "Diagnostic Value of Serum miR 182 miR 183 miR 210 ......" | 27093275 | |
| hsa-miR-182-5p | melanoma | metastasis; poor survival; progression | "Aberrant miR 182 expression promotes melanoma meta ......" | 19188590 | |
| hsa-miR-182-5p | melanoma | drug resistance | "To improve uveal melanoma specificity of adenoviru ......" | 24001901 | Luciferase |
| hsa-miR-182-5p | ovarian cancer | metastasis; malignant trasformation | "MiR 182 overexpression in tumourigenesis of high g ......" | 22322863 | |
| hsa-miR-182-5p | ovarian cancer | drug resistance | "MicroRNA 182 promotes cell growth invasion and che ......" | 23296900 | Colony formation |
| hsa-miR-182-5p | ovarian cancer | poor survival | "Molecular bases of aberrant miR 182 expression in ......" | 27295517 | |
| hsa-miR-182-5p | ovarian cancer | drug resistance | "Downregulation of DNMT3a expression increases miR ......" | 27748882 | |
| hsa-miR-182-5p | pancreatic cancer | staging; metastasis; poor survival; worse prognosis | "Circulating microRNA 182 in plasma and its potenti ......" | 25326859 | |
| hsa-miR-182-5p | prostate cancer | staging | "We investigated the expression profiles of 6 micro ......" | 20873592 | |
| hsa-miR-182-5p | prostate cancer | poor survival; progression | "MicroRNA 182 5p promotes cell invasion and prolife ......" | 23383207 | Luciferase |
| hsa-miR-182-5p | prostate cancer | drug resistance | "Inhibition of proliferation and induction of autop ......" | 23936432 | |
| hsa-miR-182-5p | prostate cancer | worse prognosis; progression; poor survival | "Identification of miR 187 and miR 182 as biomarker ......" | 24518785 | |
| hsa-miR-182-5p | prostate cancer | tumor size; progression | "Hypoxia inducible miR 182 enhances HIF1α signalin ......" | 26205124 | |
| hsa-miR-182-5p | prostate cancer | metastasis; progression; recurrence | "MiR 182 Is Associated with Growth Migration and In ......" | 26640590 | Western blot |
| hsa-miR-182-5p | prostate cancer | progression; metastasis | "Androgen receptor regulated microRNA miR 182 5p pr ......" | 27109471 | |
| hsa-miR-182-5p | prostate cancer | poor survival | "In this regulatory network 10 genes BCL2 BNC2 CCND ......" | 27179774 | |
| hsa-miR-182-5p | sarcoma | metastasis | "MicroRNA 182 drives metastasis of primary sarcomas ......" | 25180607 | |
| hsa-miR-182-5p | sarcoma | metastasis; progression | "The Downregulation of MiR 182 Is Associated with t ......" | 25973950 | Cell migration assay |
Reported gene related to hsa-miR-182-5p
| miRNA | cancer | gene | reporting | PUBMED |
|---|---|---|---|---|
| hsa-miR-182-5p | breast cancer | PDCD4 | "The effects were accompanied by up-regulation of t ......" | 22086602 |
| hsa-miR-182-5p | lung cancer | PDCD4 | "In our study we found that microRNA-182 miR-182 wa ......" | 23877371 |
| hsa-miR-182-5p | lung squamous cell cancer | PDCD4 | "MicroRNA 182 modulates chemosensitivity of human n ......" | 25012722 |
| hsa-miR-182-5p | ovarian cancer | PDCD4 | "MicroRNA 182 promotes cell growth invasion and che ......" | 23296900 |
| hsa-miR-182-5p | cervical and endocervical cancer | FOXO1 | "Western blot flow cytometry and pathway analysis f ......" | 23313739 |
| hsa-miR-182-5p | colon cancer | FOXO1 | "Immunohistochemical analysis revealed that the lev ......" | 24865442 |
| hsa-miR-182-5p | prostate cancer | FOXO1 | "MiR 182 Is Associated with Growth Migration and In ......" | 26640590 |
| hsa-miR-182-5p | colon cancer | FOXO3 | "Immunohistochemical analysis revealed that the lev ......" | 24865442 |
| hsa-miR-182-5p | lung cancer | FOXO3 | "Sp1 increased expression of miR-182 which was then ......" | 24519909 |
| hsa-miR-182-5p | melanoma | FOXO3 | "Aberrant miR 182 expression promotes melanoma meta ......" | 19188590 |
| hsa-miR-182-5p | bladder cancer | RECK | "We also identified Smad4 and RECK as potential tar ......" | 23226455 |
| hsa-miR-182-5p | breast cancer | RECK | "In our previous results we demonstrated that miR-1 ......" | 27648365 |
| hsa-miR-182-5p | breast cancer | RECK | "Up regulation of miR 182 by β catenin in breast c ......" | 23333633 |
| hsa-miR-182-5p | B cell lymphoma | BCL2 | "The expression levels of B-cell lymphoma-2 Bcl-2 a ......" | 26870290 |
| hsa-miR-182-5p | prostate cancer | BCL2 | "Inhibition of proliferation and induction of autop ......" | 23936432 |
| hsa-miR-182-5p | cervical and endocervical cancer | DNMT3A | "miR 182 induces cervical cancer cell apoptosis thr ......" | 26191165 |
| hsa-miR-182-5p | ovarian cancer | DNMT3A | "Downregulation of DNMT3a expression increases miR ......" | 27748882 |
| hsa-miR-182-5p | breast cancer | MTSS1 | "Suppression of MIM by microRNA 182 activates RhoA ......" | 23474751 |
| hsa-miR-182-5p | liver cancer | MTSS1 | "MicroRNA 182 downregulates metastasis suppressor 1 ......" | 22681717 |
| hsa-miR-182-5p | liver cancer | RASA1 | "Hypoxia inducible MiR 182 promotes angiogenesis by ......" | 26126858 |
| hsa-miR-182-5p | lung squamous cell cancer | RASA1 | "Hsa mir 182 downregulates RASA1 and suppresses lun ......" | 24600991 |
| hsa-miR-182-5p | head and neck cancer | TP53 | "Overexpression of TP53 mutation associated microRN ......" | 27744260 |
| hsa-miR-182-5p | melanoma | TP53 | "Initially we demonstrated that miR-182 expression ......" | 22848417 |
| hsa-miR-182-5p | liver cancer | AFP | "Serum miR-182 was positively correlated with serum ......" | 25903466 |
| hsa-miR-182-5p | prostate cancer | AR | "Androgen receptor regulated microRNA miR 182 5p pr ......" | 27109471 |
| hsa-miR-182-5p | breast cancer | BRCA1 | "miR 182 mediated downregulation of BRCA1 impacts D ......" | 21195000 |
| hsa-miR-182-5p | bladder cancer | CADM1 | "TGF β upregulates miR 182 expression to promote g ......" | 24445397 |
| hsa-miR-182-5p | breast cancer | CASP8 | "We then demonstrated that knockdown of miR-182 up- ......" | 27476169 |
| hsa-miR-182-5p | breast cancer | CBX7 | "Augmentation of CBX7 by knockdown of miR-182 expre ......" | 21375733 |
| hsa-miR-182-5p | prostate cancer | CD36 | "Validation study using biopsy samples revealed tha ......" | 23184537 |
| hsa-miR-182-5p | thyroid cancer | CDC37 | "Bioinformatics analysis revealed close homolog of ......" | 24971532 |
| hsa-miR-182-5p | breast cancer | CDH1 | "Augmentation of CBX7 by knockdown of miR-182 expre ......" | 21375733 |
| hsa-miR-182-5p | lung cancer | CDH2 | "Knockdown of miR-182 inhibited lung cancer cells g ......" | 24519909 |
| hsa-miR-182-5p | liver cancer | CEBPA | "MiR 182 is up regulated and targeting Cebpa in hep ......" | 24653623 |
| hsa-miR-182-5p | thyroid cancer | CHL1 | "miR 182 targets CHL1 and controls tumor growth and ......" | 24971532 |
| hsa-miR-182-5p | lung cancer | CTTN | "A microRNA miR-182 was cloned and used to study th ......" | 21503569 |
| hsa-miR-182-5p | breast cancer | CYLD | "We then demonstrated that knockdown of miR-182 up- ......" | 27476169 |
| hsa-miR-182-5p | breast cancer | DDX5 | "We demonstrated that DDX5 regulated a subset of Mi ......" | 22086602 |
| hsa-miR-182-5p | prostate cancer | EGLN1 | "Hypoxia inducible miR 182 enhances HIF1α signalin ......" | 26205124 |
| hsa-miR-182-5p | colorectal cancer | ENTPD5 | "The inverse relation between miR-182 and the expre ......" | 25115394 |
| hsa-miR-182-5p | breast cancer | ESR1 | "Furthermore the serum levels of miR-182 in the est ......" | 24260062 |
| hsa-miR-182-5p | colorectal cancer | F2 | "miR 182 promotes cell growth and invasion by targe ......" | 25738520 |
| hsa-miR-182-5p | breast cancer | FBXW7 | "We further identified the E3 ubiquitin-protein lig ......" | 27648365 |
| hsa-miR-182-5p | kidney renal cell cancer | FLOT1 | "Moreover FLOT1 was confirmed as a target of miR-18 ......" | 24886554 |
| hsa-miR-182-5p | colorectal cancer | FOXF2 | "miR 182 promotes cell growth and invasion by targe ......" | 25738520 |
| hsa-miR-182-5p | breast cancer | GHR | "miR-96 and miR-182 also targeted GHR providing a p ......" | 25873390 |
| hsa-miR-182-5p | prostate cancer | GNA13 | "MicroRNA 182 and microRNA 200a control G protein s ......" | 23329838 |
| hsa-miR-182-5p | prostate cancer | GNB2 | "MicroRNA 182 and microRNA 200a control G protein s ......" | 23329838 |
| hsa-miR-182-5p | acute myeloid leukemia | HDAC1 | "The gene repressors HDAC1 and HDAC2 became recruit ......" | 26858310 |
| hsa-miR-182-5p | acute myeloid leukemia | HDAC2 | "The gene repressors HDAC1 and HDAC2 became recruit ......" | 26858310 |
| hsa-miR-182-5p | acute myeloid leukemia | HDAC9 | "HDAC Inhibition Induces MicroRNA 182 which Targets ......" | 26858310 |
| hsa-miR-182-5p | prostate cancer | HIF1AN | "Hypoxia inducible miR 182 enhances HIF1α signalin ......" | 26205124 |
| hsa-miR-182-5p | kidney renal cell cancer | IGF1R | "MicroRNA 182 suppresses clear cell renal cell carc ......" | 27468875 |
| hsa-miR-182-5p | liver cancer | IGF2 | "Forced expression of miR-96-5p and miR-182-5p in t ......" | 25739014 |
| hsa-miR-182-5p | liver cancer | IGFBP3 | "Forced expression of miR-96-5p and miR-182-5p in t ......" | 25739014 |
| hsa-miR-182-5p | liver cancer | KLRC1 | "Our findings suggest that miR-182 may augment NK-c ......" | 27262453 |
| hsa-miR-182-5p | liver cancer | KLRK1 | "Our findings suggest that miR-182 may augment NK-c ......" | 27262453 |
| hsa-miR-182-5p | ovarian cancer | LEP | "In this report we demonstrate that crosstalk betwe ......" | 23262295 |
| hsa-miR-182-5p | melanoma | MET | "The expression of oncogene c-Met and its downstrea ......" | 22848417 |
| hsa-miR-182-5p | melanoma | MITF | "In human tissues expression of miR-182 increases w ......" | 19188590 |
| hsa-miR-182-5p | prostate cancer | NDRG1 | "Additionally we demonstrated that miR-182 could do ......" | 23874837 |
| hsa-miR-182-5p | ovarian cancer | NUP214 | "In addition to these specific effects reversing th ......" | 20081105 |
| hsa-miR-182-5p | ovarian cancer | NYS3 | "We conclude that the aberrant miR-182 expression i ......" | 27295517 |
| hsa-miR-182-5p | breast cancer | PARP1 | "Conversely antagonizing miR-182 enhances BRCA1 lev ......" | 21195000 |
| hsa-miR-182-5p | lung cancer | PDK4 | "The microRNA 182 PDK4 axis regulates lung tumorige ......" | 27641336 |
| hsa-miR-182-5p | lung cancer | PDP1 | "Here we show that microRNA-182 miR-182 suppresses ......" | 27641336 |
| hsa-miR-182-5p | breast cancer | PFN1 | "We aimed to evaluate the expression of microRNA-18 ......" | 23430586 |
| hsa-miR-182-5p | breast cancer | PGR | "The serum levels of miR-182 in the progesterone re ......" | 24260062 |
| hsa-miR-182-5p | ovarian cancer | PRDM5 | "Deletion of the PRDM5 locus may play a supportive ......" | 27295517 |
| hsa-miR-182-5p | liver cancer | PRF1 | "Finally miR-182 was reported to induce NK-cell cyt ......" | 27262453 |
| hsa-miR-182-5p | acute myeloid leukemia | RAD51 | "HDAC Inhibition Induces MicroRNA 182 which Targets ......" | 26858310 |
| hsa-miR-182-5p | lung cancer | RGS17 | "Hsa mir 182 suppresses lung tumorigenesis through ......" | 20420807 |
| hsa-miR-182-5p | breast cancer | RHOA | "Suppression of MIM by microRNA 182 activates RhoA ......" | 23474751 |
| hsa-miR-182-5p | colorectal cancer | SATB2 | "Restoring SATB2 expression could reverse the effec ......" | 24884732 |
| hsa-miR-182-5p | bladder cancer | SMAD4 | "We also identified Smad4 and RECK as potential tar ......" | 23226455 |
| hsa-miR-182-5p | lung cancer | SP1 | "Sp1 mediated microRNA 182 expression regulates lun ......" | 24519909 |
| hsa-miR-182-5p | cervical and endocervical cancer | TBATA | "Spatial expression of miR-182 in cervical carcinom ......" | 23313739 |
| hsa-miR-182-5p | endometrial cancer | TCEAL7 | "The purpose of this study was to examine the role ......" | 24021963 |
| hsa-miR-182-5p | colon cancer | THBS1 | "Effects of anti miR 182 on TSP 1 expression in hum ......" | 24053448 |
| hsa-miR-182-5p | sarcoma | TIAM1 | "The Downregulation of MiR 182 Is Associated with t ......" | 25973950 |
| hsa-miR-182-5p | breast cancer | TNF | "Knockdown of miR 182 promotes apoptosis via regula ......" | 27476169 |
| hsa-miR-182-5p | breast cancer | UBE2K | "We further identified the E3 ubiquitin-protein lig ......" | 27648365 |
| hsa-miR-182-5p | gastric cancer | ZFAND4 | "MicroRNA 182 inhibits proliferation through target ......" | 25682742 |
Expression profile in cancer corhorts:
Putative target regulations
| miRNA | Gene | Cancer | Interaction | Correlation beta |
|---|---|---|---|---|
hsa-miR-182-5p | ANO6 | 15 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.069; TCGA BRCA -0.218; TCGA CESC -0.099; TCGA ESCA -0.107; TCGA HNSC -0.132; TCGA KIRP -0.054; TCGA LGG -0.083; TCGA LUAD -0.187; TCGA LUSC -0.18; TCGA PAAD -0.192; TCGA PRAD -0.441; TCGA SARC -0.065; TCGA THCA -0.134; TCGA STAD -0.159; TCGA UCEC -0.231 |
hsa-miR-182-5p | CBX6 | 11 cancers: BLCA; BRCA; CESC; COAD; KIRC; LUAD; OV; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.188; TCGA BRCA -0.146; TCGA CESC -0.129; TCGA COAD -0.273; TCGA KIRC -0.074; TCGA LUAD -0.175; TCGA OV -0.091; TCGA PAAD -0.205; TCGA PRAD -0.332; TCGA STAD -0.423; TCGA UCEC -0.287 |
hsa-miR-182-5p | CDKN1A | 9 cancers: BLCA; BRCA; ESCA; HNSC; LUAD; LUSC; OV; PRAD; SARC | miRNAWalker2 validate | TCGA BLCA -0.109; TCGA BRCA -0.114; TCGA ESCA -0.114; TCGA HNSC -0.082; TCGA LUAD -0.191; TCGA LUSC -0.253; TCGA OV -0.125; TCGA PRAD -0.193; TCGA SARC -0.101 |
hsa-miR-182-5p | CYLD | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate; miRTarBase; miRNATAP | TCGA BLCA -0.17; TCGA BRCA -0.053; TCGA CESC -0.165; TCGA COAD -0.069; TCGA ESCA -0.104; TCGA HNSC -0.205; TCGA LGG -0.051; TCGA LUAD -0.143; TCGA LUSC -0.262; TCGA PAAD -0.089; TCGA PRAD -0.167; TCGA THCA -0.061; TCGA STAD -0.131; TCGA UCEC -0.087 |
hsa-miR-182-5p | FMNL3 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.151; TCGA BRCA -0.113; TCGA CESC -0.097; TCGA COAD -0.146; TCGA ESCA -0.137; TCGA HNSC -0.081; TCGA KIRC -0.114; TCGA KIRP -0.116; TCGA LUAD -0.196; TCGA LUSC -0.256; TCGA PAAD -0.237; TCGA PRAD -0.131; TCGA STAD -0.116; TCGA UCEC -0.108 |
hsa-miR-182-5p | FOXO1 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate; miRTarBase; miRNATAP | TCGA BLCA -0.128; TCGA BRCA -0.41; TCGA CESC -0.154; TCGA COAD -0.219; TCGA ESCA -0.11; TCGA HNSC -0.215; TCGA KIRP -0.109; TCGA LGG -0.059; TCGA LIHC -0.159; TCGA LUAD -0.275; TCGA LUSC -0.204; TCGA OV -0.145; TCGA PAAD -0.237; TCGA PRAD -0.272; TCGA SARC -0.085; TCGA STAD -0.099; TCGA UCEC -0.249 |
hsa-miR-182-5p | MITF | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | TCGA BLCA -0.46; TCGA BRCA -0.291; TCGA CESC -0.205; TCGA COAD -0.414; TCGA ESCA -0.359; TCGA HNSC -0.355; TCGA LGG -0.131; TCGA LUAD -0.303; TCGA LUSC -0.512; TCGA PAAD -0.351; TCGA PRAD -0.332; TCGA SARC -0.237; TCGA STAD -0.389; TCGA UCEC -0.357 |
hsa-miR-182-5p | PCOLCE2 | 15 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.736; TCGA BRCA -1.111; TCGA COAD -0.347; TCGA HNSC -0.191; TCGA KIRC -0.441; TCGA KIRP -0.331; TCGA LIHC -0.118; TCGA LUAD -0.688; TCGA LUSC -0.26; TCGA OV -0.149; TCGA PAAD -0.389; TCGA PRAD -0.368; TCGA THCA -0.385; TCGA STAD -0.785; TCGA UCEC -0.406 |
hsa-miR-182-5p | RECK | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate; miRNATAP | TCGA BLCA -0.402; TCGA BRCA -0.419; TCGA CESC -0.305; TCGA COAD -0.263; TCGA ESCA -0.33; TCGA HNSC -0.278; TCGA KIRC -0.145; TCGA KIRP -0.123; TCGA LUAD -0.314; TCGA LUSC -0.466; TCGA OV -0.128; TCGA PAAD -0.419; TCGA PRAD -0.151; TCGA STAD -0.457; TCGA UCEC -0.4 |
hsa-miR-182-5p | SNAI2 | 13 cancers: BLCA; BRCA; CESC; COAD; KIRP; LIHC; LUAD; OV; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate; miRNATAP | TCGA BLCA -0.227; TCGA BRCA -0.311; TCGA CESC -0.351; TCGA COAD -0.189; TCGA KIRP -0.306; TCGA LIHC -0.104; TCGA LUAD -0.28; TCGA OV -0.211; TCGA PAAD -0.33; TCGA PRAD -0.578; TCGA THCA -0.165; TCGA STAD -0.091; TCGA UCEC -0.365 |
hsa-miR-182-5p | TSC22D3 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate; miRNATAP | TCGA BLCA -0.305; TCGA BRCA -0.055; TCGA CESC -0.177; TCGA COAD -0.272; TCGA ESCA -0.311; TCGA KIRC -0.181; TCGA KIRP -0.143; TCGA LIHC -0.105; TCGA LUAD -0.123; TCGA LUSC -0.399; TCGA PAAD -0.28; TCGA PRAD -0.204; TCGA THCA -0.153; TCGA STAD -0.423; TCGA UCEC -0.186 |
hsa-miR-182-5p | WIPF1 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.413; TCGA BRCA -0.205; TCGA CESC -0.239; TCGA COAD -0.268; TCGA ESCA -0.209; TCGA HNSC -0.197; TCGA KIRC -0.095; TCGA LUAD -0.237; TCGA LUSC -0.335; TCGA OV -0.075; TCGA PAAD -0.361; TCGA PRAD -0.311; TCGA SARC -0.055; TCGA THCA -0.252; TCGA STAD -0.204; TCGA UCEC -0.19 |
hsa-miR-182-5p | CNN3 | 15 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.156; TCGA BRCA -0.149; TCGA CESC -0.073; TCGA ESCA -0.11; TCGA HNSC -0.187; TCGA KIRP -0.103; TCGA LGG -0.075; TCGA LIHC -0.053; TCGA LUAD -0.082; TCGA LUSC -0.237; TCGA PAAD -0.338; TCGA PRAD -0.188; TCGA THCA -0.111; TCGA STAD -0.203; TCGA UCEC -0.139 |
hsa-miR-182-5p | SGMS2 | 15 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; OV; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.344; TCGA BRCA -0.25; TCGA COAD -0.12; TCGA ESCA -0.289; TCGA HNSC -0.227; TCGA KIRP -0.092; TCGA LGG -0.156; TCGA LIHC -0.056; TCGA LUAD -0.18; TCGA LUSC -0.625; TCGA OV -0.08; TCGA SARC -0.217; TCGA THCA -0.346; TCGA STAD -0.115; TCGA UCEC -0.126 |
hsa-miR-182-5p | RGS5 | 14 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.238; TCGA BRCA -0.117; TCGA COAD -0.208; TCGA ESCA -0.391; TCGA HNSC -0.196; TCGA KIRC -0.311; TCGA KIRP -0.318; TCGA LUAD -0.209; TCGA LUSC -0.472; TCGA OV -0.073; TCGA PRAD -0.182; TCGA SARC -0.148; TCGA STAD -0.431; TCGA UCEC -0.283 |
hsa-miR-182-5p | PDPN | 14 cancers: BLCA; BRCA; CESC; COAD; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.344; TCGA BRCA -0.269; TCGA CESC -0.295; TCGA COAD -0.382; TCGA KIRP -0.271; TCGA LGG -0.237; TCGA LUAD -0.408; TCGA LUSC -0.293; TCGA OV -0.16; TCGA PAAD -0.721; TCGA PRAD -0.418; TCGA THCA -0.481; TCGA STAD -0.139; TCGA UCEC -0.294 |
hsa-miR-182-5p | NID1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.295; TCGA BRCA -0.222; TCGA CESC -0.155; TCGA COAD -0.262; TCGA ESCA -0.213; TCGA HNSC -0.128; TCGA KIRC -0.176; TCGA KIRP -0.264; TCGA LUAD -0.141; TCGA OV -0.088; TCGA PAAD -0.351; TCGA PRAD -0.453; TCGA SARC -0.124; TCGA STAD -0.242; TCGA UCEC -0.265 |
hsa-miR-182-5p | SETX | 10 cancers: BLCA; BRCA; CESC; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.11; TCGA BRCA -0.07; TCGA CESC -0.072; TCGA HNSC -0.052; TCGA KIRP -0.059; TCGA LUAD -0.081; TCGA LUSC -0.074; TCGA PAAD -0.068; TCGA PRAD -0.102; TCGA UCEC -0.074 |
hsa-miR-182-5p | BNC2 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.718; TCGA BRCA -0.254; TCGA CESC -0.321; TCGA COAD -0.633; TCGA ESCA -0.416; TCGA HNSC -0.423; TCGA LGG -0.074; TCGA LUAD -0.299; TCGA LUSC -0.492; TCGA PAAD -0.666; TCGA PRAD -0.536; TCGA SARC -0.07; TCGA THCA -0.41; TCGA STAD -0.663; TCGA UCEC -0.671 |
hsa-miR-182-5p | ELMO1 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.302; TCGA BRCA -0.24; TCGA CESC -0.287; TCGA COAD -0.214; TCGA ESCA -0.134; TCGA HNSC -0.174; TCGA KIRC -0.221; TCGA KIRP -0.134; TCGA LIHC -0.064; TCGA LUAD -0.249; TCGA LUSC -0.268; TCGA OV -0.193; TCGA PAAD -0.16; TCGA PRAD -0.208; TCGA SARC -0.082; TCGA STAD -0.198; TCGA UCEC -0.16 |
hsa-miR-182-5p | BMPER | 12 cancers: BLCA; BRCA; HNSC; KIRC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.31; TCGA BRCA -0.637; TCGA HNSC -0.234; TCGA KIRC -0.146; TCGA LIHC -0.208; TCGA LUAD -0.394; TCGA LUSC -0.448; TCGA OV -0.14; TCGA PAAD -0.6; TCGA PRAD -0.615; TCGA STAD -0.734; TCGA UCEC -0.542 |
hsa-miR-182-5p | EDIL3 | 13 cancers: BLCA; BRCA; CESC; COAD; HNSC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.293; TCGA BRCA -0.154; TCGA CESC -0.317; TCGA COAD -0.235; TCGA HNSC -0.224; TCGA LUAD -0.295; TCGA LUSC -0.338; TCGA OV -0.166; TCGA PAAD -0.394; TCGA PRAD -0.719; TCGA SARC -0.293; TCGA STAD -0.237; TCGA UCEC -0.426 |
hsa-miR-182-5p | COL4A4 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.363; TCGA BRCA -0.336; TCGA CESC -0.185; TCGA COAD -0.263; TCGA ESCA -0.509; TCGA HNSC -0.166; TCGA KIRP -0.131; TCGA LUAD -0.177; TCGA LUSC -0.56; TCGA PAAD -0.382; TCGA PRAD -0.383; TCGA THCA -0.141; TCGA STAD -0.361; TCGA UCEC -0.316 |
hsa-miR-182-5p | ADAMTS4 | 13 cancers: BLCA; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; UCEC | MirTarget | TCGA BLCA -0.424; TCGA COAD -0.352; TCGA ESCA -0.259; TCGA HNSC -0.179; TCGA KIRC -0.155; TCGA KIRP -0.274; TCGA LUAD -0.224; TCGA LUSC -0.227; TCGA OV -0.147; TCGA PAAD -0.276; TCGA PRAD -0.241; TCGA SARC -0.126; TCGA UCEC -0.096 |
hsa-miR-182-5p | PIK3R5 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.392; TCGA BRCA -0.108; TCGA CESC -0.253; TCGA COAD -0.336; TCGA ESCA -0.363; TCGA HNSC -0.236; TCGA LGG -0.096; TCGA LUAD -0.328; TCGA LUSC -0.574; TCGA PAAD -0.498; TCGA SARC -0.095; TCGA THCA -0.332; TCGA STAD -0.109 |
hsa-miR-182-5p | CD59 | 12 cancers: BLCA; BRCA; CESC; HNSC; LGG; LUAD; LUSC; OV; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.144; TCGA BRCA -0.17; TCGA CESC -0.083; TCGA HNSC -0.096; TCGA LGG -0.056; TCGA LUAD -0.136; TCGA LUSC -0.287; TCGA OV -0.057; TCGA PRAD -0.176; TCGA THCA -0.051; TCGA STAD -0.117; TCGA UCEC -0.067 |
hsa-miR-182-5p | SETD7 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; LUSC; PAAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.214; TCGA BRCA -0.12; TCGA CESC -0.16; TCGA COAD -0.096; TCGA ESCA -0.087; TCGA HNSC -0.167; TCGA LGG -0.052; TCGA LIHC -0.086; TCGA LUSC -0.148; TCGA PAAD -0.156; TCGA SARC -0.123; TCGA STAD -0.248; TCGA UCEC -0.319 |
hsa-miR-182-5p | SAMD4A | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.432; TCGA BRCA -0.416; TCGA CESC -0.182; TCGA COAD -0.25; TCGA ESCA -0.344; TCGA HNSC -0.229; TCGA LIHC -0.117; TCGA LUAD -0.218; TCGA LUSC -0.472; TCGA PAAD -0.305; TCGA PRAD -0.293; TCGA THCA -0.088; TCGA STAD -0.44; TCGA UCEC -0.348 |
hsa-miR-182-5p | OPTN | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.171; TCGA BRCA -0.204; TCGA CESC -0.154; TCGA COAD -0.076; TCGA ESCA -0.118; TCGA HNSC -0.09; TCGA KIRC -0.086; TCGA KIRP -0.072; TCGA LGG -0.081; TCGA LUAD -0.131; TCGA LUSC -0.19; TCGA PRAD -0.251; TCGA SARC -0.093; TCGA THCA -0.083; TCGA STAD -0.074; TCGA UCEC -0.084 |
hsa-miR-182-5p | PAPPA | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.341; TCGA BRCA -0.215; TCGA CESC -0.257; TCGA COAD -0.378; TCGA ESCA -0.252; TCGA HNSC -0.242; TCGA LUSC -0.275; TCGA OV -0.308; TCGA PAAD -0.423; TCGA PRAD -0.501; TCGA SARC -0.228; TCGA THCA -0.323; TCGA STAD -0.178; TCGA UCEC -0.546 |
hsa-miR-182-5p | CALD1 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.572; TCGA BRCA -0.255; TCGA CESC -0.194; TCGA COAD -0.427; TCGA ESCA -0.32; TCGA HNSC -0.114; TCGA KIRC -0.06; TCGA KIRP -0.084; TCGA LGG -0.069; TCGA LUAD -0.229; TCGA LUSC -0.281; TCGA PAAD -0.44; TCGA PRAD -0.442; TCGA SARC -0.209; TCGA THCA -0.111; TCGA STAD -0.64; TCGA UCEC -0.379 |
hsa-miR-182-5p | GIMAP1 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; UCEC | MirTarget | TCGA BLCA -0.367; TCGA BRCA -0.318; TCGA CESC -0.335; TCGA COAD -0.336; TCGA ESCA -0.406; TCGA HNSC -0.309; TCGA KIRC -0.212; TCGA KIRP -0.135; TCGA LGG -0.065; TCGA LIHC -0.056; TCGA LUAD -0.406; TCGA LUSC -0.592; TCGA OV -0.105; TCGA PAAD -0.326; TCGA PRAD -0.137; TCGA SARC -0.135; TCGA UCEC -0.269 |
hsa-miR-182-5p | PRICKLE2 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.403; TCGA BRCA -0.184; TCGA CESC -0.117; TCGA COAD -0.286; TCGA ESCA -0.361; TCGA HNSC -0.134; TCGA KIRC -0.121; TCGA KIRP -0.052; TCGA LUAD -0.216; TCGA LUSC -0.386; TCGA PAAD -0.411; TCGA PRAD -0.559; TCGA SARC -0.105; TCGA STAD -0.674; TCGA UCEC -0.296 |
hsa-miR-182-5p | PIK3AP1 | 9 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LIHC; LUAD; LUSC; SARC | MirTarget | TCGA BLCA -0.392; TCGA BRCA -0.183; TCGA CESC -0.114; TCGA ESCA -0.165; TCGA HNSC -0.112; TCGA LIHC -0.06; TCGA LUAD -0.309; TCGA LUSC -0.408; TCGA SARC -0.151 |
hsa-miR-182-5p | TMEM47 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.135; TCGA BRCA -0.352; TCGA CESC -0.155; TCGA COAD -0.249; TCGA ESCA -0.391; TCGA HNSC -0.229; TCGA KIRC -0.093; TCGA LGG -0.07; TCGA LUAD -0.29; TCGA LUSC -0.402; TCGA PAAD -0.267; TCGA PRAD -0.354; TCGA SARC -0.208; TCGA STAD -0.514; TCGA UCEC -0.347 |
hsa-miR-182-5p | KLF13 | 9 cancers: BLCA; BRCA; CESC; HNSC; LUAD; LUSC; PAAD; PRAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.233; TCGA BRCA -0.192; TCGA CESC -0.11; TCGA HNSC -0.1; TCGA LUAD -0.256; TCGA LUSC -0.225; TCGA PAAD -0.17; TCGA PRAD -0.125; TCGA UCEC -0.101 |
hsa-miR-182-5p | KLF7 | 15 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.233; TCGA BRCA -0.192; TCGA CESC -0.227; TCGA COAD -0.219; TCGA HNSC -0.124; TCGA KIRC -0.116; TCGA KIRP -0.169; TCGA LUAD -0.068; TCGA LUSC -0.221; TCGA OV -0.08; TCGA PAAD -0.124; TCGA PRAD -0.337; TCGA SARC -0.107; TCGA STAD -0.306; TCGA UCEC -0.219 |
hsa-miR-182-5p | PLEKHH2 | 10 cancers: BLCA; BRCA; COAD; ESCA; LUAD; LUSC; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.233; TCGA BRCA -0.432; TCGA COAD -0.384; TCGA ESCA -0.296; TCGA LUAD -0.167; TCGA LUSC -0.389; TCGA PRAD -0.407; TCGA SARC -0.165; TCGA STAD -0.389; TCGA UCEC -0.365 |
hsa-miR-182-5p | RGL1 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.281; TCGA BRCA -0.365; TCGA CESC -0.124; TCGA COAD -0.243; TCGA ESCA -0.198; TCGA HNSC -0.069; TCGA KIRC -0.201; TCGA KIRP -0.175; TCGA LIHC -0.051; TCGA LUAD -0.102; TCGA LUSC -0.246; TCGA PAAD -0.301; TCGA PRAD -0.353; TCGA THCA -0.159; TCGA STAD -0.301; TCGA UCEC -0.191 |
hsa-miR-182-5p | NUAK1 | 10 cancers: BLCA; BRCA; COAD; KIRP; LUAD; OV; PAAD; PRAD; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.167; TCGA BRCA -0.166; TCGA COAD -0.249; TCGA KIRP -0.163; TCGA LUAD -0.148; TCGA OV -0.133; TCGA PAAD -0.292; TCGA PRAD -0.225; TCGA STAD -0.096; TCGA UCEC -0.205 |
hsa-miR-182-5p | PRKACB | 13 cancers: BLCA; CESC; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.141; TCGA CESC -0.138; TCGA ESCA -0.128; TCGA HNSC -0.192; TCGA KIRP -0.051; TCGA LIHC -0.073; TCGA LUAD -0.112; TCGA LUSC -0.139; TCGA OV -0.081; TCGA PRAD -0.072; TCGA SARC -0.071; TCGA STAD -0.28; TCGA UCEC -0.207 |
hsa-miR-182-5p | NTNG1 | 13 cancers: BLCA; BRCA; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.681; TCGA BRCA -0.255; TCGA ESCA -0.508; TCGA HNSC -0.181; TCGA KIRP -0.356; TCGA LGG -0.096; TCGA LUAD -0.606; TCGA LUSC -0.844; TCGA OV -0.442; TCGA PAAD -0.538; TCGA PRAD -0.166; TCGA STAD -0.827; TCGA UCEC -0.312 |
hsa-miR-182-5p | PPM1F | 13 cancers: BLCA; BRCA; CESC; COAD; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.127; TCGA BRCA -0.263; TCGA CESC -0.162; TCGA COAD -0.182; TCGA KIRC -0.197; TCGA KIRP -0.113; TCGA LUAD -0.241; TCGA LUSC -0.064; TCGA OV -0.103; TCGA PAAD -0.155; TCGA PRAD -0.096; TCGA STAD -0.158; TCGA UCEC -0.213 |
hsa-miR-182-5p | SH2D1A | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; SARC; THCA | MirTarget; miRNATAP | TCGA BLCA -0.373; TCGA BRCA -0.194; TCGA CESC -0.266; TCGA COAD -0.289; TCGA ESCA -0.372; TCGA HNSC -0.261; TCGA LUAD -0.23; TCGA LUSC -0.462; TCGA OV -0.189; TCGA PAAD -0.608; TCGA SARC -0.267; TCGA THCA -0.579 |
hsa-miR-182-5p | TNFAIP8 | 11 cancers: BLCA; BRCA; CESC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.078; TCGA BRCA -0.233; TCGA CESC -0.087; TCGA LGG -0.149; TCGA LUAD -0.137; TCGA LUSC -0.128; TCGA PAAD -0.166; TCGA PRAD -0.089; TCGA SARC -0.068; TCGA STAD -0.152; TCGA UCEC -0.084 |
hsa-miR-182-5p | ARRDC3 | 11 cancers: BLCA; BRCA; ESCA; HNSC; KIRP; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.072; TCGA BRCA -0.261; TCGA ESCA -0.182; TCGA HNSC -0.181; TCGA KIRP -0.078; TCGA LUSC -0.241; TCGA PAAD -0.132; TCGA PRAD -0.116; TCGA THCA -0.096; TCGA STAD -0.145; TCGA UCEC -0.081 |
hsa-miR-182-5p | LRCH1 | 12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.184; TCGA BRCA -0.155; TCGA CESC -0.115; TCGA ESCA -0.106; TCGA HNSC -0.112; TCGA KIRC -0.061; TCGA LIHC -0.067; TCGA LUAD -0.241; TCGA LUSC -0.231; TCGA PRAD -0.174; TCGA STAD -0.145; TCGA UCEC -0.22 |
hsa-miR-182-5p | NECAB1 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.574; TCGA BRCA -0.503; TCGA CESC -0.271; TCGA COAD -0.458; TCGA ESCA -0.339; TCGA HNSC -0.246; TCGA KIRC -0.099; TCGA LIHC -0.079; TCGA LUAD -0.554; TCGA LUSC -0.643; TCGA OV -0.167; TCGA PAAD -0.319; TCGA PRAD -0.6; TCGA SARC -0.142; TCGA STAD -0.865; TCGA UCEC -0.669 |
hsa-miR-182-5p | TSPAN9 | 11 cancers: BLCA; CESC; COAD; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.114; TCGA CESC -0.08; TCGA COAD -0.122; TCGA KIRC -0.068; TCGA KIRP -0.135; TCGA LIHC -0.1; TCGA LUAD -0.147; TCGA LUSC -0.08; TCGA PAAD -0.172; TCGA STAD -0.205; TCGA UCEC -0.074 |
hsa-miR-182-5p | L1CAM | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LUAD; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.668; TCGA BRCA -0.27; TCGA COAD -0.55; TCGA ESCA -0.461; TCGA HNSC -0.153; TCGA KIRP -0.325; TCGA LUAD -0.252; TCGA PAAD -0.295; TCGA PRAD -0.698; TCGA THCA -0.376; TCGA STAD -0.716; TCGA UCEC -0.169 |
hsa-miR-182-5p | MAP1B | 10 cancers: BLCA; BRCA; COAD; LGG; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; mirMAP; miRNATAP | TCGA BLCA -0.55; TCGA BRCA -0.305; TCGA COAD -0.361; TCGA LGG -0.052; TCGA OV -0.108; TCGA PAAD -0.204; TCGA PRAD -0.49; TCGA SARC -0.202; TCGA STAD -0.605; TCGA UCEC -0.169 |
hsa-miR-182-5p | GIT2 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.089; TCGA BRCA -0.073; TCGA CESC -0.092; TCGA COAD -0.065; TCGA ESCA -0.092; TCGA HNSC -0.098; TCGA KIRC -0.094; TCGA LUAD -0.095; TCGA LUSC -0.115; TCGA PAAD -0.135; TCGA PRAD -0.089; TCGA STAD -0.14; TCGA UCEC -0.074 |
hsa-miR-182-5p | MYH9 | 14 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; UCEC | MirTarget | TCGA BLCA -0.084; TCGA BRCA -0.088; TCGA CESC -0.094; TCGA COAD -0.131; TCGA HNSC -0.125; TCGA KIRP -0.083; TCGA LGG -0.052; TCGA LUAD -0.142; TCGA LUSC -0.101; TCGA OV -0.061; TCGA PAAD -0.118; TCGA PRAD -0.073; TCGA SARC -0.145; TCGA UCEC -0.095 |
hsa-miR-182-5p | PALLD | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUAD; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.564; TCGA BRCA -0.147; TCGA CESC -0.131; TCGA COAD -0.289; TCGA ESCA -0.158; TCGA HNSC -0.124; TCGA KIRP -0.121; TCGA LGG -0.052; TCGA LUAD -0.208; TCGA PAAD -0.271; TCGA PRAD -0.532; TCGA SARC -0.153; TCGA THCA -0.082; TCGA STAD -0.534; TCGA UCEC -0.216 |
hsa-miR-182-5p | RIMS3 | 10 cancers: BLCA; BRCA; CESC; HNSC; KIRP; LUSC; PRAD; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.197; TCGA BRCA -0.307; TCGA CESC -0.306; TCGA HNSC -0.204; TCGA KIRP -0.089; TCGA LUSC -0.326; TCGA PRAD -0.427; TCGA THCA -0.107; TCGA STAD -0.418; TCGA UCEC -0.336 |
hsa-miR-182-5p | SPAG9 | 10 cancers: BLCA; BRCA; COAD; HNSC; KIRC; LUAD; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.057; TCGA BRCA -0.123; TCGA COAD -0.106; TCGA HNSC -0.064; TCGA KIRC -0.095; TCGA LUAD -0.063; TCGA PAAD -0.11; TCGA PRAD -0.098; TCGA STAD -0.094; TCGA UCEC -0.135 |
hsa-miR-182-5p | BHLHE22 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD | MirTarget; miRNATAP | TCGA BLCA -0.125; TCGA BRCA -0.271; TCGA CESC -0.374; TCGA COAD -0.476; TCGA ESCA -0.363; TCGA HNSC -0.223; TCGA KIRP -0.368; TCGA LUAD -0.147; TCGA LUSC -0.421; TCGA OV -0.261; TCGA PAAD -0.385; TCGA PRAD -0.17; TCGA SARC -0.249; TCGA THCA -0.563; TCGA STAD -0.421 |
hsa-miR-182-5p | FAM107A | 15 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.481; TCGA BRCA -0.734; TCGA COAD -0.485; TCGA ESCA -0.673; TCGA HNSC -0.285; TCGA KIRC -0.152; TCGA KIRP -0.306; TCGA LIHC -0.155; TCGA LUAD -0.605; TCGA LUSC -0.958; TCGA PAAD -0.401; TCGA PRAD -0.569; TCGA SARC -0.158; TCGA STAD -0.671; TCGA UCEC -0.202 |
hsa-miR-182-5p | SLCO2B1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; UCEC | MirTarget | TCGA BLCA -0.511; TCGA BRCA -0.206; TCGA CESC -0.289; TCGA COAD -0.23; TCGA ESCA -0.381; TCGA HNSC -0.356; TCGA LGG -0.06; TCGA LIHC -0.186; TCGA LUAD -0.424; TCGA LUSC -0.719; TCGA PAAD -0.434; TCGA PRAD -0.153; TCGA SARC -0.184; TCGA THCA -0.158; TCGA UCEC -0.168 |
hsa-miR-182-5p | SLCO3A1 | 10 cancers: BLCA; BRCA; COAD; LGG; LUAD; OV; PAAD; PRAD; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.151; TCGA BRCA -0.223; TCGA COAD -0.134; TCGA LGG -0.088; TCGA LUAD -0.187; TCGA OV -0.08; TCGA PAAD -0.121; TCGA PRAD -0.435; TCGA STAD -0.08; TCGA UCEC -0.093 |
hsa-miR-182-5p | RDX | 11 cancers: BLCA; BRCA; COAD; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.115; TCGA BRCA -0.203; TCGA COAD -0.253; TCGA KIRC -0.081; TCGA KIRP -0.094; TCGA LUAD -0.106; TCGA LUSC -0.125; TCGA PAAD -0.252; TCGA PRAD -0.117; TCGA STAD -0.287; TCGA UCEC -0.093 |
hsa-miR-182-5p | ELL2 | 11 cancers: BLCA; CESC; HNSC; KIRP; LIHC; LUSC; OV; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.199; TCGA CESC -0.123; TCGA HNSC -0.18; TCGA KIRP -0.114; TCGA LIHC -0.148; TCGA LUSC -0.169; TCGA OV -0.229; TCGA SARC -0.124; TCGA THCA -0.131; TCGA STAD -0.213; TCGA UCEC -0.103 |
hsa-miR-182-5p | THBS1 | 15 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.464; TCGA CESC -0.241; TCGA COAD -0.441; TCGA ESCA -0.31; TCGA HNSC -0.31; TCGA KIRP -0.267; TCGA LUAD -0.172; TCGA LUSC -0.513; TCGA OV -0.16; TCGA PAAD -0.618; TCGA PRAD -0.22; TCGA SARC -0.107; TCGA THCA -0.24; TCGA STAD -0.335; TCGA UCEC -0.307 |
hsa-miR-182-5p | EBF3 | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LUAD; PAAD; PRAD; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.268; TCGA BRCA -0.531; TCGA COAD -0.355; TCGA ESCA -0.456; TCGA HNSC -0.167; TCGA KIRC -0.323; TCGA LUAD -0.246; TCGA PAAD -0.434; TCGA PRAD -0.191; TCGA STAD -0.395; TCGA UCEC -0.351 |
hsa-miR-182-5p | EOMES | 11 cancers: BLCA; BRCA; CESC; COAD; LUAD; LUSC; OV; PAAD; SARC; THCA; UCEC | MirTarget | TCGA BLCA -0.335; TCGA BRCA -0.129; TCGA CESC -0.297; TCGA COAD -0.256; TCGA LUAD -0.219; TCGA LUSC -0.237; TCGA OV -0.198; TCGA PAAD -0.516; TCGA SARC -0.134; TCGA THCA -0.469; TCGA UCEC -0.146 |
hsa-miR-182-5p | BACH2 | 12 cancers: BLCA; BRCA; COAD; HNSC; KIRP; LUAD; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; mirMAP; miRNATAP | TCGA BLCA -0.441; TCGA BRCA -0.443; TCGA COAD -0.346; TCGA HNSC -0.143; TCGA KIRP -0.258; TCGA LUAD -0.262; TCGA OV -0.183; TCGA PAAD -0.403; TCGA PRAD -0.239; TCGA THCA -0.394; TCGA STAD -0.311; TCGA UCEC -0.394 |
hsa-miR-182-5p | ROCK1 | 12 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; LUAD; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.129; TCGA BRCA -0.079; TCGA ESCA -0.088; TCGA HNSC -0.06; TCGA KIRC -0.06; TCGA LUAD -0.074; TCGA PAAD -0.086; TCGA PRAD -0.149; TCGA SARC -0.122; TCGA THCA -0.112; TCGA STAD -0.146; TCGA UCEC -0.113 |
hsa-miR-182-5p | SLITRK4 | 15 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.49; TCGA BRCA -0.345; TCGA CESC -0.436; TCGA ESCA -0.375; TCGA HNSC -0.647; TCGA KIRC -0.228; TCGA KIRP -0.213; TCGA LUAD -0.317; TCGA LUSC -0.258; TCGA OV -0.249; TCGA PAAD -0.543; TCGA PRAD -0.362; TCGA SARC -0.135; TCGA STAD -0.551; TCGA UCEC -0.286 |
hsa-miR-182-5p | CORO1C | 10 cancers: BLCA; BRCA; COAD; LUAD; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.302; TCGA BRCA -0.202; TCGA COAD -0.056; TCGA LUAD -0.22; TCGA PAAD -0.215; TCGA PRAD -0.318; TCGA SARC -0.125; TCGA THCA -0.072; TCGA STAD -0.19; TCGA UCEC -0.149 |
hsa-miR-182-5p | DENND5B | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; PRAD; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.327; TCGA BRCA -0.153; TCGA COAD -0.216; TCGA ESCA -0.348; TCGA HNSC -0.253; TCGA KIRC -0.07; TCGA KIRP -0.128; TCGA LIHC -0.09; TCGA PRAD -0.175; TCGA STAD -0.076; TCGA UCEC -0.2 |
hsa-miR-182-5p | ATP10D | 10 cancers: BLCA; BRCA; CESC; HNSC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.222; TCGA BRCA -0.199; TCGA CESC -0.219; TCGA HNSC -0.19; TCGA LUAD -0.22; TCGA LUSC -0.22; TCGA PAAD -0.162; TCGA PRAD -0.297; TCGA STAD -0.102; TCGA UCEC -0.184 |
hsa-miR-182-5p | PTPRG | 11 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; STAD | MirTarget; miRNATAP | TCGA BLCA -0.196; TCGA BRCA -0.235; TCGA ESCA -0.214; TCGA HNSC -0.165; TCGA KIRC -0.13; TCGA KIRP -0.15; TCGA LUAD -0.186; TCGA LUSC -0.201; TCGA PAAD -0.229; TCGA PRAD -0.25; TCGA STAD -0.067 |
hsa-miR-182-5p | PCDH18 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.347; TCGA BRCA -0.451; TCGA CESC -0.21; TCGA COAD -0.163; TCGA ESCA -0.218; TCGA HNSC -0.288; TCGA KIRP -0.31; TCGA LGG -0.113; TCGA LUAD -0.213; TCGA LUSC -0.174; TCGA OV -0.151; TCGA PAAD -0.395; TCGA PRAD -0.442; TCGA SARC -0.094; TCGA THCA -0.112; TCGA STAD -0.162; TCGA UCEC -0.292 |
hsa-miR-182-5p | LPP | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.299; TCGA BRCA -0.157; TCGA CESC -0.083; TCGA COAD -0.157; TCGA ESCA -0.199; TCGA HNSC -0.096; TCGA KIRP -0.097; TCGA PAAD -0.225; TCGA PRAD -0.469; TCGA SARC -0.2; TCGA STAD -0.496; TCGA UCEC -0.138 |
hsa-miR-182-5p | TMEM150C | 10 cancers: BLCA; HNSC; KIRC; KIRP; LGG; LIHC; OV; PAAD; STAD; UCEC | MirTarget | TCGA BLCA -0.183; TCGA HNSC -0.125; TCGA KIRC -0.297; TCGA KIRP -0.432; TCGA LGG -0.133; TCGA LIHC -0.246; TCGA OV -0.078; TCGA PAAD -0.357; TCGA STAD -0.237; TCGA UCEC -0.102 |
hsa-miR-182-5p | SH3BGRL | 12 cancers: BLCA; CESC; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.221; TCGA CESC -0.175; TCGA ESCA -0.253; TCGA HNSC -0.156; TCGA KIRP -0.074; TCGA LUAD -0.194; TCGA LUSC -0.362; TCGA PAAD -0.13; TCGA PRAD -0.296; TCGA SARC -0.144; TCGA STAD -0.356; TCGA UCEC -0.204 |
hsa-miR-182-5p | VAMP3 | 11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LGG; LUAD; LUSC; PRAD; SARC; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.064; TCGA BRCA -0.113; TCGA CESC -0.114; TCGA ESCA -0.079; TCGA HNSC -0.111; TCGA LGG -0.089; TCGA LUAD -0.089; TCGA LUSC -0.185; TCGA PRAD -0.125; TCGA SARC -0.083; TCGA UCEC -0.146 |
hsa-miR-182-5p | ARHGAP6 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.212; TCGA BRCA -0.288; TCGA CESC -0.194; TCGA COAD -0.234; TCGA ESCA -0.452; TCGA HNSC -0.334; TCGA KIRP -0.133; TCGA LUAD -0.463; TCGA LUSC -0.673; TCGA PAAD -0.181; TCGA SARC -0.133; TCGA THCA -0.077; TCGA STAD -0.418; TCGA UCEC -0.588 |
hsa-miR-182-5p | CD226 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; UCEC | MirTarget | TCGA BLCA -0.426; TCGA BRCA -0.15; TCGA CESC -0.265; TCGA COAD -0.258; TCGA ESCA -0.287; TCGA HNSC -0.358; TCGA LGG -0.102; TCGA LUAD -0.234; TCGA LUSC -0.469; TCGA OV -0.117; TCGA PAAD -0.438; TCGA PRAD -0.258; TCGA SARC -0.182; TCGA THCA -0.456; TCGA UCEC -0.086 |
hsa-miR-182-5p | WWC2 | 14 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.205; TCGA BRCA -0.121; TCGA COAD -0.204; TCGA ESCA -0.186; TCGA HNSC -0.241; TCGA KIRP -0.177; TCGA LIHC -0.059; TCGA LUAD -0.312; TCGA LUSC -0.549; TCGA PAAD -0.226; TCGA PRAD -0.213; TCGA THCA -0.076; TCGA STAD -0.175; TCGA UCEC -0.166 |
hsa-miR-182-5p | PAFAH1B1 | 9 cancers: BLCA; BRCA; HNSC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.08; TCGA BRCA -0.094; TCGA HNSC -0.062; TCGA LUAD -0.064; TCGA LUSC -0.062; TCGA PAAD -0.064; TCGA PRAD -0.104; TCGA STAD -0.085; TCGA UCEC -0.075 |
hsa-miR-182-5p | MSN | 16 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.4; TCGA BRCA -0.243; TCGA CESC -0.263; TCGA COAD -0.265; TCGA HNSC -0.142; TCGA KIRC -0.051; TCGA LGG -0.163; TCGA LUAD -0.207; TCGA LUSC -0.244; TCGA OV -0.119; TCGA PAAD -0.307; TCGA PRAD -0.37; TCGA SARC -0.13; TCGA THCA -0.098; TCGA STAD -0.213; TCGA UCEC -0.145 |
hsa-miR-182-5p | FAM168A | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; PAAD; PRAD; STAD | MirTarget | TCGA BLCA -0.16; TCGA BRCA -0.097; TCGA CESC -0.115; TCGA COAD -0.117; TCGA ESCA -0.132; TCGA HNSC -0.091; TCGA KIRP -0.182; TCGA PAAD -0.201; TCGA PRAD -0.281; TCGA STAD -0.127 |
hsa-miR-182-5p | EGR3 | 11 cancers: BLCA; BRCA; ESCA; KIRP; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.52; TCGA BRCA -0.345; TCGA ESCA -0.185; TCGA KIRP -0.489; TCGA LUAD -0.367; TCGA LUSC -0.311; TCGA PAAD -0.217; TCGA PRAD -0.288; TCGA THCA -0.26; TCGA STAD -0.29; TCGA UCEC -0.155 |
hsa-miR-182-5p | AASS | 9 cancers: BLCA; BRCA; CESC; COAD; KIRC; LIHC; PAAD; STAD; UCEC | MirTarget | TCGA BLCA -0.116; TCGA BRCA -0.321; TCGA CESC -0.29; TCGA COAD -0.17; TCGA KIRC -0.118; TCGA LIHC -0.24; TCGA PAAD -0.219; TCGA STAD -0.365; TCGA UCEC -0.31 |
hsa-miR-182-5p | EPAS1 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.069; TCGA BRCA -0.362; TCGA CESC -0.1; TCGA COAD -0.09; TCGA ESCA -0.195; TCGA HNSC -0.136; TCGA KIRC -0.248; TCGA KIRP -0.186; TCGA LIHC -0.058; TCGA LUAD -0.32; TCGA LUSC -0.621; TCGA PAAD -0.156; TCGA PRAD -0.289; TCGA SARC -0.225; TCGA STAD -0.149; TCGA UCEC -0.183 |
hsa-miR-182-5p | WISP1 | 12 cancers: BLCA; CESC; COAD; ESCA; KIRP; LGG; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.392; TCGA CESC -0.275; TCGA COAD -0.42; TCGA ESCA -0.192; TCGA KIRP -0.321; TCGA LGG -0.152; TCGA OV -0.13; TCGA PAAD -0.561; TCGA PRAD -0.376; TCGA THCA -0.388; TCGA STAD -0.168; TCGA UCEC -0.281 |
hsa-miR-182-5p | PARM1 | 12 cancers: BLCA; BRCA; CESC; ESCA; KIRP; LGG; LUSC; OV; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.18; TCGA BRCA -0.288; TCGA CESC -0.259; TCGA ESCA -0.293; TCGA KIRP -0.376; TCGA LGG -0.096; TCGA LUSC -0.394; TCGA OV -0.099; TCGA PRAD -0.45; TCGA SARC -0.228; TCGA STAD -0.243; TCGA UCEC -0.275 |
hsa-miR-182-5p | ACVR1 | 9 cancers: BLCA; BRCA; CESC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.149; TCGA BRCA -0.09; TCGA CESC -0.067; TCGA PAAD -0.092; TCGA PRAD -0.075; TCGA SARC -0.057; TCGA THCA -0.099; TCGA STAD -0.071; TCGA UCEC -0.053 |
hsa-miR-182-5p | KDELC2 | 9 cancers: BLCA; BRCA; KIRC; KIRP; LGG; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.178; TCGA BRCA -0.165; TCGA KIRC -0.105; TCGA KIRP -0.134; TCGA LGG -0.052; TCGA PAAD -0.139; TCGA PRAD -0.271; TCGA STAD -0.105; TCGA UCEC -0.165 |
hsa-miR-182-5p | ARHGEF3 | 10 cancers: BLCA; CESC; HNSC; KIRP; LGG; LUAD; LUSC; PRAD; SARC; UCEC | MirTarget | TCGA BLCA -0.112; TCGA CESC -0.086; TCGA HNSC -0.096; TCGA KIRP -0.136; TCGA LGG -0.076; TCGA LUAD -0.163; TCGA LUSC -0.296; TCGA PRAD -0.077; TCGA SARC -0.075; TCGA UCEC -0.108 |
hsa-miR-182-5p | HBEGF | 9 cancers: BLCA; BRCA; KIRP; LGG; LUAD; LUSC; OV; PRAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.254; TCGA BRCA -0.288; TCGA KIRP -0.198; TCGA LGG -0.052; TCGA LUAD -0.41; TCGA LUSC -0.318; TCGA OV -0.096; TCGA PRAD -0.2; TCGA UCEC -0.174 |
hsa-miR-182-5p | PTGFR | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.775; TCGA BRCA -0.742; TCGA CESC -0.365; TCGA COAD -0.491; TCGA ESCA -0.589; TCGA HNSC -0.436; TCGA KIRP -0.246; TCGA LUAD -0.404; TCGA LUSC -0.67; TCGA OV -0.399; TCGA PAAD -0.629; TCGA PRAD -0.154; TCGA THCA -0.537; TCGA STAD -0.526; TCGA UCEC -0.802 |
hsa-miR-182-5p | JAZF1 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.445; TCGA BRCA -0.237; TCGA CESC -0.228; TCGA COAD -0.247; TCGA ESCA -0.291; TCGA HNSC -0.185; TCGA LUAD -0.214; TCGA LUSC -0.287; TCGA PAAD -0.121; TCGA PRAD -0.456; TCGA STAD -0.337; TCGA UCEC -0.237 |
hsa-miR-182-5p | GXYLT2 | 10 cancers: BLCA; BRCA; COAD; HNSC; LUAD; LUSC; PAAD; PRAD; THCA; STAD | MirTarget | TCGA BLCA -0.685; TCGA BRCA -0.164; TCGA COAD -0.214; TCGA HNSC -0.287; TCGA LUAD -0.101; TCGA LUSC -0.399; TCGA PAAD -0.658; TCGA PRAD -0.398; TCGA THCA -0.154; TCGA STAD -0.405 |
hsa-miR-182-5p | GNAQ | 10 cancers: BLCA; ESCA; HNSC; LUAD; LUSC; OV; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.095; TCGA ESCA -0.151; TCGA HNSC -0.086; TCGA LUAD -0.09; TCGA LUSC -0.224; TCGA OV -0.073; TCGA PRAD -0.061; TCGA SARC -0.078; TCGA STAD -0.11; TCGA UCEC -0.093 |
hsa-miR-182-5p | HMCN1 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; STAD | MirTarget | TCGA BLCA -0.327; TCGA BRCA -0.291; TCGA CESC -0.189; TCGA COAD -0.585; TCGA ESCA -0.292; TCGA HNSC -0.307; TCGA KIRC -0.3; TCGA KIRP -0.402; TCGA LUAD -0.304; TCGA LUSC -0.466; TCGA PAAD -0.581; TCGA PRAD -0.316; TCGA STAD -0.459 |
hsa-miR-182-5p | FMO2 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.648; TCGA BRCA -0.788; TCGA CESC -0.487; TCGA COAD -0.724; TCGA ESCA -0.372; TCGA HNSC -0.479; TCGA KIRC -0.366; TCGA KIRP -0.334; TCGA LIHC -0.164; TCGA LUAD -0.586; TCGA LUSC -0.729; TCGA OV -0.313; TCGA PAAD -0.355; TCGA PRAD -0.518; TCGA THCA -0.638; TCGA STAD -0.642; TCGA UCEC -0.3 |
hsa-miR-182-5p | MEF2C | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.364; TCGA BRCA -0.301; TCGA CESC -0.255; TCGA COAD -0.231; TCGA ESCA -0.385; TCGA HNSC -0.506; TCGA KIRC -0.172; TCGA KIRP -0.166; TCGA LGG -0.084; TCGA LUAD -0.16; TCGA LUSC -0.541; TCGA OV -0.136; TCGA PAAD -0.372; TCGA PRAD -0.36; TCGA SARC -0.106; TCGA STAD -0.358; TCGA UCEC -0.39 |
hsa-miR-182-5p | GLI2 | 11 cancers: BLCA; BRCA; COAD; KIRC; KIRP; LUAD; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.514; TCGA BRCA -0.292; TCGA COAD -0.434; TCGA KIRC -0.129; TCGA KIRP -0.366; TCGA LUAD -0.222; TCGA PAAD -0.322; TCGA PRAD -0.416; TCGA THCA -0.226; TCGA STAD -0.287; TCGA UCEC -0.402 |
hsa-miR-182-5p | APC | 13 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.074; TCGA BRCA -0.075; TCGA CESC -0.095; TCGA ESCA -0.063; TCGA HNSC -0.105; TCGA KIRC -0.07; TCGA KIRP -0.133; TCGA LUAD -0.122; TCGA LUSC -0.084; TCGA PAAD -0.09; TCGA PRAD -0.139; TCGA STAD -0.148; TCGA UCEC -0.096 |
hsa-miR-182-5p | BMPR1B | 11 cancers: BLCA; COAD; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; THCA; STAD | MirTarget | TCGA BLCA -0.352; TCGA COAD -0.437; TCGA ESCA -0.3; TCGA HNSC -0.151; TCGA KIRP -0.604; TCGA LGG -0.091; TCGA LUAD -0.186; TCGA LUSC -0.283; TCGA PAAD -0.312; TCGA THCA -0.302; TCGA STAD -0.775 |
hsa-miR-182-5p | MBNL2 | 16 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.068; TCGA BRCA -0.202; TCGA CESC -0.13; TCGA ESCA -0.141; TCGA HNSC -0.164; TCGA KIRP -0.063; TCGA LGG -0.104; TCGA LIHC -0.105; TCGA LUAD -0.088; TCGA LUSC -0.357; TCGA OV -0.09; TCGA PRAD -0.388; TCGA SARC -0.093; TCGA THCA -0.083; TCGA STAD -0.138; TCGA UCEC -0.229 |
hsa-miR-182-5p | RNF212 | 9 cancers: BLCA; BRCA; COAD; ESCA; KIRP; LUSC; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.381; TCGA BRCA -0.422; TCGA COAD -0.314; TCGA ESCA -0.267; TCGA KIRP -0.266; TCGA LUSC -0.244; TCGA PRAD -0.122; TCGA STAD -0.409; TCGA UCEC -0.346 |
hsa-miR-182-5p | LITAF | 10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LUAD; LUSC; OV; PAAD; UCEC | MirTarget | TCGA BLCA -0.155; TCGA BRCA -0.065; TCGA CESC -0.105; TCGA ESCA -0.118; TCGA HNSC -0.097; TCGA LUAD -0.12; TCGA LUSC -0.233; TCGA OV -0.105; TCGA PAAD -0.13; TCGA UCEC -0.108 |
hsa-miR-182-5p | MAN1A1 | 16 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.157; TCGA BRCA -0.192; TCGA CESC -0.274; TCGA ESCA -0.358; TCGA HNSC -0.423; TCGA KIRP -0.25; TCGA LGG -0.07; TCGA LIHC -0.105; TCGA LUAD -0.22; TCGA LUSC -0.488; TCGA OV -0.227; TCGA PRAD -0.355; TCGA SARC -0.166; TCGA THCA -0.288; TCGA STAD -0.117; TCGA UCEC -0.295 |
hsa-miR-182-5p | THBS2 | 10 cancers: BLCA; CESC; COAD; HNSC; OV; PAAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.378; TCGA CESC -0.185; TCGA COAD -0.643; TCGA HNSC -0.139; TCGA OV -0.247; TCGA PAAD -0.345; TCGA SARC -0.302; TCGA THCA -0.367; TCGA STAD -0.179; TCGA UCEC -0.291 |
hsa-miR-182-5p | TCEAL7 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.408; TCGA BRCA -0.425; TCGA CESC -0.312; TCGA COAD -0.356; TCGA ESCA -0.386; TCGA HNSC -0.318; TCGA KIRP -0.39; TCGA LUAD -0.301; TCGA LUSC -0.392; TCGA OV -0.218; TCGA PAAD -0.503; TCGA PRAD -0.443; TCGA THCA -0.18; TCGA STAD -0.581; TCGA UCEC -0.532 |
hsa-miR-182-5p | IGSF10 | 12 cancers: BLCA; BRCA; COAD; HNSC; KIRP; LGG; LIHC; LUAD; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.549; TCGA BRCA -0.765; TCGA COAD -0.353; TCGA HNSC -0.266; TCGA KIRP -0.316; TCGA LGG -0.1; TCGA LIHC -0.173; TCGA LUAD -0.467; TCGA PAAD -0.481; TCGA THCA -0.489; TCGA STAD -0.654; TCGA UCEC -0.239 |
hsa-miR-182-5p | GPR183 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.512; TCGA BRCA -0.238; TCGA CESC -0.148; TCGA COAD -0.318; TCGA ESCA -0.316; TCGA HNSC -0.227; TCGA LGG -0.121; TCGA LUAD -0.145; TCGA LUSC -0.487; TCGA OV -0.152; TCGA PAAD -0.536; TCGA PRAD -0.241; TCGA SARC -0.244; TCGA THCA -0.372; TCGA STAD -0.289; TCGA UCEC -0.1 |
hsa-miR-182-5p | CD47 | 11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; THCA | MirTarget; miRNATAP | TCGA BLCA -0.134; TCGA BRCA -0.131; TCGA CESC -0.1; TCGA ESCA -0.136; TCGA HNSC -0.151; TCGA LUAD -0.067; TCGA LUSC -0.385; TCGA PAAD -0.058; TCGA PRAD -0.104; TCGA SARC -0.1; TCGA THCA -0.256 |
hsa-miR-182-5p | SLC2A3 | 14 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.383; TCGA BRCA -0.248; TCGA COAD -0.157; TCGA ESCA -0.304; TCGA HNSC -0.126; TCGA KIRC -0.16; TCGA KIRP -0.12; TCGA LUAD -0.319; TCGA LUSC -0.308; TCGA PAAD -0.29; TCGA PRAD -0.188; TCGA THCA -0.317; TCGA STAD -0.104; TCGA UCEC -0.163 |
hsa-miR-182-5p | SH3RF3 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.376; TCGA BRCA -0.285; TCGA CESC -0.137; TCGA COAD -0.181; TCGA ESCA -0.163; TCGA HNSC -0.263; TCGA KIRC -0.219; TCGA LUAD -0.155; TCGA LUSC -0.213; TCGA PAAD -0.244; TCGA PRAD -0.086; TCGA STAD -0.29; TCGA UCEC -0.128 |
hsa-miR-182-5p | CBFA2T3 | 9 cancers: BLCA; CESC; ESCA; KIRC; LIHC; LUAD; LUSC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.102; TCGA CESC -0.215; TCGA ESCA -0.233; TCGA KIRC -0.109; TCGA LIHC -0.125; TCGA LUAD -0.181; TCGA LUSC -0.404; TCGA STAD -0.329; TCGA UCEC -0.215 |
hsa-miR-182-5p | PDZD4 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LUAD; LUSC; OV; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.405; TCGA BRCA -0.224; TCGA CESC -0.221; TCGA COAD -0.585; TCGA ESCA -0.263; TCGA KIRC -0.186; TCGA LUAD -0.221; TCGA LUSC -0.139; TCGA OV -0.184; TCGA STAD -0.88; TCGA UCEC -0.449 |
hsa-miR-182-5p | BTLA | 10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; THCA | MirTarget | TCGA BLCA -0.383; TCGA BRCA -0.254; TCGA CESC -0.275; TCGA ESCA -0.357; TCGA HNSC -0.235; TCGA LUAD -0.174; TCGA LUSC -0.39; TCGA PAAD -0.485; TCGA PRAD -0.12; TCGA THCA -0.638 |
hsa-miR-182-5p | CNTN1 | 11 cancers: BLCA; BRCA; COAD; KIRP; LUAD; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.868; TCGA BRCA -0.446; TCGA COAD -0.778; TCGA KIRP -0.677; TCGA LUAD -0.58; TCGA OV -0.261; TCGA PAAD -0.358; TCGA PRAD -0.785; TCGA THCA -0.521; TCGA STAD -1.091; TCGA UCEC -0.226 |
hsa-miR-182-5p | ZC3H12C | 14 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.1; TCGA BRCA -0.411; TCGA CESC -0.112; TCGA HNSC -0.096; TCGA KIRC -0.081; TCGA KIRP -0.12; TCGA LIHC -0.054; TCGA LUAD -0.192; TCGA LUSC -0.185; TCGA OV -0.165; TCGA PRAD -0.152; TCGA SARC -0.082; TCGA STAD -0.255; TCGA UCEC -0.27 |
hsa-miR-182-5p | EPDR1 | 10 cancers: BLCA; BRCA; HNSC; LGG; LUSC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.468; TCGA BRCA -0.434; TCGA HNSC -0.363; TCGA LGG -0.067; TCGA LUSC -0.318; TCGA PAAD -0.197; TCGA PRAD -0.178; TCGA SARC -0.189; TCGA STAD -0.248; TCGA UCEC -0.275 |
hsa-miR-182-5p | RELL1 | 9 cancers: BLCA; ESCA; LGG; LUAD; LUSC; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.132; TCGA ESCA -0.1; TCGA LGG -0.054; TCGA LUAD -0.187; TCGA LUSC -0.081; TCGA PRAD -0.054; TCGA SARC -0.142; TCGA STAD -0.052; TCGA UCEC -0.06 |
hsa-miR-182-5p | FAM78A | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; OV; PAAD; THCA; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.271; TCGA BRCA -0.112; TCGA CESC -0.23; TCGA COAD -0.21; TCGA ESCA -0.227; TCGA HNSC -0.254; TCGA KIRC -0.126; TCGA LGG -0.059; TCGA LUAD -0.311; TCGA LUSC -0.436; TCGA OV -0.099; TCGA PAAD -0.356; TCGA THCA -0.166; TCGA UCEC -0.073 |
hsa-miR-182-5p | TACC1 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.171; TCGA BRCA -0.385; TCGA CESC -0.209; TCGA COAD -0.173; TCGA ESCA -0.211; TCGA HNSC -0.186; TCGA KIRC -0.072; TCGA KIRP -0.234; TCGA LUAD -0.343; TCGA LUSC -0.27; TCGA OV -0.086; TCGA PAAD -0.198; TCGA PRAD -0.383; TCGA SARC -0.231; TCGA THCA -0.078; TCGA STAD -0.378; TCGA UCEC -0.401 |
hsa-miR-182-5p | DACT1 | 12 cancers: BLCA; BRCA; ESCA; HNSC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.429; TCGA BRCA -0.077; TCGA ESCA -0.285; TCGA HNSC -0.331; TCGA KIRP -0.324; TCGA LUAD -0.146; TCGA LUSC -0.434; TCGA OV -0.234; TCGA PAAD -0.261; TCGA PRAD -0.324; TCGA STAD -0.219; TCGA UCEC -0.245 |
hsa-miR-182-5p | TRPM6 | 12 cancers: BLCA; BRCA; CESC; ESCA; KIRC; KIRP; LGG; LUAD; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.247; TCGA BRCA -0.665; TCGA CESC -0.235; TCGA ESCA -0.424; TCGA KIRC -0.194; TCGA KIRP -0.598; TCGA LGG -0.085; TCGA LUAD -0.287; TCGA PAAD -0.23; TCGA PRAD -0.327; TCGA STAD -0.383; TCGA UCEC -0.119 |
hsa-miR-182-5p | FOXN3 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.153; TCGA BRCA -0.356; TCGA CESC -0.078; TCGA COAD -0.117; TCGA ESCA -0.156; TCGA HNSC -0.13; TCGA KIRC -0.051; TCGA KIRP -0.122; TCGA LIHC -0.116; TCGA LUAD -0.08; TCGA LUSC -0.067; TCGA PAAD -0.219; TCGA PRAD -0.17; TCGA SARC -0.075; TCGA THCA -0.101; TCGA STAD -0.296; TCGA UCEC -0.208 |
hsa-miR-182-5p | SLC7A2 | 10 cancers: BLCA; COAD; ESCA; HNSC; KIRP; LGG; LUSC; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.114; TCGA COAD -0.388; TCGA ESCA -0.277; TCGA HNSC -0.144; TCGA KIRP -0.445; TCGA LGG -0.092; TCGA LUSC -0.368; TCGA SARC -0.168; TCGA STAD -0.492; TCGA UCEC -0.523 |
hsa-miR-182-5p | GAS7 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.555; TCGA BRCA -0.295; TCGA CESC -0.286; TCGA COAD -0.519; TCGA ESCA -0.401; TCGA HNSC -0.41; TCGA LGG -0.08; TCGA LUAD -0.357; TCGA LUSC -0.616; TCGA OV -0.156; TCGA PAAD -0.478; TCGA PRAD -0.36; TCGA SARC -0.153; TCGA THCA -0.142; TCGA STAD -0.445; TCGA UCEC -0.22 |
hsa-miR-182-5p | TIMP2 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.444; TCGA BRCA -0.272; TCGA CESC -0.177; TCGA COAD -0.406; TCGA ESCA -0.228; TCGA HNSC -0.233; TCGA LUAD -0.301; TCGA LUSC -0.471; TCGA OV -0.178; TCGA PAAD -0.325; TCGA PRAD -0.328; TCGA SARC -0.065; TCGA THCA -0.146; TCGA STAD -0.348; TCGA UCEC -0.339 |
hsa-miR-182-5p | SNX29 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.129; TCGA BRCA -0.119; TCGA CESC -0.076; TCGA COAD -0.133; TCGA ESCA -0.106; TCGA HNSC -0.163; TCGA KIRP -0.053; TCGA LUAD -0.078; TCGA LUSC -0.17; TCGA PAAD -0.158; TCGA PRAD -0.131; TCGA SARC -0.06; TCGA STAD -0.219; TCGA UCEC -0.086 |
hsa-miR-182-5p | CELF2 | 13 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | mirMAP; miRNATAP | TCGA BLCA -0.543; TCGA BRCA -0.482; TCGA CESC -0.272; TCGA ESCA -0.442; TCGA HNSC -0.318; TCGA LUAD -0.237; TCGA LUSC -0.598; TCGA OV -0.134; TCGA PAAD -0.499; TCGA PRAD -0.483; TCGA SARC -0.083; TCGA STAD -0.506; TCGA UCEC -0.296 |
hsa-miR-182-5p | TMCC3 | 12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.372; TCGA BRCA -0.217; TCGA CESC -0.24; TCGA ESCA -0.14; TCGA HNSC -0.259; TCGA KIRC -0.227; TCGA KIRP -0.094; TCGA LUAD -0.254; TCGA LUSC -0.27; TCGA THCA -0.205; TCGA STAD -0.12; TCGA UCEC -0.164 |
hsa-miR-182-5p | ATP2B4 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LGG; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.289; TCGA BRCA -0.208; TCGA CESC -0.122; TCGA COAD -0.29; TCGA ESCA -0.157; TCGA KIRC -0.061; TCGA LGG -0.063; TCGA LUAD -0.127; TCGA LUSC -0.164; TCGA PRAD -0.603; TCGA SARC -0.107; TCGA THCA -0.098; TCGA STAD -0.527; TCGA UCEC -0.14 |
hsa-miR-182-5p | ASB1 | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.157; TCGA BRCA -0.161; TCGA COAD -0.067; TCGA ESCA -0.055; TCGA HNSC -0.074; TCGA KIRP -0.123; TCGA PRAD -0.143; TCGA THCA -0.068; TCGA STAD -0.139; TCGA UCEC -0.113 |
hsa-miR-182-5p | PPP1R12B | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.462; TCGA BRCA -0.329; TCGA CESC -0.281; TCGA COAD -0.44; TCGA ESCA -0.474; TCGA HNSC -0.292; TCGA KIRP -0.205; TCGA LUAD -0.131; TCGA LUSC -0.315; TCGA OV -0.067; TCGA PAAD -0.235; TCGA PRAD -0.532; TCGA SARC -0.371; TCGA STAD -0.758; TCGA UCEC -0.539 |
hsa-miR-182-5p | RUNX1T1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.54; TCGA BRCA -0.454; TCGA CESC -0.439; TCGA COAD -0.513; TCGA ESCA -0.475; TCGA HNSC -0.412; TCGA KIRC -0.198; TCGA KIRP -0.458; TCGA LUAD -0.288; TCGA LUSC -0.689; TCGA OV -0.244; TCGA PAAD -0.347; TCGA PRAD -0.625; TCGA STAD -0.595; TCGA UCEC -0.506 |
hsa-miR-182-5p | NFE2L1 | 11 cancers: BLCA; BRCA; CESC; HNSC; LGG; LIHC; LUAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.1; TCGA BRCA -0.07; TCGA CESC -0.091; TCGA HNSC -0.108; TCGA LGG -0.069; TCGA LIHC -0.069; TCGA LUAD -0.092; TCGA PRAD -0.14; TCGA SARC -0.065; TCGA STAD -0.077; TCGA UCEC -0.125 |
hsa-miR-182-5p | SSH1 | 13 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.095; TCGA BRCA -0.068; TCGA CESC -0.129; TCGA COAD -0.119; TCGA HNSC -0.083; TCGA KIRP -0.063; TCGA LUAD -0.133; TCGA LUSC -0.073; TCGA PAAD -0.177; TCGA PRAD -0.16; TCGA THCA -0.071; TCGA STAD -0.114; TCGA UCEC -0.108 |
hsa-miR-182-5p | C20orf194 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRP; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | mirMAP; miRNATAP | TCGA BLCA -0.088; TCGA BRCA -0.18; TCGA CESC -0.156; TCGA COAD -0.495; TCGA ESCA -0.14; TCGA KIRP -0.076; TCGA LUAD -0.21; TCGA LUSC -0.117; TCGA PAAD -0.137; TCGA PRAD -0.399; TCGA STAD -0.411; TCGA UCEC -0.219 |
hsa-miR-182-5p | CD209 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.639; TCGA BRCA -0.699; TCGA CESC -0.313; TCGA COAD -0.29; TCGA ESCA -0.419; TCGA HNSC -0.396; TCGA LIHC -0.084; TCGA LUAD -0.278; TCGA LUSC -0.431; TCGA PAAD -0.535; TCGA PRAD -0.162; TCGA SARC -0.237; TCGA THCA -0.242; TCGA STAD -0.143; TCGA UCEC -0.101 |
hsa-miR-182-5p | CECR1 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.155; TCGA BRCA -0.142; TCGA CESC -0.27; TCGA COAD -0.367; TCGA ESCA -0.339; TCGA HNSC -0.245; TCGA LGG -0.119; TCGA LUAD -0.293; TCGA LUSC -0.55; TCGA PAAD -0.34; TCGA PRAD -0.364; TCGA SARC -0.113; TCGA THCA -0.239; TCGA STAD -0.132 |
hsa-miR-182-5p | STX1B | 12 cancers: BLCA; BRCA; CESC; COAD; KIRC; LIHC; LUAD; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.336; TCGA BRCA -0.114; TCGA CESC -0.289; TCGA COAD -0.274; TCGA KIRC -0.2; TCGA LIHC -0.118; TCGA LUAD -0.148; TCGA PAAD -0.157; TCGA PRAD -0.113; TCGA THCA -0.166; TCGA STAD -0.277; TCGA UCEC -0.306 |
hsa-miR-182-5p | RIN3 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.241; TCGA BRCA -0.2; TCGA CESC -0.179; TCGA COAD -0.138; TCGA ESCA -0.188; TCGA HNSC -0.217; TCGA KIRC -0.085; TCGA LUAD -0.273; TCGA LUSC -0.423; TCGA OV -0.107; TCGA PAAD -0.214; TCGA PRAD -0.267; TCGA SARC -0.084; TCGA STAD -0.274; TCGA UCEC -0.074 |
hsa-miR-182-5p | NFATC2 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.275; TCGA BRCA -0.32; TCGA CESC -0.321; TCGA COAD -0.266; TCGA ESCA -0.567; TCGA HNSC -0.547; TCGA KIRP -0.263; TCGA LGG -0.084; TCGA LUAD -0.18; TCGA LUSC -0.731; TCGA PAAD -0.228; TCGA PRAD -0.636; TCGA THCA -0.217; TCGA STAD -0.096; TCGA UCEC -0.249 |
hsa-miR-182-5p | KLHL4 | 14 cancers: BLCA; BRCA; COAD; HNSC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.699; TCGA BRCA -0.428; TCGA COAD -0.413; TCGA HNSC -0.511; TCGA KIRP -0.336; TCGA LUAD -0.408; TCGA LUSC -0.456; TCGA OV -0.244; TCGA PAAD -0.686; TCGA PRAD -0.685; TCGA SARC -0.324; TCGA THCA -0.16; TCGA STAD -0.625; TCGA UCEC -0.761 |
hsa-miR-182-5p | CRISPLD2 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.421; TCGA BRCA -0.124; TCGA CESC -0.262; TCGA COAD -0.422; TCGA ESCA -0.358; TCGA HNSC -0.213; TCGA LUAD -0.201; TCGA LUSC -0.482; TCGA OV -0.186; TCGA PAAD -0.481; TCGA PRAD -0.316; TCGA SARC -0.178; TCGA THCA -0.238; TCGA STAD -0.414; TCGA UCEC -0.305 |
hsa-miR-182-5p | SFRP1 | 13 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRP; LIHC; LUAD; OV; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.69; TCGA BRCA -0.967; TCGA CESC -0.371; TCGA COAD -0.932; TCGA HNSC -0.626; TCGA KIRP -0.878; TCGA LIHC -0.13; TCGA LUAD -0.271; TCGA OV -0.267; TCGA PAAD -0.412; TCGA PRAD -0.338; TCGA STAD -1.12; TCGA UCEC -0.438 |
hsa-miR-182-5p | NOVA2 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.088; TCGA BRCA -0.164; TCGA CESC -0.138; TCGA COAD -0.248; TCGA ESCA -0.238; TCGA HNSC -0.11; TCGA KIRC -0.308; TCGA KIRP -0.223; TCGA LUAD -0.377; TCGA LUSC -0.48; TCGA OV -0.152; TCGA PAAD -0.12; TCGA PRAD -0.086; TCGA STAD -0.134; TCGA UCEC -0.178 |
hsa-miR-182-5p | PRX | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; LUAD; LUSC; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.161; TCGA BRCA -0.131; TCGA CESC -0.134; TCGA COAD -0.188; TCGA ESCA -0.171; TCGA KIRC -0.203; TCGA KIRP -0.274; TCGA LUAD -0.432; TCGA LUSC -0.466; TCGA PRAD -0.095; TCGA THCA -0.162; TCGA STAD -0.262; TCGA UCEC -0.315 |
hsa-miR-182-5p | SH3PXD2A | 14 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.172; TCGA BRCA -0.079; TCGA CESC -0.114; TCGA COAD -0.089; TCGA HNSC -0.095; TCGA KIRC -0.106; TCGA KIRP -0.1; TCGA LUSC -0.087; TCGA OV -0.106; TCGA PAAD -0.196; TCGA PRAD -0.302; TCGA THCA -0.131; TCGA STAD -0.168; TCGA UCEC -0.21 |
hsa-miR-182-5p | DUSP3 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.217; TCGA BRCA -0.09; TCGA CESC -0.062; TCGA COAD -0.105; TCGA ESCA -0.165; TCGA HNSC -0.136; TCGA LGG -0.061; TCGA LUAD -0.123; TCGA LUSC -0.11; TCGA PAAD -0.104; TCGA PRAD -0.238; TCGA SARC -0.122; TCGA STAD -0.244; TCGA UCEC -0.132 |
hsa-miR-182-5p | TSPAN11 | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUSC; OV; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BLCA -0.347; TCGA BRCA -0.42; TCGA COAD -0.404; TCGA ESCA -0.397; TCGA HNSC -0.124; TCGA LUSC -0.41; TCGA OV -0.143; TCGA PAAD -0.515; TCGA PRAD -0.442; TCGA THCA -0.184; TCGA STAD -0.349 |
hsa-miR-182-5p | MDGA1 | 10 cancers: BLCA; BRCA; CESC; COAD; KIRP; LUAD; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.393; TCGA BRCA -0.095; TCGA CESC -0.207; TCGA COAD -0.458; TCGA KIRP -0.155; TCGA LUAD -0.496; TCGA PAAD -0.329; TCGA PRAD -0.146; TCGA STAD -0.382; TCGA UCEC -0.265 |
hsa-miR-182-5p | PHACTR2 | 12 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.057; TCGA BRCA -0.221; TCGA ESCA -0.188; TCGA HNSC -0.228; TCGA KIRC -0.11; TCGA KIRP -0.09; TCGA LUAD -0.235; TCGA LUSC -0.372; TCGA PAAD -0.151; TCGA PRAD -0.248; TCGA STAD -0.102; TCGA UCEC -0.125 |
hsa-miR-182-5p | QKI | 13 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.136; TCGA BRCA -0.308; TCGA CESC -0.111; TCGA COAD -0.29; TCGA HNSC -0.168; TCGA KIRP -0.098; TCGA LUAD -0.227; TCGA LUSC -0.198; TCGA OV -0.053; TCGA PAAD -0.331; TCGA PRAD -0.146; TCGA STAD -0.298; TCGA UCEC -0.188 |
hsa-miR-182-5p | RASGRF2 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.28; TCGA BRCA -0.333; TCGA CESC -0.192; TCGA COAD -0.196; TCGA ESCA -0.349; TCGA HNSC -0.29; TCGA KIRC -0.172; TCGA KIRP -0.403; TCGA LUAD -0.158; TCGA LUSC -0.475; TCGA OV -0.17; TCGA PAAD -0.48; TCGA PRAD -0.436; TCGA SARC -0.07; TCGA STAD -0.22; TCGA UCEC -0.294 |
hsa-miR-182-5p | PDE4D | 11 cancers: BLCA; BRCA; ESCA; HNSC; LUAD; LUSC; OV; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.286; TCGA BRCA -0.107; TCGA ESCA -0.175; TCGA HNSC -0.201; TCGA LUAD -0.158; TCGA LUSC -0.238; TCGA OV -0.195; TCGA PRAD -0.289; TCGA SARC -0.151; TCGA STAD -0.262; TCGA UCEC -0.298 |
hsa-miR-182-5p | LIFR | 14 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUSC; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.391; TCGA BRCA -0.387; TCGA COAD -0.437; TCGA ESCA -0.348; TCGA HNSC -0.206; TCGA KIRC -0.146; TCGA KIRP -0.151; TCGA LGG -0.074; TCGA LIHC -0.154; TCGA LUSC -0.344; TCGA PAAD -0.311; TCGA PRAD -0.128; TCGA STAD -0.416; TCGA UCEC -0.439 |
hsa-miR-182-5p | PRKAR2A | 9 cancers: BLCA; BRCA; ESCA; HNSC; KIRP; LIHC; LUSC; PRAD; SARC | mirMAP | TCGA BLCA -0.153; TCGA BRCA -0.095; TCGA ESCA -0.084; TCGA HNSC -0.261; TCGA KIRP -0.217; TCGA LIHC -0.062; TCGA LUSC -0.115; TCGA PRAD -0.288; TCGA SARC -0.115 |
hsa-miR-182-5p | C1orf21 | 10 cancers: BLCA; CESC; HNSC; KIRP; LUAD; LUSC; OV; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.137; TCGA CESC -0.245; TCGA HNSC -0.134; TCGA KIRP -0.18; TCGA LUAD -0.153; TCGA LUSC -0.085; TCGA OV -0.09; TCGA SARC -0.16; TCGA STAD -0.274; TCGA UCEC -0.234 |
hsa-miR-182-5p | CD274 | 14 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; UCEC | mirMAP | TCGA BLCA -0.316; TCGA BRCA -0.178; TCGA CESC -0.34; TCGA COAD -0.216; TCGA HNSC -0.266; TCGA KIRP -0.164; TCGA LGG -0.15; TCGA LUAD -0.313; TCGA LUSC -0.161; TCGA PAAD -0.238; TCGA PRAD -0.366; TCGA SARC -0.133; TCGA THCA -0.307; TCGA UCEC -0.087 |
hsa-miR-182-5p | CSMD2 | 9 cancers: BLCA; CESC; COAD; KIRC; KIRP; LUSC; OV; PAAD; STAD | mirMAP | TCGA BLCA -0.221; TCGA CESC -0.158; TCGA COAD -0.516; TCGA KIRC -0.174; TCGA KIRP -0.349; TCGA LUSC -0.223; TCGA OV -0.216; TCGA PAAD -0.427; TCGA STAD -0.154 |
hsa-miR-182-5p | HIF3A | 13 cancers: BLCA; BRCA; COAD; ESCA; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.595; TCGA BRCA -0.935; TCGA COAD -0.282; TCGA ESCA -0.752; TCGA KIRC -0.132; TCGA KIRP -0.402; TCGA LIHC -0.189; TCGA LUAD -0.237; TCGA LUSC -0.214; TCGA PAAD -0.302; TCGA PRAD -0.721; TCGA STAD -0.829; TCGA UCEC -0.453 |
hsa-miR-182-5p | ATXN1 | 11 cancers: BLCA; CESC; COAD; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | mirMAP; miRNATAP | TCGA BLCA -0.31; TCGA CESC -0.108; TCGA COAD -0.073; TCGA HNSC -0.092; TCGA KIRC -0.095; TCGA LUAD -0.092; TCGA LUSC -0.106; TCGA PAAD -0.199; TCGA PRAD -0.18; TCGA STAD -0.242; TCGA UCEC -0.136 |
hsa-miR-182-5p | WDFY4 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.514; TCGA BRCA -0.15; TCGA CESC -0.295; TCGA COAD -0.371; TCGA ESCA -0.44; TCGA HNSC -0.326; TCGA LGG -0.118; TCGA LUAD -0.233; TCGA LUSC -0.703; TCGA PAAD -0.604; TCGA PRAD -0.22; TCGA SARC -0.167; TCGA THCA -0.506; TCGA STAD -0.136 |
hsa-miR-182-5p | TTBK2 | 11 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRP; LUAD; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.156; TCGA BRCA -0.214; TCGA CESC -0.168; TCGA COAD -0.144; TCGA HNSC -0.105; TCGA KIRP -0.157; TCGA LUAD -0.107; TCGA PAAD -0.219; TCGA PRAD -0.367; TCGA STAD -0.244; TCGA UCEC -0.173 |
hsa-miR-182-5p | PRRG1 | 12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; PRAD; THCA; UCEC | mirMAP | TCGA BLCA -0.154; TCGA BRCA -0.334; TCGA CESC -0.273; TCGA ESCA -0.178; TCGA HNSC -0.298; TCGA LGG -0.078; TCGA LIHC -0.065; TCGA LUAD -0.274; TCGA LUSC -0.502; TCGA PRAD -0.264; TCGA THCA -0.2; TCGA UCEC -0.202 |
hsa-miR-182-5p | IL6ST | 14 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.423; TCGA CESC -0.313; TCGA COAD -0.19; TCGA ESCA -0.337; TCGA HNSC -0.525; TCGA KIRP -0.412; TCGA LIHC -0.118; TCGA LUAD -0.156; TCGA LUSC -0.487; TCGA PAAD -0.266; TCGA PRAD -0.646; TCGA SARC -0.132; TCGA STAD -0.27; TCGA UCEC -0.263 |
hsa-miR-182-5p | DTNA | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LGG; LUAD; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.709; TCGA BRCA -0.095; TCGA COAD -0.371; TCGA ESCA -0.422; TCGA HNSC -0.349; TCGA LGG -0.067; TCGA LUAD -0.197; TCGA PAAD -0.249; TCGA PRAD -0.441; TCGA STAD -0.772; TCGA UCEC -0.416 |
hsa-miR-182-5p | KIAA1614 | 14 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.395; TCGA BRCA -0.428; TCGA COAD -0.361; TCGA HNSC -0.109; TCGA KIRC -0.158; TCGA KIRP -0.19; TCGA LUAD -0.28; TCGA LUSC -0.101; TCGA OV -0.088; TCGA PAAD -0.259; TCGA PRAD -0.556; TCGA SARC -0.094; TCGA STAD -0.415; TCGA UCEC -0.186 |
hsa-miR-182-5p | SCRN1 | 9 cancers: BLCA; BRCA; CESC; COAD; ESCA; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.201; TCGA BRCA -0.09; TCGA CESC -0.091; TCGA COAD -0.253; TCGA ESCA -0.106; TCGA PRAD -0.389; TCGA THCA -0.056; TCGA STAD -0.254; TCGA UCEC -0.115 |
hsa-miR-182-5p | ENTPD1 | 14 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.264; TCGA CESC -0.12; TCGA COAD -0.194; TCGA ESCA -0.247; TCGA HNSC -0.069; TCGA KIRC -0.061; TCGA KIRP -0.062; TCGA LUAD -0.152; TCGA LUSC -0.234; TCGA PAAD -0.278; TCGA PRAD -0.152; TCGA SARC -0.119; TCGA STAD -0.214; TCGA UCEC -0.177 |
hsa-miR-182-5p | ACVRL1 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.251; TCGA BRCA -0.267; TCGA CESC -0.238; TCGA COAD -0.127; TCGA ESCA -0.332; TCGA HNSC -0.166; TCGA KIRC -0.185; TCGA KIRP -0.139; TCGA LUAD -0.44; TCGA LUSC -0.587; TCGA OV -0.124; TCGA PAAD -0.218; TCGA PRAD -0.226; TCGA SARC -0.099; TCGA STAD -0.129; TCGA UCEC -0.165 |
hsa-miR-182-5p | NTRK3 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.495; TCGA BRCA -0.438; TCGA CESC -0.452; TCGA COAD -0.519; TCGA ESCA -0.478; TCGA HNSC -0.257; TCGA KIRP -0.187; TCGA LUAD -0.476; TCGA LUSC -0.697; TCGA OV -0.473; TCGA PAAD -0.397; TCGA PRAD -0.548; TCGA THCA -0.164; TCGA STAD -0.774; TCGA UCEC -0.44 |
hsa-miR-182-5p | FTO | 13 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; LIHC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.09; TCGA BRCA -0.125; TCGA CESC -0.081; TCGA COAD -0.058; TCGA HNSC -0.114; TCGA KIRC -0.052; TCGA LIHC -0.054; TCGA LUAD -0.08; TCGA LUSC -0.137; TCGA PAAD -0.112; TCGA PRAD -0.181; TCGA STAD -0.175; TCGA UCEC -0.104 |
hsa-miR-182-5p | ASXL3 | 10 cancers: BLCA; BRCA; COAD; ESCA; KIRC; LUAD; LUSC; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.369; TCGA BRCA -0.448; TCGA COAD -0.339; TCGA ESCA -0.414; TCGA KIRC -0.35; TCGA LUAD -0.151; TCGA LUSC -0.475; TCGA PRAD -0.642; TCGA STAD -0.585; TCGA UCEC -0.521 |
hsa-miR-182-5p | PRDM16 | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LGG; LUSC; PRAD; UCEC | mirMAP; miRNATAP | TCGA BLCA -0.248; TCGA BRCA -0.346; TCGA COAD -0.251; TCGA ESCA -0.366; TCGA HNSC -0.2; TCGA KIRP -0.741; TCGA LGG -0.109; TCGA LUSC -0.44; TCGA PRAD -0.343; TCGA UCEC -0.267 |
hsa-miR-182-5p | ITPKB | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; LGG; OV; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.206; TCGA BRCA -0.13; TCGA CESC -0.097; TCGA COAD -0.156; TCGA ESCA -0.118; TCGA KIRC -0.078; TCGA KIRP -0.179; TCGA LGG -0.121; TCGA OV -0.07; TCGA PAAD -0.167; TCGA PRAD -0.072; TCGA STAD -0.453; TCGA UCEC -0.146 |
hsa-miR-182-5p | TMEM108 | 12 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRP; LUSC; OV; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.554; TCGA BRCA -0.235; TCGA CESC -0.237; TCGA COAD -0.263; TCGA HNSC -0.241; TCGA KIRP -0.362; TCGA LUSC -0.328; TCGA OV -0.14; TCGA PAAD -0.225; TCGA PRAD -0.651; TCGA STAD -0.422; TCGA UCEC -0.238 |
hsa-miR-182-5p | FEM1C | 10 cancers: BLCA; ESCA; HNSC; LGG; LUSC; PRAD; SARC; THCA; STAD; UCEC | mirMAP; miRNATAP | TCGA BLCA -0.073; TCGA ESCA -0.124; TCGA HNSC -0.11; TCGA LGG -0.079; TCGA LUSC -0.095; TCGA PRAD -0.056; TCGA SARC -0.095; TCGA THCA -0.052; TCGA STAD -0.103; TCGA UCEC -0.056 |
hsa-miR-182-5p | GFOD1 | 11 cancers: BLCA; BRCA; CESC; COAD; KIRC; LIHC; LUAD; LUSC; PAAD; PRAD; STAD | mirMAP | TCGA BLCA -0.331; TCGA BRCA -0.23; TCGA CESC -0.172; TCGA COAD -0.202; TCGA KIRC -0.188; TCGA LIHC -0.114; TCGA LUAD -0.336; TCGA LUSC -0.108; TCGA PAAD -0.129; TCGA PRAD -0.311; TCGA STAD -0.405 |
hsa-miR-182-5p | DAAM2 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.376; TCGA BRCA -0.429; TCGA CESC -0.207; TCGA COAD -0.359; TCGA ESCA -0.496; TCGA HNSC -0.326; TCGA KIRC -0.103; TCGA KIRP -0.517; TCGA LIHC -0.151; TCGA LUAD -0.213; TCGA LUSC -0.646; TCGA OV -0.193; TCGA PAAD -0.572; TCGA PRAD -0.636; TCGA STAD -0.598; TCGA UCEC -0.247 |
hsa-miR-182-5p | RNF217 | 11 cancers: BLCA; BRCA; CESC; COAD; LIHC; LUAD; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.363; TCGA BRCA -0.32; TCGA CESC -0.137; TCGA COAD -0.327; TCGA LIHC -0.133; TCGA LUAD -0.146; TCGA PAAD -0.398; TCGA PRAD -0.238; TCGA SARC -0.066; TCGA STAD -0.442; TCGA UCEC -0.092 |
hsa-miR-182-5p | CREB5 | 9 cancers: BLCA; BRCA; KIRC; LGG; LUAD; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BLCA -0.464; TCGA BRCA -0.489; TCGA KIRC -0.121; TCGA LGG -0.088; TCGA LUAD -0.196; TCGA PAAD -0.289; TCGA PRAD -0.135; TCGA THCA -0.414; TCGA STAD -0.29 |
hsa-miR-182-5p | NTRK2 | 9 cancers: BLCA; BRCA; KIRP; LGG; LUAD; OV; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.543; TCGA BRCA -0.571; TCGA KIRP -0.497; TCGA LGG -0.072; TCGA LUAD -0.395; TCGA OV -0.309; TCGA PRAD -0.543; TCGA STAD -0.483; TCGA UCEC -0.236 |
hsa-miR-182-5p | FAM124A | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; STAD | mirMAP | TCGA BLCA -0.465; TCGA BRCA -0.291; TCGA COAD -0.396; TCGA ESCA -0.389; TCGA HNSC -0.169; TCGA KIRP -0.247; TCGA LUAD -0.245; TCGA LUSC -0.252; TCGA PAAD -0.308; TCGA PRAD -0.492; TCGA STAD -0.543 |
hsa-miR-182-5p | FER | 13 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.209; TCGA BRCA -0.255; TCGA CESC -0.147; TCGA ESCA -0.148; TCGA HNSC -0.142; TCGA KIRP -0.073; TCGA LUAD -0.119; TCGA LUSC -0.116; TCGA PAAD -0.157; TCGA PRAD -0.303; TCGA THCA -0.101; TCGA STAD -0.212; TCGA UCEC -0.088 |
hsa-miR-182-5p | SETBP1 | 11 cancers: BLCA; CESC; COAD; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.351; TCGA CESC -0.151; TCGA COAD -0.37; TCGA HNSC -0.16; TCGA KIRP -0.123; TCGA LUAD -0.215; TCGA LUSC -0.117; TCGA PAAD -0.199; TCGA PRAD -0.277; TCGA STAD -0.649; TCGA UCEC -0.313 |
hsa-miR-182-5p | ASAP1 | 12 cancers: BLCA; BRCA; CESC; COAD; KIRC; KIRP; LUAD; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.109; TCGA BRCA -0.104; TCGA CESC -0.067; TCGA COAD -0.109; TCGA KIRC -0.115; TCGA KIRP -0.1; TCGA LUAD -0.128; TCGA PAAD -0.198; TCGA PRAD -0.248; TCGA SARC -0.055; TCGA STAD -0.053; TCGA UCEC -0.095 |
hsa-miR-182-5p | PDE1C | 13 cancers: BLCA; BRCA; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.607; TCGA BRCA -0.654; TCGA ESCA -0.61; TCGA HNSC -0.291; TCGA KIRP -0.662; TCGA LGG -0.144; TCGA LUAD -0.369; TCGA LUSC -0.65; TCGA PAAD -0.21; TCGA PRAD -0.941; TCGA SARC -0.284; TCGA STAD -0.54; TCGA UCEC -0.416 |
hsa-miR-182-5p | FBXO32 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.37; TCGA BRCA -0.242; TCGA CESC -0.198; TCGA COAD -0.235; TCGA ESCA -0.217; TCGA HNSC -0.165; TCGA LGG -0.163; TCGA PAAD -0.216; TCGA PRAD -0.254; TCGA SARC -0.209; TCGA STAD -0.593; TCGA UCEC -0.322 |
hsa-miR-182-5p | RBPMS | 14 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LGG; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.163; TCGA BRCA -0.11; TCGA COAD -0.158; TCGA ESCA -0.344; TCGA HNSC -0.097; TCGA LGG -0.121; TCGA LUSC -0.317; TCGA OV -0.191; TCGA PAAD -0.172; TCGA PRAD -0.428; TCGA SARC -0.383; TCGA THCA -0.066; TCGA STAD -0.44; TCGA UCEC -0.212 |
hsa-miR-182-5p | ERG | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; STAD; UCEC | mirMAP | TCGA BLCA -0.266; TCGA BRCA -0.32; TCGA CESC -0.227; TCGA COAD -0.342; TCGA ESCA -0.26; TCGA HNSC -0.211; TCGA KIRC -0.22; TCGA KIRP -0.261; TCGA LIHC -0.069; TCGA LUAD -0.377; TCGA LUSC -0.499; TCGA OV -0.115; TCGA PAAD -0.354; TCGA STAD -0.252; TCGA UCEC -0.243 |
hsa-miR-182-5p | WASF2 | 13 cancers: BLCA; BRCA; CESC; COAD; KIRC; LGG; LUAD; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP; miRNATAP | TCGA BLCA -0.089; TCGA BRCA -0.139; TCGA CESC -0.094; TCGA COAD -0.091; TCGA KIRC -0.069; TCGA LGG -0.08; TCGA LUAD -0.109; TCGA PAAD -0.125; TCGA PRAD -0.062; TCGA SARC -0.053; TCGA THCA -0.054; TCGA STAD -0.119; TCGA UCEC -0.135 |
hsa-miR-182-5p | UBR1 | 9 cancers: BLCA; ESCA; HNSC; KIRP; LUSC; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.107; TCGA ESCA -0.123; TCGA HNSC -0.125; TCGA KIRP -0.082; TCGA LUSC -0.13; TCGA PRAD -0.144; TCGA SARC -0.063; TCGA STAD -0.079; TCGA UCEC -0.109 |
hsa-miR-182-5p | IL6R | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.308; TCGA BRCA -0.379; TCGA CESC -0.182; TCGA COAD -0.283; TCGA ESCA -0.18; TCGA HNSC -0.143; TCGA KIRC -0.209; TCGA KIRP -0.128; TCGA LIHC -0.142; TCGA LUAD -0.106; TCGA LUSC -0.408; TCGA PAAD -0.243; TCGA PRAD -0.351; TCGA SARC -0.198; TCGA THCA -0.389; TCGA STAD -0.285; TCGA UCEC -0.257 |
hsa-miR-182-5p | PLXDC1 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUSC; PAAD; STAD; UCEC | mirMAP | TCGA BLCA -0.194; TCGA BRCA -0.096; TCGA CESC -0.239; TCGA COAD -0.195; TCGA ESCA -0.224; TCGA HNSC -0.165; TCGA KIRC -0.116; TCGA KIRP -0.14; TCGA LUSC -0.151; TCGA PAAD -0.184; TCGA STAD -0.119; TCGA UCEC -0.267 |
hsa-miR-182-5p | KLHL21 | 11 cancers: BLCA; BRCA; CESC; COAD; KIRP; LGG; LIHC; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.173; TCGA BRCA -0.24; TCGA CESC -0.152; TCGA COAD -0.1; TCGA KIRP -0.117; TCGA LGG -0.084; TCGA LIHC -0.073; TCGA PRAD -0.153; TCGA SARC -0.066; TCGA STAD -0.184; TCGA UCEC -0.116 |
hsa-miR-182-5p | SGCB | 14 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.327; TCGA BRCA -0.213; TCGA ESCA -0.172; TCGA HNSC -0.111; TCGA KIRC -0.164; TCGA KIRP -0.073; TCGA LUAD -0.179; TCGA LUSC -0.167; TCGA OV -0.089; TCGA PAAD -0.089; TCGA PRAD -0.334; TCGA SARC -0.071; TCGA STAD -0.211; TCGA UCEC -0.083 |
hsa-miR-182-5p | CDC42EP3 | 12 cancers: BLCA; BRCA; HNSC; KIRC; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.251; TCGA BRCA -0.218; TCGA HNSC -0.105; TCGA KIRC -0.066; TCGA LUSC -0.165; TCGA OV -0.054; TCGA PAAD -0.11; TCGA PRAD -0.422; TCGA SARC -0.117; TCGA THCA -0.136; TCGA STAD -0.387; TCGA UCEC -0.25 |
hsa-miR-182-5p | EIF4E3 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.11; TCGA BRCA -0.131; TCGA CESC -0.178; TCGA COAD -0.122; TCGA ESCA -0.284; TCGA HNSC -0.311; TCGA KIRC -0.087; TCGA LUAD -0.156; TCGA LUSC -0.418; TCGA OV -0.086; TCGA PAAD -0.09; TCGA PRAD -0.205; TCGA THCA -0.124; TCGA STAD -0.323; TCGA UCEC -0.217 |
hsa-miR-182-5p | NFASC | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; OV; PRAD; STAD; UCEC | mirMAP; miRNATAP | TCGA BLCA -0.356; TCGA BRCA -0.232; TCGA CESC -0.408; TCGA COAD -0.336; TCGA ESCA -0.462; TCGA HNSC -0.284; TCGA KIRP -0.515; TCGA LGG -0.077; TCGA LUAD -0.339; TCGA LUSC -0.375; TCGA OV -0.243; TCGA PRAD -0.364; TCGA STAD -0.757; TCGA UCEC -0.365 |
hsa-miR-182-5p | EIF5A2 | 11 cancers: BLCA; BRCA; CESC; KIRP; LGG; LUAD; OV; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.349; TCGA BRCA -0.251; TCGA CESC -0.207; TCGA KIRP -0.128; TCGA LGG -0.064; TCGA LUAD -0.103; TCGA OV -0.142; TCGA PAAD -0.155; TCGA PRAD -0.192; TCGA STAD -0.116; TCGA UCEC -0.244 |
hsa-miR-182-5p | FAT3 | 11 cancers: BLCA; BRCA; COAD; KIRP; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.306; TCGA BRCA -0.354; TCGA COAD -0.463; TCGA KIRP -0.191; TCGA LUAD -0.468; TCGA LUSC -0.479; TCGA OV -0.355; TCGA PAAD -0.475; TCGA PRAD -0.873; TCGA STAD -0.972; TCGA UCEC -0.437 |
hsa-miR-182-5p | RAB31 | 14 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.369; TCGA CESC -0.26; TCGA COAD -0.423; TCGA ESCA -0.148; TCGA HNSC -0.113; TCGA LUAD -0.205; TCGA LUSC -0.36; TCGA OV -0.101; TCGA PAAD -0.42; TCGA PRAD -0.357; TCGA SARC -0.069; TCGA THCA -0.118; TCGA STAD -0.34; TCGA UCEC -0.251 |
hsa-miR-182-5p | FEM1B | 9 cancers: BLCA; CESC; KIRP; LUAD; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.078; TCGA CESC -0.102; TCGA KIRP -0.069; TCGA LUAD -0.053; TCGA PAAD -0.099; TCGA PRAD -0.159; TCGA SARC -0.096; TCGA STAD -0.141; TCGA UCEC -0.157 |
hsa-miR-182-5p | SCN9A | 12 cancers: BLCA; BRCA; COAD; KIRC; KIRP; LUAD; OV; PAAD; PRAD; THCA; STAD; UCEC | mirMAP; miRNATAP | TCGA BLCA -0.251; TCGA BRCA -0.539; TCGA COAD -0.435; TCGA KIRC -0.364; TCGA KIRP -0.513; TCGA LUAD -0.137; TCGA OV -0.423; TCGA PAAD -0.259; TCGA PRAD -0.313; TCGA THCA -0.311; TCGA STAD -0.52; TCGA UCEC -0.245 |
hsa-miR-182-5p | LUZP1 | 10 cancers: BLCA; BRCA; CESC; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; UCEC | mirMAP; miRNATAP | TCGA BLCA -0.076; TCGA BRCA -0.174; TCGA CESC -0.152; TCGA HNSC -0.12; TCGA LGG -0.053; TCGA LUAD -0.152; TCGA LUSC -0.1; TCGA PAAD -0.132; TCGA PRAD -0.164; TCGA UCEC -0.119 |
hsa-miR-182-5p | SIK2 | 9 cancers: BLCA; BRCA; ESCA; KIRP; LIHC; LUAD; LUSC; STAD; UCEC | mirMAP | TCGA BLCA -0.118; TCGA BRCA -0.367; TCGA ESCA -0.155; TCGA KIRP -0.084; TCGA LIHC -0.081; TCGA LUAD -0.077; TCGA LUSC -0.159; TCGA STAD -0.112; TCGA UCEC -0.056 |
hsa-miR-182-5p | PTEN | 12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LIHC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.09; TCGA BRCA -0.099; TCGA CESC -0.101; TCGA ESCA -0.092; TCGA HNSC -0.129; TCGA LIHC -0.066; TCGA LUAD -0.072; TCGA LUSC -0.242; TCGA PAAD -0.092; TCGA PRAD -0.165; TCGA STAD -0.088; TCGA UCEC -0.119 |
hsa-miR-182-5p | IL16 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.309; TCGA BRCA -0.224; TCGA CESC -0.357; TCGA COAD -0.176; TCGA ESCA -0.305; TCGA HNSC -0.224; TCGA KIRC -0.139; TCGA LGG -0.064; TCGA LUAD -0.298; TCGA LUSC -0.483; TCGA OV -0.101; TCGA PAAD -0.413; TCGA PRAD -0.201; TCGA SARC -0.171; TCGA THCA -0.21; TCGA STAD -0.2; TCGA UCEC -0.172 |
hsa-miR-182-5p | ZDHHC14 | 9 cancers: BLCA; BRCA; CESC; ESCA; KIRC; LUAD; LUSC; SARC; UCEC | mirMAP | TCGA BLCA -0.108; TCGA BRCA -0.102; TCGA CESC -0.1; TCGA ESCA -0.18; TCGA KIRC -0.071; TCGA LUAD -0.216; TCGA LUSC -0.183; TCGA SARC -0.11; TCGA UCEC -0.165 |
hsa-miR-182-5p | GNG7 | 12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LUAD; LUSC; OV; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.334; TCGA BRCA -0.192; TCGA CESC -0.254; TCGA ESCA -0.488; TCGA HNSC -0.211; TCGA KIRP -0.079; TCGA LUAD -0.194; TCGA LUSC -0.523; TCGA OV -0.129; TCGA PRAD -0.085; TCGA STAD -0.514; TCGA UCEC -0.455 |
hsa-miR-182-5p | MTHFR | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; UCEC | mirMAP | TCGA BLCA -0.054; TCGA CESC -0.141; TCGA COAD -0.142; TCGA ESCA -0.148; TCGA HNSC -0.129; TCGA KIRC -0.115; TCGA KIRP -0.069; TCGA LUAD -0.069; TCGA LUSC -0.232; TCGA UCEC -0.076 |
hsa-miR-182-5p | SCN4B | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.26; TCGA BRCA -0.48; TCGA CESC -0.276; TCGA COAD -0.363; TCGA ESCA -0.301; TCGA HNSC -0.134; TCGA KIRC -0.301; TCGA KIRP -0.239; TCGA LGG -0.114; TCGA LIHC -0.071; TCGA LUAD -0.469; TCGA LUSC -0.424; TCGA PAAD -0.341; TCGA PRAD -0.369; TCGA STAD -0.52; TCGA UCEC -0.419 |
hsa-miR-182-5p | CHD9 | 10 cancers: BLCA; BRCA; CESC; HNSC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.089; TCGA BRCA -0.159; TCGA CESC -0.14; TCGA HNSC -0.109; TCGA LUAD -0.077; TCGA LUSC -0.112; TCGA PAAD -0.08; TCGA PRAD -0.225; TCGA STAD -0.127; TCGA UCEC -0.178 |
hsa-miR-182-5p | FAM26E | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.433; TCGA BRCA -0.238; TCGA CESC -0.151; TCGA COAD -0.347; TCGA ESCA -0.367; TCGA HNSC -0.21; TCGA KIRC -0.118; TCGA KIRP -0.436; TCGA LUAD -0.301; TCGA LUSC -0.34; TCGA PAAD -0.465; TCGA PRAD -0.214; TCGA SARC -0.199; TCGA STAD -0.199; TCGA UCEC -0.302 |
hsa-miR-182-5p | MAF | 16 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | mirMAP; miRNATAP | TCGA BLCA -0.353; TCGA BRCA -0.31; TCGA CESC -0.276; TCGA COAD -0.281; TCGA HNSC -0.183; TCGA KIRC -0.25; TCGA KIRP -0.285; TCGA LGG -0.062; TCGA LIHC -0.079; TCGA LUAD -0.206; TCGA LUSC -0.141; TCGA OV -0.192; TCGA PAAD -0.278; TCGA PRAD -0.231; TCGA STAD -0.262; TCGA UCEC -0.369 |
hsa-miR-182-5p | GIPC3 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.087; TCGA BRCA -0.132; TCGA CESC -0.12; TCGA COAD -0.166; TCGA ESCA -0.334; TCGA HNSC -0.077; TCGA KIRC -0.258; TCGA KIRP -0.266; TCGA LUAD -0.319; TCGA LUSC -0.426; TCGA OV -0.069; TCGA PAAD -0.138; TCGA PRAD -0.235; TCGA SARC -0.132; TCGA STAD -0.16; TCGA UCEC -0.161 |
hsa-miR-182-5p | MCFD2 | 9 cancers: BLCA; BRCA; ESCA; HNSC; LGG; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.105; TCGA BRCA -0.09; TCGA ESCA -0.051; TCGA HNSC -0.122; TCGA LGG -0.061; TCGA PAAD -0.094; TCGA PRAD -0.113; TCGA STAD -0.075; TCGA UCEC -0.131 |
hsa-miR-182-5p | UNC5C | 14 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.519; TCGA BRCA -0.225; TCGA COAD -0.264; TCGA ESCA -0.52; TCGA HNSC -0.302; TCGA KIRP -0.608; TCGA LGG -0.099; TCGA LUAD -0.26; TCGA LUSC -0.632; TCGA PAAD -0.379; TCGA PRAD -0.514; TCGA THCA -0.224; TCGA STAD -0.126; TCGA UCEC -0.13 |
hsa-miR-182-5p | GJC1 | 12 cancers: BLCA; BRCA; COAD; KIRC; KIRP; LGG; LUAD; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.238; TCGA BRCA -0.126; TCGA COAD -0.282; TCGA KIRC -0.232; TCGA KIRP -0.136; TCGA LGG -0.088; TCGA LUAD -0.155; TCGA PAAD -0.284; TCGA PRAD -0.439; TCGA SARC -0.105; TCGA STAD -0.478; TCGA UCEC -0.363 |
hsa-miR-182-5p | GRIN2A | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.433; TCGA BRCA -0.399; TCGA CESC -0.377; TCGA COAD -0.648; TCGA ESCA -0.751; TCGA HNSC -0.34; TCGA KIRP -0.61; TCGA LGG -0.182; TCGA LUAD -0.229; TCGA LUSC -0.243; TCGA PRAD -0.611; TCGA SARC -0.169; TCGA THCA -0.134; TCGA STAD -0.842; TCGA UCEC -0.465 |
hsa-miR-182-5p | GPR132 | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; THCA | mirMAP | TCGA BLCA -0.339; TCGA CESC -0.121; TCGA COAD -0.176; TCGA ESCA -0.331; TCGA HNSC -0.081; TCGA LGG -0.12; TCGA LUAD -0.096; TCGA LUSC -0.429; TCGA PAAD -0.219; TCGA PRAD -0.156; TCGA THCA -0.139 |
hsa-miR-182-5p | ST6GALNAC3 | 15 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.25; TCGA BRCA -0.371; TCGA CESC -0.215; TCGA ESCA -0.415; TCGA HNSC -0.198; TCGA KIRC -0.231; TCGA KIRP -0.41; TCGA LGG -0.057; TCGA LIHC -0.115; TCGA LUAD -0.201; TCGA LUSC -0.48; TCGA PAAD -0.238; TCGA PRAD -0.289; TCGA STAD -0.273; TCGA UCEC -0.36 |
hsa-miR-182-5p | KCNJ12 | 10 cancers: BLCA; BRCA; COAD; HNSC; KIRP; LUAD; LUSC; PAAD; THCA; UCEC | mirMAP | TCGA BLCA -0.525; TCGA BRCA -0.314; TCGA COAD -0.7; TCGA HNSC -0.208; TCGA KIRP -0.366; TCGA LUAD -0.303; TCGA LUSC -0.523; TCGA PAAD -0.418; TCGA THCA -0.144; TCGA UCEC -0.161 |
hsa-miR-182-5p | SV2B | 13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LUAD; OV; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.573; TCGA BRCA -0.494; TCGA COAD -0.649; TCGA ESCA -0.303; TCGA HNSC -0.308; TCGA KIRP -0.266; TCGA LUAD -0.28; TCGA OV -0.234; TCGA PRAD -0.519; TCGA SARC -0.183; TCGA THCA -0.484; TCGA STAD -0.472; TCGA UCEC -0.362 |
hsa-miR-182-5p | IKZF1 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA | mirMAP | TCGA BLCA -0.371; TCGA BRCA -0.159; TCGA CESC -0.324; TCGA COAD -0.308; TCGA ESCA -0.327; TCGA HNSC -0.316; TCGA LGG -0.084; TCGA LUAD -0.295; TCGA LUSC -0.524; TCGA OV -0.11; TCGA PAAD -0.508; TCGA PRAD -0.102; TCGA SARC -0.165; TCGA THCA -0.463 |
hsa-miR-182-5p | BACE1 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.225; TCGA BRCA -0.178; TCGA CESC -0.103; TCGA COAD -0.126; TCGA ESCA -0.078; TCGA HNSC -0.09; TCGA KIRP -0.103; TCGA LIHC -0.073; TCGA LUAD -0.119; TCGA LUSC -0.134; TCGA PAAD -0.15; TCGA PRAD -0.104; TCGA STAD -0.223; TCGA UCEC -0.116 |
hsa-miR-182-5p | TEAD1 | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | mirMAP; miRNATAP | TCGA BLCA -0.208; TCGA BRCA -0.212; TCGA COAD -0.065; TCGA ESCA -0.083; TCGA HNSC -0.192; TCGA LUAD -0.084; TCGA LUSC -0.088; TCGA PAAD -0.134; TCGA PRAD -0.345; TCGA SARC -0.058; TCGA STAD -0.345; TCGA UCEC -0.182 |
hsa-miR-182-5p | THSD4 | 9 cancers: BLCA; CESC; HNSC; LUAD; LUSC; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BLCA -0.236; TCGA CESC -0.202; TCGA HNSC -0.118; TCGA LUAD -0.237; TCGA LUSC -0.178; TCGA PAAD -0.168; TCGA PRAD -0.439; TCGA THCA -0.085; TCGA STAD -0.276 |
hsa-miR-182-5p | C15orf52 | 11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LUAD; LUSC; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.156; TCGA BRCA -0.126; TCGA CESC -0.212; TCGA ESCA -0.263; TCGA HNSC -0.192; TCGA LUAD -0.238; TCGA LUSC -0.303; TCGA PRAD -0.152; TCGA SARC -0.274; TCGA STAD -0.497; TCGA UCEC -0.207 |
hsa-miR-182-5p | AFAP1 | 11 cancers: BLCA; ESCA; HNSC; KIRC; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.263; TCGA ESCA -0.114; TCGA HNSC -0.09; TCGA KIRC -0.113; TCGA LUSC -0.058; TCGA OV -0.08; TCGA PRAD -0.162; TCGA SARC -0.149; TCGA THCA -0.097; TCGA STAD -0.184; TCGA UCEC -0.126 |
hsa-miR-182-5p | SLC6A17 | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUSC; OV; STAD | mirMAP | TCGA BLCA -0.289; TCGA BRCA -0.124; TCGA CESC -0.361; TCGA COAD -0.392; TCGA ESCA -0.439; TCGA HNSC -0.535; TCGA KIRP -0.259; TCGA LUSC -0.192; TCGA OV -0.222; TCGA STAD -0.33 |
hsa-miR-182-5p | GRIN3A | 10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LUAD; LUSC; OV; PAAD; UCEC | mirMAP | TCGA BLCA -0.202; TCGA BRCA -0.154; TCGA CESC -0.17; TCGA ESCA -0.157; TCGA HNSC -0.176; TCGA LUAD -0.129; TCGA LUSC -0.215; TCGA OV -0.134; TCGA PAAD -0.103; TCGA UCEC -0.132 |
hsa-miR-182-5p | MAFB | 10 cancers: BLCA; BRCA; CESC; COAD; HNSC; LUAD; LUSC; PAAD; SARC; STAD | mirMAP | TCGA BLCA -0.277; TCGA BRCA -0.128; TCGA CESC -0.257; TCGA COAD -0.342; TCGA HNSC -0.247; TCGA LUAD -0.243; TCGA LUSC -0.144; TCGA PAAD -0.341; TCGA SARC -0.111; TCGA STAD -0.237 |
hsa-miR-182-5p | BMPR2 | 11 cancers: BLCA; CESC; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.084; TCGA CESC -0.065; TCGA ESCA -0.116; TCGA HNSC -0.129; TCGA KIRP -0.058; TCGA LUAD -0.149; TCGA LUSC -0.224; TCGA PAAD -0.099; TCGA PRAD -0.106; TCGA STAD -0.12; TCGA UCEC -0.139 |
hsa-miR-182-5p | HLA-DOA | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; THCA; UCEC | mirMAP | TCGA BLCA -0.36; TCGA BRCA -0.171; TCGA CESC -0.349; TCGA COAD -0.313; TCGA ESCA -0.484; TCGA HNSC -0.341; TCGA KIRP -0.1; TCGA LGG -0.199; TCGA LUAD -0.394; TCGA LUSC -0.655; TCGA OV -0.253; TCGA PAAD -0.467; TCGA PRAD -0.285; TCGA THCA -0.582; TCGA UCEC -0.158 |
hsa-miR-182-5p | DPF3 | 13 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; OV; PAAD; STAD; UCEC | mirMAP | TCGA BLCA -0.432; TCGA BRCA -0.398; TCGA CESC -0.144; TCGA ESCA -0.471; TCGA HNSC -0.474; TCGA KIRC -0.177; TCGA LIHC -0.163; TCGA LUAD -0.216; TCGA LUSC -0.412; TCGA OV -0.238; TCGA PAAD -0.311; TCGA STAD -0.168; TCGA UCEC -0.107 |
hsa-miR-182-5p | ITSN1 | 12 cancers: BLCA; BRCA; COAD; HNSC; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.094; TCGA BRCA -0.278; TCGA COAD -0.126; TCGA HNSC -0.09; TCGA LIHC -0.061; TCGA LUAD -0.061; TCGA LUSC -0.112; TCGA PAAD -0.167; TCGA PRAD -0.274; TCGA SARC -0.056; TCGA STAD -0.129; TCGA UCEC -0.118 |
hsa-miR-182-5p | ATP10A | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; THCA; STAD | mirMAP | TCGA BLCA -0.404; TCGA BRCA -0.124; TCGA CESC -0.194; TCGA COAD -0.456; TCGA ESCA -0.367; TCGA HNSC -0.254; TCGA LUAD -0.33; TCGA LUSC -0.752; TCGA PAAD -0.266; TCGA THCA -0.224; TCGA STAD -0.26 |
hsa-miR-182-5p | C17orf51 | 9 cancers: BLCA; BRCA; COAD; LUAD; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.229; TCGA BRCA -0.373; TCGA COAD -0.121; TCGA LUAD -0.075; TCGA PAAD -0.164; TCGA PRAD -0.196; TCGA SARC -0.055; TCGA STAD -0.237; TCGA UCEC -0.23 |
hsa-miR-182-5p | ZNF407 | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.08; TCGA CESC -0.07; TCGA COAD -0.06; TCGA ESCA -0.067; TCGA HNSC -0.097; TCGA KIRC -0.092; TCGA KIRP -0.063; TCGA LUAD -0.076; TCGA PRAD -0.116; TCGA STAD -0.1; TCGA UCEC -0.097 |
hsa-miR-182-5p | PLXNA4 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.677; TCGA BRCA -0.541; TCGA CESC -0.193; TCGA COAD -0.667; TCGA ESCA -0.353; TCGA HNSC -0.182; TCGA KIRP -0.35; TCGA LUAD -0.225; TCGA LUSC -0.528; TCGA PAAD -0.649; TCGA PRAD -0.32; TCGA SARC -0.157; TCGA STAD -0.543 |
hsa-miR-182-5p | TIFAB | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; SARC; THCA | mirMAP | TCGA BLCA -0.334; TCGA CESC -0.312; TCGA COAD -0.24; TCGA ESCA -0.249; TCGA HNSC -0.266; TCGA LUAD -0.282; TCGA LUSC -0.261; TCGA PAAD -0.401; TCGA SARC -0.121; TCGA THCA -0.544 |
hsa-miR-182-5p | CACNB4 | 9 cancers: BLCA; BRCA; KIRP; LUAD; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.317; TCGA BRCA -0.161; TCGA KIRP -0.268; TCGA LUAD -0.207; TCGA PAAD -0.286; TCGA PRAD -0.353; TCGA SARC -0.11; TCGA STAD -0.358; TCGA UCEC -0.169 |
hsa-miR-182-5p | LRCH2 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.446; TCGA BRCA -0.392; TCGA CESC -0.292; TCGA COAD -0.488; TCGA ESCA -0.402; TCGA HNSC -0.291; TCGA KIRP -0.412; TCGA LUAD -0.36; TCGA LUSC -0.532; TCGA OV -0.158; TCGA PAAD -0.393; TCGA PRAD -0.558; TCGA STAD -0.545; TCGA UCEC -0.611 |
hsa-miR-182-5p | VAT1L | 13 cancers: BLCA; BRCA; ESCA; HNSC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.31; TCGA BRCA -0.43; TCGA ESCA -0.443; TCGA HNSC -0.182; TCGA KIRP -0.531; TCGA LUAD -0.291; TCGA LUSC -0.289; TCGA OV -0.15; TCGA PAAD -0.348; TCGA PRAD -0.531; TCGA THCA -0.279; TCGA STAD -0.382; TCGA UCEC -0.363 |
hsa-miR-182-5p | ZFP36L1 | 10 cancers: BLCA; BRCA; CESC; HNSC; LIHC; PAAD; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.128; TCGA BRCA -0.156; TCGA CESC -0.093; TCGA HNSC -0.06; TCGA LIHC -0.065; TCGA PAAD -0.208; TCGA PRAD -0.302; TCGA THCA -0.169; TCGA STAD -0.164; TCGA UCEC -0.109 |
hsa-miR-182-5p | JMJD1C | 14 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.079; TCGA BRCA -0.127; TCGA ESCA -0.157; TCGA HNSC -0.15; TCGA KIRC -0.084; TCGA KIRP -0.067; TCGA LIHC -0.052; TCGA LUAD -0.066; TCGA LUSC -0.225; TCGA PAAD -0.075; TCGA PRAD -0.051; TCGA THCA -0.09; TCGA STAD -0.071; TCGA UCEC -0.153 |
hsa-miR-182-5p | PRKAR1A | 13 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.057; TCGA BRCA -0.052; TCGA CESC -0.062; TCGA ESCA -0.062; TCGA HNSC -0.108; TCGA KIRP -0.052; TCGA LGG -0.051; TCGA LIHC -0.056; TCGA LUAD -0.064; TCGA LUSC -0.118; TCGA PRAD -0.104; TCGA STAD -0.087; TCGA UCEC -0.149 |
hsa-miR-182-5p | MTM1 | 10 cancers: BLCA; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PRAD; THCA; UCEC | miRNATAP | TCGA BLCA -0.098; TCGA HNSC -0.082; TCGA KIRP -0.078; TCGA LIHC -0.074; TCGA LUAD -0.109; TCGA LUSC -0.13; TCGA OV -0.057; TCGA PRAD -0.19; TCGA THCA -0.076; TCGA UCEC -0.112 |
hsa-miR-182-5p | DLG2 | 14 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.202; TCGA BRCA -0.264; TCGA COAD -0.492; TCGA ESCA -0.486; TCGA HNSC -0.346; TCGA KIRP -0.121; TCGA LIHC -0.102; TCGA LUAD -0.147; TCGA LUSC -0.472; TCGA OV -0.188; TCGA PAAD -0.496; TCGA PRAD -0.145; TCGA STAD -0.747; TCGA UCEC -0.316 |
hsa-miR-182-5p | TNS3 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD | miRNATAP | TCGA BLCA -0.112; TCGA BRCA -0.142; TCGA CESC -0.094; TCGA COAD -0.124; TCGA ESCA -0.228; TCGA HNSC -0.237; TCGA KIRP -0.129; TCGA LIHC -0.076; TCGA LUAD -0.224; TCGA LUSC -0.504; TCGA PAAD -0.128; TCGA PRAD -0.127 |
hsa-miR-182-5p | MYO1C | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PRAD; SARC; STAD | miRNATAP | TCGA BLCA -0.088; TCGA BRCA -0.092; TCGA COAD -0.072; TCGA ESCA -0.068; TCGA HNSC -0.067; TCGA LGG -0.052; TCGA LUAD -0.128; TCGA LUSC -0.196; TCGA PRAD -0.114; TCGA SARC -0.087; TCGA STAD -0.13 |
hsa-miR-182-5p | STARD13 | 18 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.412; TCGA BRCA -0.159; TCGA CESC -0.149; TCGA COAD -0.142; TCGA ESCA -0.311; TCGA HNSC -0.214; TCGA KIRC -0.089; TCGA KIRP -0.13; TCGA LGG -0.071; TCGA LIHC -0.123; TCGA LUAD -0.341; TCGA LUSC -0.594; TCGA OV -0.065; TCGA PAAD -0.181; TCGA PRAD -0.171; TCGA SARC -0.057; TCGA STAD -0.281; TCGA UCEC -0.22 |
hsa-miR-182-5p | DAB2IP | 9 cancers: BLCA; BRCA; CESC; HNSC; KIRC; LUAD; LUSC; PRAD; UCEC | miRNATAP | TCGA BLCA -0.076; TCGA BRCA -0.202; TCGA CESC -0.167; TCGA HNSC -0.067; TCGA KIRC -0.079; TCGA LUAD -0.149; TCGA LUSC -0.112; TCGA PRAD -0.261; TCGA UCEC -0.084 |
hsa-miR-182-5p | CCDC88A | 11 cancers: BLCA; BRCA; COAD; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.272; TCGA BRCA -0.267; TCGA COAD -0.262; TCGA HNSC -0.08; TCGA KIRC -0.084; TCGA LUAD -0.196; TCGA LUSC -0.063; TCGA PAAD -0.22; TCGA PRAD -0.366; TCGA STAD -0.182; TCGA UCEC -0.19 |
hsa-miR-182-5p | ITPR1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.334; TCGA BRCA -0.112; TCGA CESC -0.266; TCGA COAD -0.361; TCGA ESCA -0.412; TCGA HNSC -0.179; TCGA KIRP -0.192; TCGA LGG -0.119; TCGA LUAD -0.192; TCGA LUSC -0.383; TCGA PAAD -0.313; TCGA PRAD -0.489; TCGA SARC -0.166; TCGA STAD -0.412; TCGA UCEC -0.391 |
hsa-miR-182-5p | SH3PXD2B | 11 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.183; TCGA BRCA -0.128; TCGA CESC -0.14; TCGA COAD -0.138; TCGA HNSC -0.134; TCGA KIRC -0.091; TCGA PAAD -0.313; TCGA PRAD -0.393; TCGA SARC -0.067; TCGA STAD -0.209; TCGA UCEC -0.065 |
hsa-miR-182-5p | NLGN2 | 9 cancers: BLCA; BRCA; CESC; COAD; PAAD; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.105; TCGA BRCA -0.075; TCGA CESC -0.113; TCGA COAD -0.372; TCGA PAAD -0.241; TCGA PRAD -0.113; TCGA THCA -0.118; TCGA STAD -0.346; TCGA UCEC -0.202 |
hsa-miR-182-5p | CACNA2D1 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; OV; PAAD; PRAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.802; TCGA BRCA -0.501; TCGA CESC -0.347; TCGA COAD -0.68; TCGA ESCA -0.283; TCGA HNSC -0.425; TCGA KIRP -0.38; TCGA LUAD -0.28; TCGA OV -0.217; TCGA PAAD -0.486; TCGA PRAD -0.778; TCGA STAD -0.568; TCGA UCEC -0.542 |
hsa-miR-182-5p | SOX5 | 9 cancers: BLCA; BRCA; COAD; KIRP; LIHC; LUAD; PRAD; THCA; STAD | miRNATAP | TCGA BLCA -0.339; TCGA BRCA -0.442; TCGA COAD -0.265; TCGA KIRP -0.511; TCGA LIHC -0.159; TCGA LUAD -0.338; TCGA PRAD -0.575; TCGA THCA -0.158; TCGA STAD -0.396 |
hsa-miR-182-5p | RHOBTB1 | 10 cancers: BLCA; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; PAAD; PRAD; UCEC | miRNATAP | TCGA BLCA -0.069; TCGA ESCA -0.146; TCGA HNSC -0.164; TCGA KIRC -0.133; TCGA LIHC -0.106; TCGA LUAD -0.079; TCGA LUSC -0.19; TCGA PAAD -0.161; TCGA PRAD -0.161; TCGA UCEC -0.053 |
hsa-miR-182-5p | F13A1 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.601; TCGA BRCA -0.372; TCGA CESC -0.213; TCGA COAD -0.336; TCGA ESCA -0.357; TCGA HNSC -0.532; TCGA KIRP -0.27; TCGA LGG -0.105; TCGA LUAD -0.306; TCGA LUSC -0.573; TCGA OV -0.162; TCGA PAAD -0.619; TCGA PRAD -0.267; TCGA SARC -0.226; TCGA THCA -0.196; TCGA STAD -0.523; TCGA UCEC -0.136 |
hsa-miR-182-5p | FYCO1 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.184; TCGA BRCA -0.067; TCGA CESC -0.116; TCGA COAD -0.151; TCGA ESCA -0.238; TCGA HNSC -0.317; TCGA LGG -0.091; TCGA LUAD -0.099; TCGA LUSC -0.235; TCGA PAAD -0.09; TCGA PRAD -0.256; TCGA SARC -0.077; TCGA STAD -0.343; TCGA UCEC -0.212 |
hsa-miR-182-5p | PDGFRA | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.375; TCGA BRCA -0.488; TCGA CESC -0.317; TCGA COAD -0.351; TCGA ESCA -0.361; TCGA HNSC -0.251; TCGA KIRP -0.46; TCGA LUAD -0.228; TCGA LUSC -0.395; TCGA OV -0.202; TCGA PAAD -0.577; TCGA PRAD -0.349; TCGA THCA -0.672; TCGA STAD -0.166; TCGA UCEC -0.379 |
hsa-miR-182-5p | LAMC1 | 9 cancers: BLCA; BRCA; COAD; KIRC; LGG; PAAD; PRAD; SARC; STAD | miRNATAP | TCGA BLCA -0.209; TCGA BRCA -0.279; TCGA COAD -0.13; TCGA KIRC -0.063; TCGA LGG -0.067; TCGA PAAD -0.208; TCGA PRAD -0.071; TCGA SARC -0.124; TCGA STAD -0.248 |
hsa-miR-182-5p | STAG1 | 9 cancers: BLCA; BRCA; HNSC; KIRP; PAAD; PRAD; SARC; THCA; UCEC | miRNATAP | TCGA BLCA -0.055; TCGA BRCA -0.089; TCGA HNSC -0.081; TCGA KIRP -0.082; TCGA PAAD -0.11; TCGA PRAD -0.156; TCGA SARC -0.051; TCGA THCA -0.097; TCGA UCEC -0.137 |
hsa-miR-182-5p | TSHZ2 | 13 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRP; LIHC; OV; PAAD; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.307; TCGA BRCA -0.565; TCGA CESC -0.284; TCGA COAD -0.497; TCGA HNSC -0.278; TCGA KIRP -0.197; TCGA LIHC -0.086; TCGA OV -0.119; TCGA PAAD -0.31; TCGA PRAD -0.508; TCGA THCA -0.204; TCGA STAD -0.315; TCGA UCEC -0.157 |
hsa-miR-182-5p | PTGER3 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.637; TCGA BRCA -0.239; TCGA CESC -0.509; TCGA COAD -0.672; TCGA ESCA -0.393; TCGA HNSC -0.366; TCGA KIRP -1.122; TCGA LIHC -0.082; TCGA LUAD -0.316; TCGA LUSC -0.493; TCGA OV -0.253; TCGA PAAD -0.433; TCGA PRAD -0.452; TCGA SARC -0.415; TCGA STAD -0.605; TCGA UCEC -0.806 |
hsa-miR-182-5p | CPEB1 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.748; TCGA BRCA -0.406; TCGA CESC -0.252; TCGA COAD -0.713; TCGA ESCA -0.425; TCGA HNSC -0.302; TCGA KIRP -0.316; TCGA LGG -0.063; TCGA LUAD -0.464; TCGA LUSC -0.214; TCGA OV -0.319; TCGA PAAD -0.433; TCGA PRAD -0.722; TCGA SARC -0.148; TCGA THCA -0.167; TCGA STAD -0.837; TCGA UCEC -0.62 |
hsa-miR-182-5p | DAAM1 | 12 cancers: BLCA; CESC; ESCA; HNSC; KIRP; LIHC; LUSC; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.075; TCGA CESC -0.096; TCGA ESCA -0.121; TCGA HNSC -0.15; TCGA KIRP -0.219; TCGA LIHC -0.098; TCGA LUSC -0.165; TCGA PRAD -0.163; TCGA SARC -0.09; TCGA THCA -0.112; TCGA STAD -0.172; TCGA UCEC -0.063 |
hsa-miR-182-5p | ADCY2 | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LGG; OV; PRAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.401; TCGA BRCA -0.282; TCGA COAD -0.595; TCGA ESCA -0.362; TCGA HNSC -0.459; TCGA KIRC -0.259; TCGA LGG -0.071; TCGA OV -0.349; TCGA PRAD -0.32; TCGA STAD -0.767; TCGA UCEC -0.508 |
hsa-miR-182-5p | REEP1 | 11 cancers: BLCA; COAD; ESCA; KIRC; KIRP; LUAD; LUSC; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.568; TCGA COAD -0.359; TCGA ESCA -0.276; TCGA KIRC -0.094; TCGA KIRP -0.246; TCGA LUAD -0.388; TCGA LUSC -0.241; TCGA PRAD -0.418; TCGA SARC -0.162; TCGA STAD -0.718; TCGA UCEC -0.281 |
hsa-miR-182-5p | MYADM | 15 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.512; TCGA BRCA -0.154; TCGA COAD -0.177; TCGA ESCA -0.237; TCGA HNSC -0.18; TCGA KIRC -0.121; TCGA LGG -0.055; TCGA LUAD -0.328; TCGA LUSC -0.582; TCGA OV -0.128; TCGA PAAD -0.143; TCGA PRAD -0.288; TCGA SARC -0.099; TCGA STAD -0.289; TCGA UCEC -0.23 |
hsa-miR-182-5p | RFTN1 | 18 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.238; TCGA BRCA -0.26; TCGA CESC -0.226; TCGA COAD -0.3; TCGA ESCA -0.28; TCGA HNSC -0.177; TCGA KIRC -0.127; TCGA KIRP -0.171; TCGA LGG -0.054; TCGA LUAD -0.154; TCGA LUSC -0.543; TCGA OV -0.091; TCGA PAAD -0.283; TCGA PRAD -0.218; TCGA SARC -0.086; TCGA THCA -0.256; TCGA STAD -0.187; TCGA UCEC -0.305 |
hsa-miR-182-5p | GPRASP2 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; OV; PRAD; UCEC | miRNATAP | TCGA BLCA -0.199; TCGA BRCA -0.205; TCGA CESC -0.107; TCGA COAD -0.12; TCGA ESCA -0.119; TCGA HNSC -0.076; TCGA KIRC -0.094; TCGA KIRP -0.203; TCGA LIHC -0.062; TCGA OV -0.098; TCGA PRAD -0.121; TCGA UCEC -0.364 |
hsa-miR-182-5p | KIF19 | 12 cancers: BLCA; BRCA; CESC; ESCA; KIRC; LGG; LIHC; LUAD; LUSC; OV; PRAD; STAD | miRNATAP | TCGA BLCA -0.395; TCGA BRCA -0.424; TCGA CESC -0.221; TCGA ESCA -0.513; TCGA KIRC -0.226; TCGA LGG -0.154; TCGA LIHC -0.17; TCGA LUAD -0.29; TCGA LUSC -0.616; TCGA OV -0.285; TCGA PRAD -0.163; TCGA STAD -0.252 |
hsa-miR-182-5p | PPP1R12A | 11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LUAD; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.191; TCGA BRCA -0.091; TCGA CESC -0.098; TCGA ESCA -0.128; TCGA HNSC -0.069; TCGA LUAD -0.063; TCGA PAAD -0.095; TCGA PRAD -0.263; TCGA SARC -0.124; TCGA STAD -0.281; TCGA UCEC -0.195 |
hsa-miR-182-5p | GRIA3 | 11 cancers: BLCA; BRCA; CESC; ESCA; KIRP; LUSC; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.449; TCGA BRCA -0.438; TCGA CESC -0.249; TCGA ESCA -0.256; TCGA KIRP -0.364; TCGA LUSC -0.297; TCGA PRAD -0.581; TCGA SARC -0.261; TCGA THCA -0.367; TCGA STAD -0.418; TCGA UCEC -0.549 |
hsa-miR-182-5p | EDNRB | 15 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.225; TCGA BRCA -0.361; TCGA CESC -0.185; TCGA ESCA -0.427; TCGA HNSC -0.249; TCGA KIRC -0.287; TCGA LIHC -0.147; TCGA LUAD -0.483; TCGA LUSC -0.787; TCGA OV -0.121; TCGA PAAD -0.356; TCGA PRAD -0.551; TCGA SARC -0.208; TCGA STAD -0.208; TCGA UCEC -0.357 |
hsa-miR-182-5p | KCNJ2 | 9 cancers: BLCA; BRCA; HNSC; KIRC; LGG; LUAD; PRAD; THCA; UCEC | miRNATAP | TCGA BLCA -0.126; TCGA BRCA -0.367; TCGA HNSC -0.267; TCGA KIRC -0.149; TCGA LGG -0.074; TCGA LUAD -0.302; TCGA PRAD -0.106; TCGA THCA -0.269; TCGA UCEC -0.098 |
hsa-miR-182-5p | MAGEL2 | 12 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRP; LUAD; LUSC; OV; PAAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.149; TCGA BRCA -0.204; TCGA CESC -0.393; TCGA COAD -0.501; TCGA HNSC -0.22; TCGA KIRP -0.444; TCGA LUAD -0.137; TCGA LUSC -0.254; TCGA OV -0.182; TCGA PAAD -0.408; TCGA STAD -0.428; TCGA UCEC -0.476 |
hsa-miR-182-5p | ETS2 | 13 cancers: BLCA; BRCA; CESC; HNSC; KIRC; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; UCEC | miRNATAP | TCGA BLCA -0.071; TCGA BRCA -0.277; TCGA CESC -0.147; TCGA HNSC -0.112; TCGA KIRC -0.165; TCGA LIHC -0.095; TCGA LUAD -0.089; TCGA LUSC -0.17; TCGA PAAD -0.083; TCGA PRAD -0.327; TCGA SARC -0.096; TCGA THCA -0.054; TCGA UCEC -0.109 |
hsa-miR-182-5p | ANTXR2 | 18 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.452; TCGA BRCA -0.397; TCGA CESC -0.254; TCGA COAD -0.14; TCGA ESCA -0.316; TCGA HNSC -0.249; TCGA KIRC -0.061; TCGA KIRP -0.131; TCGA LGG -0.118; TCGA LUAD -0.125; TCGA LUSC -0.437; TCGA OV -0.184; TCGA PAAD -0.145; TCGA PRAD -0.259; TCGA SARC -0.248; TCGA THCA -0.132; TCGA STAD -0.457; TCGA UCEC -0.448 |
hsa-miR-182-5p | RUNDC3B | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.209; TCGA BRCA -0.229; TCGA CESC -0.2; TCGA COAD -0.209; TCGA ESCA -0.375; TCGA HNSC -0.162; TCGA KIRC -0.208; TCGA LIHC -0.275; TCGA LUAD -0.189; TCGA LUSC -0.342; TCGA OV -0.126; TCGA PAAD -0.202; TCGA PRAD -0.203; TCGA STAD -0.395; TCGA UCEC -0.26 |
hsa-miR-182-5p | ZHX1 | 10 cancers: BLCA; BRCA; CESC; HNSC; KIRP; LIHC; LUSC; OV; STAD; UCEC | miRNATAP | TCGA BLCA -0.053; TCGA BRCA -0.135; TCGA CESC -0.13; TCGA HNSC -0.204; TCGA KIRP -0.137; TCGA LIHC -0.051; TCGA LUSC -0.075; TCGA OV -0.054; TCGA STAD -0.059; TCGA UCEC -0.136 |
hsa-miR-182-5p | MEF2D | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUSC; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.171; TCGA CESC -0.124; TCGA COAD -0.131; TCGA ESCA -0.153; TCGA HNSC -0.133; TCGA KIRC -0.096; TCGA KIRP -0.09; TCGA LUSC -0.128; TCGA PRAD -0.09; TCGA SARC -0.057; TCGA STAD -0.174; TCGA UCEC -0.147 |
hsa-miR-182-5p | LMOD1 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.79; TCGA BRCA -0.479; TCGA CESC -0.377; TCGA COAD -0.752; TCGA ESCA -0.619; TCGA HNSC -0.338; TCGA KIRP -0.448; TCGA LIHC -0.153; TCGA LUAD -0.379; TCGA LUSC -0.653; TCGA OV -0.164; TCGA PAAD -0.524; TCGA PRAD -0.668; TCGA SARC -0.536; TCGA STAD -1.084; TCGA UCEC -0.663 |
hsa-miR-182-5p | SCN3A | 11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; OV; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.314; TCGA BRCA -0.624; TCGA CESC -0.218; TCGA ESCA -0.431; TCGA HNSC -0.214; TCGA OV -0.221; TCGA PRAD -0.26; TCGA SARC -0.269; TCGA THCA -0.431; TCGA STAD -0.334; TCGA UCEC -0.242 |
hsa-miR-182-5p | EPM2A | 12 cancers: BLCA; BRCA; ESCA; HNSC; KIRP; LIHC; LUAD; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.249; TCGA BRCA -0.145; TCGA ESCA -0.19; TCGA HNSC -0.18; TCGA KIRP -0.22; TCGA LIHC -0.116; TCGA LUAD -0.173; TCGA PAAD -0.138; TCGA PRAD -0.257; TCGA SARC -0.083; TCGA STAD -0.414; TCGA UCEC -0.194 |
hsa-miR-182-5p | ADAM19 | 15 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.533; TCGA CESC -0.129; TCGA COAD -0.229; TCGA ESCA -0.235; TCGA HNSC -0.226; TCGA KIRP -0.121; TCGA LUAD -0.187; TCGA LUSC -0.255; TCGA OV -0.125; TCGA PAAD -0.308; TCGA PRAD -0.417; TCGA SARC -0.13; TCGA THCA -0.256; TCGA STAD -0.241; TCGA UCEC -0.058 |
hsa-miR-182-5p | SMAD7 | 10 cancers: BLCA; CESC; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; UCEC | miRNATAP | TCGA BLCA -0.14; TCGA CESC -0.08; TCGA ESCA -0.113; TCGA HNSC -0.06; TCGA KIRC -0.112; TCGA LUAD -0.135; TCGA LUSC -0.378; TCGA PAAD -0.095; TCGA PRAD -0.139; TCGA UCEC -0.117 |
hsa-miR-182-5p | EBF1 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.419; TCGA BRCA -0.572; TCGA CESC -0.265; TCGA COAD -0.265; TCGA ESCA -0.355; TCGA HNSC -0.284; TCGA KIRC -0.154; TCGA KIRP -0.335; TCGA LUAD -0.299; TCGA LUSC -0.415; TCGA OV -0.254; TCGA PAAD -0.216; TCGA PRAD -0.298; TCGA THCA -0.095; TCGA STAD -0.385; TCGA UCEC -0.291 |
hsa-miR-182-5p | GRID1 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.194; TCGA BRCA -0.311; TCGA CESC -0.249; TCGA COAD -0.363; TCGA ESCA -0.18; TCGA HNSC -0.146; TCGA LUAD -0.438; TCGA LUSC -0.419; TCGA OV -0.216; TCGA PAAD -0.202; TCGA PRAD -0.347; TCGA THCA -0.171; TCGA STAD -0.497; TCGA UCEC -0.378 |
hsa-miR-182-5p | MAP3K3 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.192; TCGA BRCA -0.175; TCGA CESC -0.154; TCGA COAD -0.232; TCGA ESCA -0.195; TCGA HNSC -0.184; TCGA KIRP -0.051; TCGA LUAD -0.173; TCGA LUSC -0.256; TCGA OV -0.066; TCGA PAAD -0.23; TCGA PRAD -0.127; TCGA SARC -0.09; TCGA THCA -0.088; TCGA STAD -0.238; TCGA UCEC -0.216 |
hsa-miR-182-5p | CADM1 | 10 cancers: BLCA; BRCA; COAD; KIRP; LIHC; LUSC; OV; PAAD; THCA; STAD | miRNATAP | TCGA BLCA -0.139; TCGA BRCA -0.096; TCGA COAD -0.203; TCGA KIRP -0.07; TCGA LIHC -0.113; TCGA LUSC -0.509; TCGA OV -0.096; TCGA PAAD -0.229; TCGA THCA -0.183; TCGA STAD -0.241 |
hsa-miR-182-5p | TOX | 10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LUSC; PRAD; THCA; STAD | miRNATAP | TCGA BLCA -0.426; TCGA BRCA -0.364; TCGA CESC -0.179; TCGA ESCA -0.326; TCGA HNSC -0.177; TCGA KIRP -0.397; TCGA LUSC -0.382; TCGA PRAD -0.212; TCGA THCA -0.388; TCGA STAD -0.411 |
hsa-miR-182-5p | PHLDB1 | 13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.193; TCGA BRCA -0.238; TCGA COAD -0.217; TCGA ESCA -0.161; TCGA HNSC -0.085; TCGA KIRP -0.061; TCGA LUAD -0.066; TCGA LUSC -0.229; TCGA PAAD -0.2; TCGA PRAD -0.182; TCGA SARC -0.065; TCGA STAD -0.227; TCGA UCEC -0.077 |
hsa-miR-182-5p | AMOTL2 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.239; TCGA BRCA -0.296; TCGA CESC -0.132; TCGA COAD -0.122; TCGA ESCA -0.092; TCGA HNSC -0.227; TCGA LIHC -0.064; TCGA LUAD -0.184; TCGA LUSC -0.258; TCGA OV -0.078; TCGA PAAD -0.222; TCGA PRAD -0.29; TCGA STAD -0.083; TCGA UCEC -0.183 |
hsa-miR-182-5p | PRDM1 | 13 cancers: BLCA; BRCA; CESC; HNSC; KIRC; LGG; LUAD; LUSC; OV; PAAD; PRAD; THCA; UCEC | miRNATAP | TCGA BLCA -0.15; TCGA BRCA -0.096; TCGA CESC -0.222; TCGA HNSC -0.15; TCGA KIRC -0.213; TCGA LGG -0.065; TCGA LUAD -0.168; TCGA LUSC -0.171; TCGA OV -0.102; TCGA PAAD -0.287; TCGA PRAD -0.217; TCGA THCA -0.17; TCGA UCEC -0.166 |
hsa-miR-182-5p | PRUNE2 | 14 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LGG; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.966; TCGA BRCA -0.368; TCGA CESC -0.248; TCGA ESCA -0.779; TCGA HNSC -0.701; TCGA KIRC -0.281; TCGA LGG -0.069; TCGA LUSC -0.489; TCGA PAAD -0.326; TCGA PRAD -0.387; TCGA SARC -0.407; TCGA THCA -0.155; TCGA STAD -0.993; TCGA UCEC -0.61 |
hsa-miR-182-5p | RTN4 | 11 cancers: BLCA; BRCA; CESC; HNSC; LIHC; LUAD; LUSC; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.051; TCGA BRCA -0.068; TCGA CESC -0.072; TCGA HNSC -0.106; TCGA LIHC -0.086; TCGA LUAD -0.079; TCGA LUSC -0.069; TCGA PRAD -0.124; TCGA THCA -0.082; TCGA STAD -0.154; TCGA UCEC -0.105 |
hsa-miR-182-5p | PRKD1 | 10 cancers: BLCA; BRCA; COAD; KIRC; LUSC; OV; PAAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.21; TCGA BRCA -0.384; TCGA COAD -0.492; TCGA KIRC -0.07; TCGA LUSC -0.217; TCGA OV -0.179; TCGA PAAD -0.295; TCGA SARC -0.162; TCGA STAD -0.436; TCGA UCEC -0.307 |
hsa-miR-182-5p | VCL | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.251; TCGA BRCA -0.177; TCGA CESC -0.075; TCGA COAD -0.157; TCGA ESCA -0.148; TCGA HNSC -0.143; TCGA KIRP -0.062; TCGA LUAD -0.179; TCGA LUSC -0.157; TCGA PAAD -0.131; TCGA PRAD -0.516; TCGA SARC -0.139; TCGA THCA -0.058; TCGA STAD -0.323; TCGA UCEC -0.181 |
hsa-miR-182-5p | TMOD1 | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.319; TCGA BRCA -0.349; TCGA COAD -0.2; TCGA ESCA -0.354; TCGA HNSC -0.253; TCGA LIHC -0.1; TCGA LUAD -0.193; TCGA LUSC -0.244; TCGA PRAD -0.177; TCGA SARC -0.232; TCGA STAD -0.409; TCGA UCEC -0.218 |
hsa-miR-182-5p | PCDH17 | 13 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.135; TCGA CESC -0.127; TCGA COAD -0.221; TCGA ESCA -0.186; TCGA HNSC -0.113; TCGA KIRC -0.269; TCGA KIRP -0.342; TCGA LUAD -0.324; TCGA LUSC -0.427; TCGA PAAD -0.343; TCGA PRAD -0.157; TCGA STAD -0.139; TCGA UCEC -0.183 |
hsa-miR-182-5p | KLHL2 | 9 cancers: BLCA; BRCA; HNSC; LGG; LIHC; LUAD; LUSC; PRAD; SARC | miRNATAP | TCGA BLCA -0.086; TCGA BRCA -0.146; TCGA HNSC -0.108; TCGA LGG -0.069; TCGA LIHC -0.12; TCGA LUAD -0.06; TCGA LUSC -0.218; TCGA PRAD -0.157; TCGA SARC -0.106 |
hsa-miR-182-5p | RAB11FIP5 | 10 cancers: BLCA; CESC; COAD; HNSC; KIRP; LGG; LUAD; PAAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.11; TCGA CESC -0.127; TCGA COAD -0.107; TCGA HNSC -0.072; TCGA KIRP -0.068; TCGA LGG -0.076; TCGA LUAD -0.08; TCGA PAAD -0.084; TCGA STAD -0.076; TCGA UCEC -0.189 |
hsa-miR-182-5p | PCGF5 | 10 cancers: BLCA; BRCA; ESCA; HNSC; KIRP; LUAD; LUSC; PRAD; THCA; UCEC | miRNATAP | TCGA BLCA -0.109; TCGA BRCA -0.142; TCGA ESCA -0.133; TCGA HNSC -0.086; TCGA KIRP -0.093; TCGA LUAD -0.108; TCGA LUSC -0.144; TCGA PRAD -0.136; TCGA THCA -0.063; TCGA UCEC -0.078 |
hsa-miR-182-5p | MYOCD | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.723; TCGA BRCA -0.428; TCGA CESC -0.471; TCGA COAD -0.539; TCGA ESCA -0.779; TCGA KIRP -0.532; TCGA LUAD -0.513; TCGA LUSC -0.894; TCGA PAAD -0.638; TCGA PRAD -0.901; TCGA SARC -0.445; TCGA STAD -0.938; TCGA UCEC -0.838 |
hsa-miR-182-5p | NR3C1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.349; TCGA BRCA -0.369; TCGA CESC -0.138; TCGA COAD -0.25; TCGA ESCA -0.122; TCGA HNSC -0.131; TCGA KIRP -0.097; TCGA LIHC -0.066; TCGA LUAD -0.094; TCGA LUSC -0.205; TCGA OV -0.09; TCGA PAAD -0.196; TCGA PRAD -0.317; TCGA STAD -0.314; TCGA UCEC -0.414 |
hsa-miR-182-5p | ZNF532 | 11 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; PAAD; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.176; TCGA BRCA -0.133; TCGA CESC -0.151; TCGA COAD -0.214; TCGA HNSC -0.072; TCGA KIRC -0.132; TCGA PAAD -0.274; TCGA PRAD -0.214; TCGA THCA -0.054; TCGA STAD -0.206; TCGA UCEC -0.129 |
hsa-miR-182-5p | CLIC5 | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PRAD; SARC | miRNATAP | TCGA BLCA -0.308; TCGA BRCA -0.433; TCGA COAD -0.161; TCGA ESCA -0.563; TCGA HNSC -0.552; TCGA KIRC -0.212; TCGA KIRP -0.455; TCGA LUAD -0.536; TCGA LUSC -1.065; TCGA PRAD -0.296; TCGA SARC -0.121 |
hsa-miR-182-5p | HDAC9 | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUSC; PAAD; PRAD; SARC; STAD | miRNATAP | TCGA BLCA -0.394; TCGA BRCA -0.283; TCGA COAD -0.216; TCGA ESCA -0.434; TCGA HNSC -0.277; TCGA LUSC -0.23; TCGA PAAD -0.213; TCGA PRAD -0.259; TCGA SARC -0.125; TCGA STAD -0.27 |
hsa-miR-182-5p | TLN1 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.286; TCGA BRCA -0.192; TCGA CESC -0.159; TCGA COAD -0.182; TCGA ESCA -0.205; TCGA HNSC -0.172; TCGA KIRC -0.089; TCGA KIRP -0.077; TCGA LGG -0.054; TCGA LUAD -0.175; TCGA LUSC -0.242; TCGA OV -0.057; TCGA PAAD -0.207; TCGA PRAD -0.298; TCGA SARC -0.14; TCGA STAD -0.33; TCGA UCEC -0.175 |
hsa-miR-182-5p | SDC2 | 14 cancers: BLCA; BRCA; COAD; ESCA; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.329; TCGA BRCA -0.274; TCGA COAD -0.265; TCGA ESCA -0.144; TCGA LGG -0.085; TCGA LIHC -0.105; TCGA LUAD -0.126; TCGA LUSC -0.205; TCGA OV -0.142; TCGA PAAD -0.198; TCGA PRAD -0.208; TCGA SARC -0.065; TCGA STAD -0.293; TCGA UCEC -0.195 |
hsa-miR-182-5p | PCDH10 | 12 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.517; TCGA BRCA -0.209; TCGA CESC -0.208; TCGA HNSC -0.22; TCGA KIRC -0.4; TCGA KIRP -0.565; TCGA LUAD -0.364; TCGA LUSC -0.279; TCGA PAAD -0.349; TCGA PRAD -0.595; TCGA STAD -1.252; TCGA UCEC -0.492 |
hsa-miR-182-5p | MPP1 | 15 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.433; TCGA BRCA -0.23; TCGA CESC -0.219; TCGA ESCA -0.258; TCGA HNSC -0.245; TCGA LGG -0.052; TCGA LUAD -0.233; TCGA LUSC -0.406; TCGA OV -0.095; TCGA PAAD -0.236; TCGA PRAD -0.102; TCGA SARC -0.055; TCGA THCA -0.077; TCGA STAD -0.225; TCGA UCEC -0.221 |
hsa-miR-182-5p | EPHA3 | 16 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.431; TCGA BRCA -0.215; TCGA COAD -0.249; TCGA ESCA -0.41; TCGA HNSC -0.417; TCGA KIRC -0.155; TCGA KIRP -0.397; TCGA LGG -0.099; TCGA LUAD -0.236; TCGA LUSC -0.381; TCGA OV -0.149; TCGA PAAD -0.352; TCGA PRAD -0.41; TCGA THCA -0.257; TCGA STAD -0.504; TCGA UCEC -0.376 |
hsa-miR-182-5p | CACNB2 | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PRAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.365; TCGA CESC -0.291; TCGA COAD -0.161; TCGA ESCA -0.485; TCGA HNSC -0.165; TCGA KIRC -0.163; TCGA LUAD -0.219; TCGA LUSC -0.319; TCGA PRAD -0.151; TCGA STAD -0.683; TCGA UCEC -0.507 |
hsa-miR-182-5p | MAP1A | 13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LUAD; OV; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.534; TCGA BRCA -0.217; TCGA COAD -0.44; TCGA ESCA -0.246; TCGA HNSC -0.2; TCGA KIRP -0.123; TCGA LUAD -0.101; TCGA OV -0.099; TCGA PAAD -0.322; TCGA PRAD -0.574; TCGA SARC -0.102; TCGA STAD -0.548; TCGA UCEC -0.167 |
hsa-miR-182-5p | MRAS | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.35; TCGA BRCA -0.525; TCGA CESC -0.129; TCGA COAD -0.394; TCGA ESCA -0.27; TCGA HNSC -0.342; TCGA LGG -0.055; TCGA LUAD -0.217; TCGA LUSC -0.478; TCGA PAAD -0.448; TCGA PRAD -0.284; TCGA THCA -0.071; TCGA STAD -0.359; TCGA UCEC -0.189 |
hsa-miR-182-5p | EEA1 | 12 cancers: BLCA; BRCA; CESC; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.064; TCGA BRCA -0.121; TCGA CESC -0.164; TCGA HNSC -0.204; TCGA KIRP -0.053; TCGA LUAD -0.078; TCGA LUSC -0.078; TCGA PAAD -0.095; TCGA PRAD -0.103; TCGA SARC -0.108; TCGA STAD -0.093; TCGA UCEC -0.162 |
hsa-miR-182-5p | FBN1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.548; TCGA BRCA -0.228; TCGA CESC -0.261; TCGA COAD -0.458; TCGA ESCA -0.361; TCGA HNSC -0.279; TCGA KIRP -0.151; TCGA LUAD -0.156; TCGA LUSC -0.402; TCGA OV -0.219; TCGA PAAD -0.502; TCGA PRAD -0.34; TCGA SARC -0.114; TCGA STAD -0.294; TCGA UCEC -0.352 |
hsa-miR-182-5p | PDZRN4 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.84; TCGA BRCA -0.362; TCGA CESC -0.316; TCGA COAD -0.975; TCGA ESCA -0.579; TCGA HNSC -0.38; TCGA KIRP -0.414; TCGA LUAD -0.434; TCGA LUSC -0.467; TCGA OV -0.179; TCGA PAAD -0.764; TCGA PRAD -0.708; TCGA SARC -0.29; TCGA THCA -0.509; TCGA STAD -1.269; TCGA UCEC -0.651 |
hsa-miR-182-5p | NCAM1 | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; PRAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.881; TCGA BRCA -0.566; TCGA CESC -0.286; TCGA COAD -0.411; TCGA ESCA -0.57; TCGA HNSC -0.538; TCGA KIRP -0.409; TCGA PRAD -0.762; TCGA STAD -0.743; TCGA UCEC -0.616 |
hsa-miR-182-5p | AFF4 | 9 cancers: BLCA; CESC; ESCA; HNSC; KIRP; LUSC; PRAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.053; TCGA CESC -0.053; TCGA ESCA -0.11; TCGA HNSC -0.165; TCGA KIRP -0.069; TCGA LUSC -0.105; TCGA PRAD -0.073; TCGA STAD -0.119; TCGA UCEC -0.09 |
hsa-miR-182-5p | CHST11 | 10 cancers: BLCA; CESC; COAD; HNSC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.367; TCGA CESC -0.183; TCGA COAD -0.236; TCGA HNSC -0.121; TCGA LUAD -0.242; TCGA LUSC -0.398; TCGA PAAD -0.253; TCGA PRAD -0.364; TCGA STAD -0.096; TCGA UCEC -0.073 |
hsa-miR-182-5p | DOCK1 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUSC; PRAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.098; TCGA BRCA -0.096; TCGA CESC -0.092; TCGA COAD -0.067; TCGA ESCA -0.088; TCGA HNSC -0.105; TCGA KIRC -0.064; TCGA KIRP -0.076; TCGA LUSC -0.096; TCGA PRAD -0.188; TCGA STAD -0.103; TCGA UCEC -0.13 |
hsa-miR-182-5p | SEC14L1 | 9 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC | miRNATAP | TCGA BLCA -0.068; TCGA BRCA -0.188; TCGA COAD -0.109; TCGA ESCA -0.108; TCGA HNSC -0.063; TCGA KIRC -0.16; TCGA KIRP -0.112; TCGA LUAD -0.19; TCGA LUSC -0.113 |
hsa-miR-182-5p | PIK3R1 | 13 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; STAD | miRNATAP | TCGA BLCA -0.078; TCGA BRCA -0.21; TCGA CESC -0.124; TCGA ESCA -0.16; TCGA HNSC -0.245; TCGA KIRP -0.112; TCGA LIHC -0.099; TCGA LUAD -0.154; TCGA LUSC -0.143; TCGA PAAD -0.226; TCGA PRAD -0.311; TCGA SARC -0.091; TCGA STAD -0.195 |
hsa-miR-182-5p | ANK2 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.753; TCGA BRCA -0.521; TCGA CESC -0.288; TCGA COAD -0.55; TCGA ESCA -0.701; TCGA HNSC -0.571; TCGA KIRP -0.67; TCGA LGG -0.092; TCGA LUAD -0.36; TCGA LUSC -0.581; TCGA PAAD -0.344; TCGA PRAD -0.549; TCGA SARC -0.173; TCGA STAD -0.779; TCGA UCEC -0.302 |
hsa-miR-182-5p | NPTX1 | 9 cancers: BLCA; BRCA; COAD; ESCA; KIRP; LUSC; PRAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.204; TCGA BRCA -0.163; TCGA COAD -0.714; TCGA ESCA -0.419; TCGA KIRP -0.27; TCGA LUSC -0.238; TCGA PRAD -0.363; TCGA STAD -1.167; TCGA UCEC -0.17 |
hsa-miR-182-5p | POU2F2 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.348; TCGA BRCA -0.135; TCGA CESC -0.193; TCGA COAD -0.309; TCGA ESCA -0.284; TCGA HNSC -0.116; TCGA LUAD -0.097; TCGA LUSC -0.448; TCGA OV -0.092; TCGA PAAD -0.377; TCGA PRAD -0.376; TCGA SARC -0.097; TCGA THCA -0.331; TCGA STAD -0.187 |
hsa-miR-182-5p | EVI5 | 10 cancers: BRCA; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; PRAD; STAD; UCEC | miRNAWalker2 validate; MirTarget; miRNATAP | TCGA BRCA -0.09; TCGA ESCA -0.082; TCGA HNSC -0.079; TCGA KIRP -0.059; TCGA LGG -0.062; TCGA LUAD -0.067; TCGA LUSC -0.138; TCGA PRAD -0.08; TCGA STAD -0.052; TCGA UCEC -0.094 |
hsa-miR-182-5p | FOXF2 | 9 cancers: BRCA; COAD; ESCA; KIRC; LUAD; LUSC; PAAD; PRAD; STAD | miRNAWalker2 validate; miRNATAP | TCGA BRCA -0.119; TCGA COAD -0.231; TCGA ESCA -0.228; TCGA KIRC -0.253; TCGA LUAD -0.373; TCGA LUSC -0.247; TCGA PAAD -0.242; TCGA PRAD -0.346; TCGA STAD -0.526 |
hsa-miR-182-5p | TTC28 | 10 cancers: BRCA; COAD; ESCA; KIRC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BRCA -0.265; TCGA COAD -0.401; TCGA ESCA -0.155; TCGA KIRC -0.149; TCGA LUAD -0.148; TCGA LUSC -0.099; TCGA PAAD -0.284; TCGA PRAD -0.369; TCGA STAD -0.43; TCGA UCEC -0.118 |
hsa-miR-182-5p | LIMCH1 | 9 cancers: BRCA; COAD; HNSC; KIRP; LGG; LUAD; LUSC; PRAD; STAD | MirTarget; miRNATAP | TCGA BRCA -0.19; TCGA COAD -0.159; TCGA HNSC -0.308; TCGA KIRP -0.121; TCGA LGG -0.072; TCGA LUAD -0.088; TCGA LUSC -0.586; TCGA PRAD -0.15; TCGA STAD -0.237 |
hsa-miR-182-5p | KLF15 | 12 cancers: BRCA; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; PAAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.606; TCGA COAD -0.253; TCGA ESCA -0.36; TCGA HNSC -0.208; TCGA KIRP -0.206; TCGA LIHC -0.181; TCGA LUAD -0.169; TCGA LUSC -0.282; TCGA PAAD -0.266; TCGA SARC -0.139; TCGA STAD -0.77; TCGA UCEC -0.261 |
hsa-miR-182-5p | DOCK9 | 13 cancers: BRCA; CESC; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.086; TCGA CESC -0.104; TCGA HNSC -0.15; TCGA KIRC -0.163; TCGA KIRP -0.076; TCGA LGG -0.053; TCGA LUAD -0.078; TCGA LUSC -0.27; TCGA PAAD -0.082; TCGA PRAD -0.134; TCGA THCA -0.122; TCGA STAD -0.065; TCGA UCEC -0.086 |
hsa-miR-182-5p | SWAP70 | 10 cancers: BRCA; KIRC; LGG; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.123; TCGA KIRC -0.094; TCGA LGG -0.135; TCGA LUAD -0.058; TCGA LUSC -0.122; TCGA PAAD -0.212; TCGA PRAD -0.127; TCGA THCA -0.06; TCGA STAD -0.124; TCGA UCEC -0.071 |
hsa-miR-182-5p | AMT | 9 cancers: BRCA; COAD; ESCA; LGG; LIHC; LUSC; PRAD; THCA; STAD | MirTarget | TCGA BRCA -0.182; TCGA COAD -0.231; TCGA ESCA -0.184; TCGA LGG -0.083; TCGA LIHC -0.156; TCGA LUSC -0.099; TCGA PRAD -0.234; TCGA THCA -0.264; TCGA STAD -0.185 |
hsa-miR-182-5p | GCNT4 | 12 cancers: BRCA; CESC; ESCA; HNSC; KIRP; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.334; TCGA CESC -0.249; TCGA ESCA -0.305; TCGA HNSC -0.237; TCGA KIRP -0.174; TCGA LUAD -0.288; TCGA LUSC -0.366; TCGA PRAD -0.8; TCGA SARC -0.213; TCGA THCA -0.355; TCGA STAD -0.328; TCGA UCEC -0.391 |
hsa-miR-182-5p | PLD1 | 9 cancers: BRCA; CESC; KIRC; KIRP; LGG; LUAD; PRAD; SARC; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.397; TCGA CESC -0.155; TCGA KIRC -0.191; TCGA KIRP -0.083; TCGA LGG -0.104; TCGA LUAD -0.078; TCGA PRAD -0.344; TCGA SARC -0.17; TCGA UCEC -0.158 |
hsa-miR-182-5p | FGD4 | 9 cancers: BRCA; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; PRAD; SARC | MirTarget | TCGA BRCA -0.19; TCGA ESCA -0.192; TCGA HNSC -0.099; TCGA LGG -0.07; TCGA LIHC -0.067; TCGA LUAD -0.145; TCGA LUSC -0.347; TCGA PRAD -0.142; TCGA SARC -0.095 |
hsa-miR-182-5p | DMXL1 | 10 cancers: BRCA; CESC; ESCA; HNSC; KIRP; LUAD; LUSC; PRAD; STAD; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.061; TCGA CESC -0.087; TCGA ESCA -0.161; TCGA HNSC -0.134; TCGA KIRP -0.11; TCGA LUAD -0.101; TCGA LUSC -0.144; TCGA PRAD -0.071; TCGA STAD -0.136; TCGA UCEC -0.103 |
hsa-miR-182-5p | CLCN6 | 12 cancers: BRCA; CESC; COAD; ESCA; KIRC; KIRP; LUAD; LUSC; PAAD; THCA; STAD; UCEC | mirMAP | TCGA BRCA -0.161; TCGA CESC -0.098; TCGA COAD -0.128; TCGA ESCA -0.103; TCGA KIRC -0.147; TCGA KIRP -0.072; TCGA LUAD -0.064; TCGA LUSC -0.145; TCGA PAAD -0.084; TCGA THCA -0.089; TCGA STAD -0.158; TCGA UCEC -0.159 |
hsa-miR-182-5p | FOSL2 | 11 cancers: BRCA; CESC; COAD; HNSC; LUAD; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BRCA -0.088; TCGA CESC -0.126; TCGA COAD -0.108; TCGA HNSC -0.101; TCGA LUAD -0.17; TCGA PAAD -0.195; TCGA PRAD -0.273; TCGA SARC -0.076; TCGA THCA -0.163; TCGA STAD -0.072; TCGA UCEC -0.101 |
hsa-miR-182-5p | ZNF423 | 12 cancers: BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BRCA -0.248; TCGA COAD -0.345; TCGA ESCA -0.373; TCGA HNSC -0.344; TCGA KIRC -0.138; TCGA KIRP -0.133; TCGA LUAD -0.407; TCGA LUSC -0.473; TCGA PAAD -0.32; TCGA PRAD -0.432; TCGA STAD -0.512; TCGA UCEC -0.142 |
hsa-miR-182-5p | MYLK4 | 10 cancers: BRCA; CESC; ESCA; HNSC; KIRC; LUAD; LUSC; PRAD; STAD; UCEC | mirMAP | TCGA BRCA -0.233; TCGA CESC -0.183; TCGA ESCA -0.154; TCGA HNSC -0.318; TCGA KIRC -0.143; TCGA LUAD -0.109; TCGA LUSC -0.194; TCGA PRAD -0.146; TCGA STAD -0.119; TCGA UCEC -0.112 |
hsa-miR-182-5p | CREB3L2 | 9 cancers: BRCA; COAD; ESCA; HNSC; LGG; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BRCA -0.086; TCGA COAD -0.08; TCGA ESCA -0.139; TCGA HNSC -0.061; TCGA LGG -0.054; TCGA PAAD -0.096; TCGA PRAD -0.054; TCGA STAD -0.161; TCGA UCEC -0.122 |
hsa-miR-182-5p | FIGN | 12 cancers: BRCA; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BRCA -0.428; TCGA COAD -0.466; TCGA ESCA -0.501; TCGA HNSC -0.502; TCGA KIRC -0.093; TCGA LUAD -0.213; TCGA LUSC -0.529; TCGA PAAD -0.275; TCGA PRAD -0.232; TCGA SARC -0.158; TCGA THCA -0.141; TCGA STAD -0.496 |
hsa-miR-182-5p | KBTBD12 | 9 cancers: BRCA; ESCA; HNSC; KIRP; LGG; LUSC; PRAD; SARC; STAD | mirMAP | TCGA BRCA -0.574; TCGA ESCA -0.752; TCGA HNSC -0.722; TCGA KIRP -0.355; TCGA LGG -0.152; TCGA LUSC -0.404; TCGA PRAD -0.571; TCGA SARC -0.165; TCGA STAD -0.666 |
hsa-miR-182-5p | ATXN1L | 10 cancers: BRCA; CESC; COAD; HNSC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BRCA -0.143; TCGA CESC -0.084; TCGA COAD -0.083; TCGA HNSC -0.099; TCGA LUAD -0.081; TCGA LUSC -0.053; TCGA PAAD -0.071; TCGA PRAD -0.171; TCGA STAD -0.092; TCGA UCEC -0.116 |
hsa-miR-182-5p | PRTG | 10 cancers: BRCA; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | miRNATAP | TCGA BRCA -0.139; TCGA COAD -0.336; TCGA ESCA -0.24; TCGA HNSC -0.218; TCGA LUAD -0.14; TCGA LUSC -0.635; TCGA PAAD -0.358; TCGA PRAD -0.135; TCGA STAD -0.431; TCGA UCEC -0.353 |
hsa-miR-182-5p | VGLL3 | 15 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BRCA -0.434; TCGA CESC -0.179; TCGA COAD -0.477; TCGA ESCA -0.295; TCGA HNSC -0.351; TCGA KIRP -0.332; TCGA LUAD -0.468; TCGA LUSC -0.747; TCGA OV -0.286; TCGA PAAD -0.502; TCGA PRAD -0.541; TCGA SARC -0.433; TCGA THCA -0.172; TCGA STAD -0.426; TCGA UCEC -0.547 |
hsa-miR-182-5p | ASTN1 | 11 cancers: BRCA; CESC; COAD; ESCA; KIRP; LIHC; LUAD; LUSC; PRAD; STAD; UCEC | miRNATAP | TCGA BRCA -0.536; TCGA CESC -0.229; TCGA COAD -0.596; TCGA ESCA -0.504; TCGA KIRP -0.556; TCGA LIHC -0.133; TCGA LUAD -0.409; TCGA LUSC -0.233; TCGA PRAD -0.649; TCGA STAD -1.084; TCGA UCEC -0.303 |
hsa-miR-182-5p | PDE7B | 17 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BRCA -0.343; TCGA CESC -0.191; TCGA COAD -0.262; TCGA ESCA -0.407; TCGA HNSC -0.259; TCGA KIRC -0.184; TCGA KIRP -0.195; TCGA LGG -0.072; TCGA LIHC -0.104; TCGA LUAD -0.217; TCGA LUSC -0.35; TCGA OV -0.145; TCGA PAAD -0.331; TCGA PRAD -0.448; TCGA SARC -0.141; TCGA STAD -0.591; TCGA UCEC -0.413 |
hsa-miR-182-5p | HMGCLL1 | 9 cancers: BRCA; KIRC; KIRP; LUAD; LUSC; OV; PRAD; STAD; UCEC | miRNATAP | TCGA BRCA -0.201; TCGA KIRC -0.364; TCGA KIRP -0.356; TCGA LUAD -0.287; TCGA LUSC -0.663; TCGA OV -0.275; TCGA PRAD -0.676; TCGA STAD -0.643; TCGA UCEC -0.372 |
hsa-miR-182-5p | GPC3 | 9 cancers: BRCA; KIRP; LGG; LUAD; PAAD; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA BRCA -0.559; TCGA KIRP -0.401; TCGA LGG -0.113; TCGA LUAD -0.318; TCGA PAAD -0.258; TCGA PRAD -0.103; TCGA THCA -0.255; TCGA STAD -0.387; TCGA UCEC -0.201 |
hsa-miR-182-5p | SKAP2 | 9 cancers: BRCA; ESCA; LGG; LUAD; LUSC; OV; THCA; STAD; UCEC | miRNATAP | TCGA BRCA -0.267; TCGA ESCA -0.131; TCGA LGG -0.167; TCGA LUAD -0.074; TCGA LUSC -0.194; TCGA OV -0.091; TCGA THCA -0.219; TCGA STAD -0.125; TCGA UCEC -0.146 |
hsa-miR-182-5p | TCF7L2 | 9 cancers: BRCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PRAD; UCEC | miRNATAP | TCGA BRCA -0.285; TCGA HNSC -0.06; TCGA KIRC -0.067; TCGA KIRP -0.059; TCGA LUAD -0.099; TCGA LUSC -0.154; TCGA OV -0.056; TCGA PRAD -0.076; TCGA UCEC -0.128 |
hsa-miR-182-5p | MFAP3L | 10 cancers: BRCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; STAD | miRNATAP | TCGA BRCA -0.207; TCGA HNSC -0.158; TCGA KIRP -0.152; TCGA LGG -0.113; TCGA LIHC -0.258; TCGA LUAD -0.479; TCGA LUSC -0.176; TCGA PAAD -0.285; TCGA PRAD -0.203; TCGA STAD -0.244 |
hsa-miR-182-5p | CITED2 | 10 cancers: BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; SARC; STAD; UCEC | miRNATAP | TCGA BRCA -0.059; TCGA CESC -0.111; TCGA COAD -0.101; TCGA ESCA -0.228; TCGA HNSC -0.201; TCGA LUAD -0.14; TCGA LUSC -0.424; TCGA SARC -0.145; TCGA STAD -0.309; TCGA UCEC -0.279 |
hsa-miR-182-5p | AHR | 9 cancers: BRCA; KIRC; LGG; LIHC; LUSC; OV; PRAD; SARC; THCA | miRNATAP | TCGA BRCA -0.175; TCGA KIRC -0.064; TCGA LGG -0.056; TCGA LIHC -0.127; TCGA LUSC -0.118; TCGA OV -0.07; TCGA PRAD -0.305; TCGA SARC -0.068; TCGA THCA -0.168 |
hsa-miR-182-5p | TMEM170B | 10 cancers: BRCA; ESCA; HNSC; KIRC; KIRP; LIHC; LUSC; PAAD; STAD; UCEC | miRNATAP | TCGA BRCA -0.223; TCGA ESCA -0.169; TCGA HNSC -0.221; TCGA KIRC -0.052; TCGA KIRP -0.161; TCGA LIHC -0.107; TCGA LUSC -0.151; TCGA PAAD -0.137; TCGA STAD -0.333; TCGA UCEC -0.195 |
hsa-miR-182-5p | FRMD4A | 10 cancers: BRCA; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; STAD | miRNATAP | TCGA BRCA -0.225; TCGA COAD -0.167; TCGA HNSC -0.065; TCGA KIRC -0.061; TCGA KIRP -0.126; TCGA LUAD -0.277; TCGA LUSC -0.255; TCGA PAAD -0.281; TCGA PRAD -0.052; TCGA STAD -0.252 |
hsa-miR-182-5p | CBLN4 | 9 cancers: BRCA; KIRC; LIHC; LUAD; LUSC; OV; THCA; STAD; UCEC | miRNATAP | TCGA BRCA -0.171; TCGA KIRC -0.149; TCGA LIHC -0.417; TCGA LUAD -0.337; TCGA LUSC -0.562; TCGA OV -0.212; TCGA THCA -0.423; TCGA STAD -0.459; TCGA UCEC -0.462 |
hsa-miR-182-5p | BHLHE41 | 12 cancers: BRCA; CESC; COAD; HNSC; KIRC; LGG; LUAD; LUSC; PAAD; PRAD; THCA; STAD | miRNATAP | TCGA BRCA -0.245; TCGA CESC -0.166; TCGA COAD -0.224; TCGA HNSC -0.214; TCGA KIRC -0.133; TCGA LGG -0.103; TCGA LUAD -0.339; TCGA LUSC -0.487; TCGA PAAD -0.124; TCGA PRAD -0.089; TCGA THCA -0.24; TCGA STAD -0.255 |
hsa-miR-182-5p | C3orf58 | 9 cancers: BRCA; KIRC; LIHC; LUAD; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BRCA -0.265; TCGA KIRC -0.06; TCGA LIHC -0.092; TCGA LUAD -0.144; TCGA PAAD -0.162; TCGA PRAD -0.123; TCGA SARC -0.081; TCGA STAD -0.134; TCGA UCEC -0.146 |
hsa-miR-182-5p | NTN4 | 11 cancers: BRCA; CESC; ESCA; HNSC; LIHC; LUAD; LUSC; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BRCA -0.138; TCGA CESC -0.172; TCGA ESCA -0.308; TCGA HNSC -0.295; TCGA LIHC -0.066; TCGA LUAD -0.31; TCGA LUSC -0.438; TCGA PRAD -0.374; TCGA SARC -0.104; TCGA STAD -0.257; TCGA UCEC -0.235 |
hsa-miR-182-5p | TGFBR3 | 13 cancers: BRCA; ESCA; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BRCA -0.484; TCGA ESCA -0.291; TCGA KIRC -0.138; TCGA KIRP -0.169; TCGA LGG -0.08; TCGA LIHC -0.184; TCGA LUAD -0.534; TCGA LUSC -0.162; TCGA PAAD -0.365; TCGA PRAD -0.466; TCGA SARC -0.162; TCGA STAD -0.465; TCGA UCEC -0.424 |
hsa-miR-182-5p | NLGN4X | 11 cancers: BRCA; COAD; HNSC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA BRCA -0.445; TCGA COAD -0.448; TCGA HNSC -0.248; TCGA LUAD -0.277; TCGA LUSC -0.2; TCGA OV -0.142; TCGA PAAD -0.667; TCGA PRAD -0.33; TCGA THCA -0.129; TCGA STAD -0.473; TCGA UCEC -0.157 |
hsa-miR-182-5p | VAT1 | 11 cancers: BRCA; HNSC; KIRC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BRCA -0.068; TCGA HNSC -0.092; TCGA KIRC -0.076; TCGA LUAD -0.143; TCGA LUSC -0.171; TCGA OV -0.053; TCGA PAAD -0.069; TCGA PRAD -0.084; TCGA SARC -0.133; TCGA STAD -0.117; TCGA UCEC -0.115 |
hsa-miR-182-5p | SIK1 | 12 cancers: BRCA; COAD; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA BRCA -0.199; TCGA COAD -0.128; TCGA HNSC -0.128; TCGA KIRC -0.08; TCGA KIRP -0.132; TCGA LIHC -0.141; TCGA LUAD -0.147; TCGA LUSC -0.241; TCGA PRAD -0.364; TCGA THCA -0.148; TCGA STAD -0.115; TCGA UCEC -0.217 |
hsa-miR-182-5p | FREM1 | 9 cancers: BRCA; KIRP; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA BRCA -0.716; TCGA KIRP -0.212; TCGA LUAD -0.247; TCGA LUSC -0.219; TCGA PAAD -0.636; TCGA PRAD -0.285; TCGA THCA -0.48; TCGA STAD -0.604; TCGA UCEC -0.321 |
hsa-miR-182-5p | SBF2 | 10 cancers: BRCA; CESC; HNSC; KIRC; KIRP; LUAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BRCA -0.163; TCGA CESC -0.078; TCGA HNSC -0.101; TCGA KIRC -0.079; TCGA KIRP -0.073; TCGA LUAD -0.072; TCGA PRAD -0.074; TCGA SARC -0.054; TCGA STAD -0.145; TCGA UCEC -0.099 |
hsa-miR-182-5p | MFAP3 | 10 cancers: CESC; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; UCEC | MirTarget | TCGA CESC -0.058; TCGA ESCA -0.089; TCGA HNSC -0.167; TCGA KIRC -0.052; TCGA KIRP -0.055; TCGA LUAD -0.069; TCGA LUSC -0.133; TCGA OV -0.068; TCGA PAAD -0.144; TCGA UCEC -0.051 |
hsa-miR-182-5p | FAR2 | 9 cancers: CESC; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PRAD | MirTarget | TCGA CESC -0.144; TCGA ESCA -0.259; TCGA HNSC -0.172; TCGA KIRC -0.094; TCGA KIRP -0.175; TCGA LGG -0.103; TCGA LUAD -0.4; TCGA LUSC -0.409; TCGA PRAD -0.22 |
hsa-miR-182-5p | ST3GAL1 | 14 cancers: CESC; COAD; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA CESC -0.217; TCGA COAD -0.223; TCGA HNSC -0.127; TCGA KIRP -0.088; TCGA LGG -0.073; TCGA LIHC -0.132; TCGA LUAD -0.183; TCGA LUSC -0.127; TCGA OV -0.237; TCGA PAAD -0.187; TCGA PRAD -0.227; TCGA SARC -0.091; TCGA STAD -0.115; TCGA UCEC -0.14 |
hsa-miR-182-5p | UNC5B | 11 cancers: CESC; COAD; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD | mirMAP | TCGA CESC -0.118; TCGA COAD -0.134; TCGA HNSC -0.078; TCGA KIRC -0.287; TCGA KIRP -0.305; TCGA LGG -0.083; TCGA LUAD -0.19; TCGA LUSC -0.252; TCGA OV -0.135; TCGA PAAD -0.196; TCGA PRAD -0.409 |
hsa-miR-182-5p | MAST4 | 10 cancers: CESC; HNSC; KIRC; KIRP; LUAD; LUSC; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA CESC -0.255; TCGA HNSC -0.241; TCGA KIRC -0.161; TCGA KIRP -0.231; TCGA LUAD -0.122; TCGA LUSC -0.184; TCGA PRAD -0.419; TCGA SARC -0.082; TCGA STAD -0.196; TCGA UCEC -0.115 |
hsa-miR-182-5p | RERE | 10 cancers: CESC; COAD; ESCA; HNSC; KIRP; LUSC; SARC; THCA; STAD; UCEC | miRNATAP | TCGA CESC -0.062; TCGA COAD -0.068; TCGA ESCA -0.143; TCGA HNSC -0.116; TCGA KIRP -0.052; TCGA LUSC -0.083; TCGA SARC -0.066; TCGA THCA -0.055; TCGA STAD -0.13; TCGA UCEC -0.106 |
hsa-miR-182-5p | LRRC55 | 10 cancers: COAD; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; STAD; UCEC | MirTarget | TCGA COAD -0.466; TCGA KIRC -0.304; TCGA KIRP -0.291; TCGA LIHC -0.091; TCGA LUAD -0.226; TCGA LUSC -0.325; TCGA OV -0.211; TCGA PAAD -0.431; TCGA STAD -0.364; TCGA UCEC -0.252 |
hsa-miR-182-5p | UBXN10 | 10 cancers: COAD; ESCA; HNSC; KIRC; LGG; LIHC; LUSC; PRAD; THCA; STAD | miRNATAP | TCGA COAD -0.238; TCGA ESCA -0.61; TCGA HNSC -0.232; TCGA KIRC -0.08; TCGA LGG -0.211; TCGA LIHC -0.292; TCGA LUSC -0.756; TCGA PRAD -0.764; TCGA THCA -0.28; TCGA STAD -0.446 |
hsa-miR-182-5p | PRKCE | 9 cancers: ESCA; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | miRNATAP | TCGA ESCA -0.082; TCGA KIRC -0.08; TCGA KIRP -0.2; TCGA LUAD -0.181; TCGA LUSC -0.272; TCGA PAAD -0.088; TCGA PRAD -0.152; TCGA STAD -0.123; TCGA UCEC -0.103 |
hsa-miR-182-5p | TUSC1 | 9 cancers: HNSC; KIRC; LUAD; LUSC; OV; PAAD; SARC; STAD; UCEC | MirTarget | TCGA HNSC -0.107; TCGA KIRC -0.118; TCGA LUAD -0.086; TCGA LUSC -0.114; TCGA OV -0.102; TCGA PAAD -0.107; TCGA SARC -0.066; TCGA STAD -0.153; TCGA UCEC -0.23 |
Enriched cancer pathways of putative targets